CN102316795B - Body-associated receiver and method - Google Patents

Body-associated receiver and method Download PDF

Info

Publication number
CN102316795B
CN102316795B CN2009801566979A CN200980156697A CN102316795B CN 102316795 B CN102316795 B CN 102316795B CN 2009801566979 A CN2009801566979 A CN 2009801566979A CN 200980156697 A CN200980156697 A CN 200980156697A CN 102316795 B CN102316795 B CN 102316795B
Authority
CN
China
Prior art keywords
receptor
signal
module
data
power
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009801566979A
Other languages
Chinese (zh)
Other versions
CN102316795A (en
Inventor
蒂莫西·罗伯森
法塔内·奥米德瓦
亚沙尔·贝扎迪
劳伦斯·阿恩
肯尼思·罗伯里
詹姆斯·哈奇森
罗伯特·莱希纳
乔治·萨瓦奇
安德鲁·汤普逊
马克·兹德布利克
马克·克赖德勒
霍曼·哈菲奇
罗伯特·达克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Proteus Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Biomedical Inc filed Critical Proteus Biomedical Inc
Priority to CN201210324259.2A priority Critical patent/CN102885615B/en
Publication of CN102316795A publication Critical patent/CN102316795A/en
Application granted granted Critical
Publication of CN102316795B publication Critical patent/CN102316795B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0026Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
    • A61B5/0028Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/30Input circuits therefor
    • A61B5/307Input circuits therefor specially adapted for particular uses
    • A61B5/308Input circuits therefor specially adapted for particular uses for electrocardiography [ECG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/332Portable devices specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B13/00Transmission systems characterised by the medium used for transmission, not provided for in groups H04B3/00 - H04B11/00
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B13/00Transmission systems characterised by the medium used for transmission, not provided for in groups H04B3/00 - H04B11/00
    • H04B13/005Transmission systems in which the medium consists of the human body
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B7/00Radio transmission systems, i.e. using radiation field
    • H04B7/24Radio transmission systems, i.e. using radiation field for communication between two or more posts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0209Operational features of power management adapted for power saving
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0406Constructional details of apparatus specially shaped apparatus housings
    • A61B2560/0412Low-profile patch shaped housings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0462Apparatus with built-in sensors
    • A61B2560/0468Built-in electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055Simultaneously evaluating both cardiovascular condition and temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1112Global tracking of patients, e.g. by using GPS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/282Holders for multiple electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/30Input circuits therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4094Diagnosing or monitoring seizure diseases, e.g. epilepsy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Business, Economics & Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Business, Economics & Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Power Sources (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Electrotherapy Devices (AREA)
  • Prostheses (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.

Description

The receptor related with health
The cross reference of related application
According to 35U.S.C. § 119 (e), the application requires the U.S. Provisional Patent Application serial number 61/122 of December in 2008 submission on the 15th, 723, the U.S. Provisional Patent Application serial number 61/160 of submitting on March 13rd, 2009,289, the U.S. Provisional Patent Application serial number 61/240 of JIUYUE in 2009 submission on the 8th, the U.S. Provisional Patent Application serial number 61/251 that on October 13rd, 571 and 2009 submitted to, the priority of 088 submission day, the disclosure of these patent applications is incorporated this paper by reference into.The application also is the U.S. Patent Application Serial Number 11/912 of submitting on April 28th, 2006, the U.S. Patent Application Serial Number 12/324 that 475 continuation-in-part application and on November 26th, 2008 submit to, 798 continuation-in-part application, the disclosure of these patent applications is incorporated this paper by reference into.
Technical field
The present invention relates to the receptor in the communication system, more specifically, relate to the transfer of data that detects in the electric current be coded in the conducting solution of flowing through and can managing power and control the receptor of dosage.
Background technology
In medical treatment and non-medical use, in many cases, people wish to record individual event, namely are directed to the event of given individuality.People may wish recording needle include, but not limited to the physiological parameter of one or more concern for the example of the medical use of the event of the given individuality generation of---comprising disease symptoms, administration etc.---.People wish that recording needle includes, but not limited to the beginning etc. of absorption (such as for the individuality of keeping on a diet), exercise plan of certain type food for the example of the non-medical use of the event of given individuality.
Because in many cases, people wish to record individual event, so developed multiple diverse ways and technology makes this type of record become possibility.For example, developed log book and technology, wherein for example patient and/or their medical supplier's individuality can come by for example Hand writing or data typing the time and date of recording events.But, still need individual event-monitoring is improved.For example, hand-kept may be consuming time and be made mistakes easily when event occurs.
Summary of the invention
The invention provides can be outside, implantable or half implantable etc. receptor.The aspect of receptor of the present invention comprises and has in following one or more: high power-low power module; Intermediate module; Power module is configured to start and one or more power supply of inactive high power handling piece; Connect main piece and from the serial peripheral interface bus of piece; And Multipurpose connector.Receptor of the present invention can be configured to receive the signal that transmits with electrically conducting manner.The present invention also provides the system that comprises described receptor and the method for using described receptor.
Description of drawings
Fig. 1 is the sketch map for detection of the receptor of the transfer of data of passing through the live body experimenter.
Figure 1A is the block diagram according to the receptor of Fig. 1 of instruction of the present invention.
Figure 1B is the block diagram according to the power management module of the receptor of Figure 1A of instruction of the present invention.
Fig. 2 is the functional block diagram according to the demodulator circuit of the execution coherent demodulation in the be present in receptor of an aspect.
Fig. 3 A illustrates the beacon handover module in the spy cycle of smelling that provides longer than the transmitted signal repetition period.
Fig. 3 B illustrates to provide to have short but smells frequently the beacon handover module in spy cycle, and long hair send bag.
Fig. 3 C illustrates and visits the performed flow chart of smelling the spy process of module according to an aspect by smelling.
Fig. 3 D illustrates the functional block diagram according to the beacon module in the receptor of an aspect.
Fig. 4 illustrates with beacon and frequency dependence and with the beacon function of message and another frequency dependence connection.
Fig. 5 illustrates the functional block diagram according to the ECG sensing module in the be present in receptor of an aspect.
Fig. 6 illustrates according to the functional block diagram that is present in the accelerometer module in the receptor of the present invention on the one hand.
Fig. 7 is the functional block diagram according to the difference in functionality module in the be present in receptor of an aspect.
Fig. 8 is the block diagram according to the receptor of an aspect.
Fig. 9 provides the block diagram according to the high-frequency signal chain in the receptor of an aspect.
Figure 10 is the 3-D view according to the external signal receptor of an aspect.
Figure 11 provides the exploded view according to the signal receiver shown in Figure 10 of an aspect.
Figure 12 provides the exploded view according to the tab member of Figure 10 of an aspect and the signal receiver shown in Figure 11.
Figure 13 A to Figure 13 E provides the various views according to the bipolar electrode external signal receptor of an aspect.
Figure 14 A to Figure 14 D provides the block diagram according to the hardware configuration in the signal receiver shown in be present in Figure 13 A to Figure 13 E of an aspect.
Figure 15 A provides according to an aspect, can how to adopt the sketch map of the system that comprises signal receiver and Ingestible event marker.
Figure 15 B provides from the receptor receiving control information and controls the drug delivery system that dosage is sent.
Figure 16 provides the block diagram that the receptor that is connected with the patient is shown.
Figure 17 provides the block diagram that the receptor that is connected with external charger is shown.
Figure 18 provides the block diagram that the receptor that is connected with data communication equipment with external control is shown.
Figure 19 A-Figure 19 B illustrates the sketch map that comes the router according to an aspect of the present invention of distinguishing signal based on voltage level.
Figure 20 A-Figure 20 C illustrates the sketch map that comes the router according to an aspect of the present invention of distinguishing signal based on frequency.
Figure 21 illustrates the sketch map by the router according to an aspect of the present invention that adopts the active switch distinguishing signal.
The circuit diagram that Figure 22 A-C (totally being called Figure 22) provides multipurpose electrode according to an aspect of the present invention to connect.
Figure 23 A-B (totally being called Figure 23) provides the circuit diagram of the internal electric source piece of outside receptor according to an aspect of the present invention.
Figure 24 A-C (totally being called Figure 24) provides the circuit diagram of the internal electric source piece of outside receptor according to an aspect of the present invention.
Figure 25 provides the sketch map of components/functions relation.
Figure 26 A-B (totally being called Figure 26) provides the circuit diagram of power supply of a plurality of parts that control comprises the receptor of Multipurpose connector that is used for according to an aspect.
Figure 27 provide according to an aspect in the electrode impedance measurement module to the circuit diagram of drive scheme modeling.
Figure 28 provides the circuit diagram of the electrode impedance measurement module of use three line ohmmeters according to an aspect of the present invention.
Figure 29 illustrates the power management module of receptor and the state flow chart of operation.
Figure 30 provides the block diagram according to the hardware accelerator module of an aspect.
The specific embodiment
The invention provides a kind of can be outside or implantable receptor.The aspect of receptor of the present invention comprises one or more the existence in following: high power-low power module; Intermediate module; Power module is configured to start and one or more power supply of inactive high power handling piece; Connect main piece and from the serial peripheral interface bus of piece; And Multipurpose connector.Receptor of the present invention can be configured to receive the signal that transmits with electrically conducting manner.The present invention also provides the system that comprises this receptor and the method for using described receptor.
Receptor of the present invention is to comprise the circuit that is present in the shell and the electric device of logic, and wherein these devices are configured to carry out one or more of medical functions.Term " medical treatment " is used for making a general reference the function for healthy performed any type of live body experimenter such as patient.Therefore, if the device realization receives and the function of the data of one or more parameter correlation of experimenter, then this device is considered to be medical treatment device, and no matter this experimenter is in health status or morbid state.The parameter of paying close attention to comprise hereinafter more detailed description those, such as physiological parameter, come from the signal such as other medical treatment devices such as Ingestible event marker (IEM) devices.Therefore, the medical treatment device of paying close attention to is can be at those medical treatment devices that treatment is used or non-treatment is used in using, for example hereinafter in greater detail those.
In certain embodiments of the present invention, mode that receptor is that size is designed to basically not affect live body experimenter's movement and the function of expectation also is provided during the time period that prolongs---for example signal receiving function---and with for example patient's live body experimenter related device stably.Term " patient " is made a general reference doubtful or is diagnosed as ill or unusual experimenter and healthy experimenter as used in this article.Receptor according to instruction of the present invention can be related with patient's health by any easily mode, for example utilizes adhesive tape or use clip, the collar or band that device is attached on patient's the health or clothes.Alternatively, device can be placed the interlayer of the clothes that the patient wears---for example patient's pocket---.When needed, device can be configured to the constantly time period of related prolongation with the patient, and for example several minutes to the several months.In one embodiment, device can be configured to constantly related week or the longer time with the patient.In some instances, device is configured to directly related with experimenter's local skin position.Aspect other, device is configured to implantable.Because being size, device is designed in the mode of the movement that basically do not affect the live body experimenter the related device stably with the live body experimenter, so when being used for the experimenter for example during the human experimenter, the size of the each side of device will can not have any difference in mobility so that the experimenter experiences it.Therefore, in these areas, the size of described device is designed to make its size and shape can not hinder experimenter's health locomotivity.Device of the present invention can have when putting on the local body position be used to the size that function is provided, for example as mentioned above.In this type of example, device can have 50cm 3Or less cumulative volume, such as 30cm 3Or less, comprise 25cm 3Or less, 20cm for example 3Or less.In some aspects, device has small size, and wherein in some aspects, device occupies about 5cm 3Or less volumetric spaces, according to appointment 3cm 3Or less, comprise about 1cm 3Or less.Device of the present invention can have 30cm or less longest dimension, such as 20cm or less, comprises 15cm or less.
Although the receptor size is little, the time period that device can be worked and be prolonged.So, receptor can work one the week or the longer time, for example two the week or longer, comprise one month or longer, three months or longer, six months or longer, comprise 12 months or longer.For the work in the time period that this prolongation is provided and in view of the small size of receptor, device is configured to low-power consumption.Low-power consumption is that the average power consumption of finger device during 24 hours is mA or less, such as 100 μ A or less, and comprises 10 μ A or less.The average current consumption of receptor is 100 μ A or less when being in standby mode (hereinafter giving more detailed description), such as 10 μ A or less, comprises μ A or less.The average current consumption of the receptor that (hereinafter gives more detailed description) when being in storage mode is 10 μ A or less, such as 1 μ A or less, and comprises 0.1 μ A or less.In some instances, the current drain of receptor is in 3 μ A to the scope of 30mA when being in active state (hereinafter giving more detailed description), to 3mA, and comprises that 30 μ A are to 300 μ A such as 30 μ A.
In some aspects, receptor of the present invention is signal receiver.Signal receiver is the device that is configured to receive from another device signal, and described signal is for example to stride the signal (hereinafter repeating in more detail) that health transmits with electrically conducting manner (trans-body).Be in the situation of signal receiver at receptor, receptor can be configured to receive the signal of Ingestible event marker emission, such as more detailed description hereinafter.
Receptor of the present invention can comprise various module, and these modules are configured to for example to realize carrying out by hardware and/or software the one or more of functions of this device.Module is made of one or more functional device, and these functional device combineds effect are to carry out specific function, and described specific function is the purpose of described module.Given module can be implemented as hardware, software or their combination.Repeat in more detail below the module that can in receptor of the present invention, exist.
The aspect of device comprises high power-low power module.High power-low power module is the module that comprises high power function piece and low power function piece.The low power function piece refers to carry out the functional device of processing and needing low-power consumption and low-power consumption.The low power function piece is carried out at least a independently function---and for example, need the function of non-high-performance treatments, wherein the example of this type of function comprises the signal appearance of maintenance holding state, supervision bus, wait such as interrupt signal etc.What pay close attention to as the low power function piece is to consume 10 μ A or still less and comprise the functional device of 1 μ A or electric current still less.The high power function piece refers to carry out need to be than the functional device of the more high-performance treatments of the large current drain of low power function piece and power consumption.The high power function piece is carried out at least a independently function, as processing the signal that transmits with electrically conducting manner, the physiological data of processing reception etc.Larger computing can relate to such as combine digital signal processing algorithm (such as finite impulse response (FIR) wave filter, fast fourier transform (FFT) etc.).The example of high power function piece is to consume 30 μ A or larger for example 50 μ A or larger electric current in order to carry out the functional device of their appointed function.
Can realize low power function piece and high power function piece with various mode.For example, except other configuration, low power function piece and high power function piece can be implemented on the independent processor or can be implemented as the independent component of SOC(system on a chip) (SOC) structure.The relevant hard-wired further details of paying close attention to hereinafter is provided.The receptor of paying close attention to comprises at least one low power function piece and at least one high power function piece.In some instances, receptor will comprise extra low power function piece and/or high power function piece, to realize as required specific receptor.
Receptor of the present invention can also comprise intermediate module, and described intermediate module is configured to make the high power function piece to circulate between active state and inactive state.Active state refers to one or more of functions that functional device carries out appointment such as demodulation and/or processes the signal that receives, processes the state of physiological data etc.Inactive state refers to that functional device does not have the state in the one or more of functions of carrying out appointment, wherein inactive state can be standby or resting state, for example wherein functional device consumes minimum electric current (such as 1 μ A or less, comprising 0.1 μ A or less) or the functional device off-mode of current sinking not wherein." circulation " refers to that intermediate module is changed the high power function piece between active state and inactive state.In other words, intermediate module transfers the state of high power function piece to inactive from activity, or vice versa.Intermediate module can be according to different inputs, such as predetermined time table (for example being provided by the programming of receptor) or the excitation that applies the high power function piece are circulated between active state and inactive state.In some instances, intermediate module can circulate the high power function piece according to the predetermined time table between active state and inactive state.For example, intermediate module can be per 20 seconds, for example per 10 seconds and comprise per 5 seconds the high power function piece is circulated between active state and inactive state.In some instances, intermediate module can circulate the high power function piece according to the excitation that applies between active state and inactive state, described excitation is such as receiving the signal that transmits with electrically conducting manner, responding one or more predetermined physiological parameter, response user instruction (such as realizing by pressing the action button on the receptor or sending command signal to receptor) etc.
Receptor can be configured to have various states---for example holding state or one or more of active state.Correspondingly, intermediate module can be according to device at the required function of preset time and the high power function piece is circulated between active state and inactive state.Under active state, receptor is carried out one or more of movable functions, as receiving signal, processing signals, transmitted signal, obtain physiological data, processing physiological data etc.Under holding state, receptor consumes minimum current, for example as mentioned above.Under holding state, receptor can be carried out minimum function in order to current drain is reduced to minimum, as keeps configuration, keeps park mode etc.But under holding state, receptor is not carried out need to be more than the function of minimal current consumption.Intermediate module can be according to different inputs, for example aforesaid predetermined time table (for example being provided by the receptor programming) or the excitation that applies and receptor is circulated between active state and holding state.
The receptor of paying close attention to can be configured to carry out strides health electrically conductive signal (such as IEM or intelligent non-intestinal device signal) detection protocol.Such device can be considered as signal receiver.Striding health electrically conductive signal detection protocol is following process: signal receiver is in the state that can receive the signal of being launched by IEM or intelligent non-intestinal device and for example comes processing signals by carrying out one or more task as required, for example signal is deciphered, storage signal, signal is added timestamp and forward signal, as hereinafter in greater detail.
The receptor of paying close attention to such as signal receiver can also be configured to for example carry out the physiological data detection protocol when being in active state, in order to obtain ECG data, accelerometer data, temperature data etc., as hereinafter in greater detail.
With reference now to Fig. 1,, Figure 1A and Figure 1B illustrate an embodiment of receptor of the present invention.Showing receptor 100 is positioned on the live body experimenter 102.Show the left side, middle part that receptor 100 is attached to experimenter 102.But scope of the present invention is not limited to the position of receptor 100 on experimenter 102.
With reference now to Figure 1A,, receptor 100 comprises power subsystem or power supply 200, comprises the operating unit 202 of electrode 202A, operation or processing unit 204 and memory cell 206.Receptor 100 also comprises the power management module 208 of controlling power consumption.Receptor 100 can use transport module 210 to communicate by letter with near other device.In addition, receptor 100 can comprise various features, such as for detection of receptor 100 towards accelerometer.The experimenter lie down or situation about being horizontal under, receptor 100 can detect the persistent period that this position and experimenter remain on this position.
In addition, receptor 100 can also comprise one or more of different physiological parameter sensing functions.The physiological parameter sensing function refers to physiological parameter that sensing is following or the ability of biomarker, include but not limited to the chemical composition of heart rate, breathing rate, temperature, pressure, fluid such as the detection of analytes in the blood, fluidised form, blood flow rate, accelerometer exercise data, IEGM (intracardiac EGM) data etc.
Correspondingly, receptor 100 can comprise the physiological parameter measurement instrument, and described physiological parameter measurement instrument makes receptor can determine that the experimenter lies down or whether the experimenter has suffered from certain disease and make it be in this position.For example, the experimenter may have a heart attack, and receptor 100 can detect this disease and in conjunction with the information of accelerometer 212, receptor 100 can determine that this patient has potential serious disease.Another example can comprise the moment that the patient is tormented by epilepsy.Accelerometer 212 can provide information to receptor 100, and the information that comes from accelerometer 212 will make receptor 100 can determine the occurent disease processed immediately of will needing in conjunction with the physiological parameter of measuring.
With reference now to Figure 1B,, power management module 208 comprises high power operation module 300, middle power operational module 302 and low-power operation module 304.Power management module 208 is controlled the power of the parts that offer receptor 100 via beacon handover module 306.Beacon handover module 306 produces such signal: described signal makes information that power management module 208 can provide according to modules and the unit of receptor 100 that the state of receptor is transformed into the activity off working state to inactive state from active state.
As mentioned above, in the described embodiment of Fig. 1, receptor 100 can be transformed into another kind of state from a kind of state according to the information that environment provides.Under standby or inactive state, receptor 100 is not carried out any movable function and is kept standby.Receptor 100 can be changed between inactive state and other state according to the function of required execution.According to function, the middle power operational module can make receptor 100 circulate between inactive (for example standby) state and active state.For example, when receptor 100 from inactive state be transformed into detect or the activity off working state so that when collecting ECG and/or accelerometer data, intermediate module makes receptor 100 from inactive (for example standby) cycle of states to active state.When receptor 100 was finished collection ECG and accelerometer data, intermediate module made receptor 100 be circulated back to inactive state (for example holding state), and receptor 100 turns back to inactive state.
When being transformed into from inactive state, receptor 100 smells spy (sniff) state so that scanning data transfer signal relevant with emission of ions---be used for come generation current to be encoded as its a part of transfer of data---(for example uses and smell the spy module for movable inoperative situation, such as more detailed description hereinafter) or during the detection of the transfer of data relevant with radio communication, intermediate module makes receptor 100 from inactive (such as standby) cycle of states to the activity off working state.If receptor 100 receives signal in this scanning or during smelling spy, then receptor 100 enters the active operation state, and the high power operation module 300 of Figure 1B provides all operations unit 202 from high power to Figure 1A, processing unit 204 and memory cell 206.Then, receptor 100 is processing signals under the active operation state, for example, signal is carried out demodulation, signal is added timestamp and storage signal, as hereinafter in greater detail.When receptor 100 was finished processing to signal, power management module 208 made receptor 100 be circulated back to inactive state (such as holding state), and receptor 100 turns back to inactive state.
In some respects, scan the data transfer signal of the communication module in the experimenter 102 who comes from Fig. 1, such as activity off working state 130, receptor 100 does not need high power to be recycled to the activity off working state.In this type of situation, before detecting for the signal of separating mediation decoding, there is not high power requirements.
According to instruction of the present invention, the signal receiver aspect of receptor 100 can be configured to receive the signal that transmits with electrically conducting manner.The signal that transmits with electrically conducting manner can be the signal that any physiology part by health transmits with electrically conducting manner, or come from use by from the solid to the conducting solution or the emission of ions of the controlled delivery quality of fluid transmit the signal of the device of signal with electrically conducting manner through health.Described signal can be by emission of ions module or Ingestible event marker (IEM) or intelligent non-intestinal delivery system generation.The Ingestible event marker of paying close attention to comprises those Ingestible event markers of describing in the following patent documentation: the PCT patent application serial numbers PCT/US2006/016370 that is disclosed as WO/2006/116718; Be disclosed as the PCT patent application serial numbers PCT/US2007/082563 of WO/2008/052136; Be disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO/2008/063626; Be disclosed as the PCT patent application serial numbers PCT/US2007/022257 of WO/2008/066617; Be disclosed as the PCT patent application serial numbers PCT/US2008/052845 of WO/2008/095183; Be disclosed as the PCT patent application serial numbers PCT/US2008/053999 of WO/2008/101107; Be disclosed as the PCT patent application serial numbers PCT/US2008/056296 of WO/2008/112577; Be disclosed as the PCT patent application serial numbers PCT/US2008/056299 of WO/2008/112578; And the PCT patent application serial numbers PCT/US2008/077753 that is disclosed as WO/2009/042812; The disclosure of these patent applications is incorporated this paper by reference into.The non-intestinal delivery system of intelligence is described in being disclosed as the PCT patent application serial numbers PCT/US2007/015547 of WO 2008/008281; Aforementioned each apply for that disclosed full text incorporates this paper by reference into.
Because the receptor of these aspects is configured to receive the data in the electric current that is coded in the conductor fluid of flowing through, so receptor uses the live body of associated as telecommunication media with the device (such as IEM) that transmits.In order to adopt the signal telecommunication media of health, body fluid plays the effect of conductor fluid, and patient's health is as the conductive media of communication.Therefore, at ion launcher and any other sender unit and receptor---such as the receptor 100 of Fig. 1---between the health transmission of signal by experimenter 102 of transmission.The signal that transmits with electrically conducting manner of paying close attention to can adopt skin and other bodily tissue that is transmitted through experimenter's health through the form of alternating current (a.c.) signal of bodily tissue conduction, and receives from the skin of experimenter's health and other bodily tissue and to pass the signal that transmits with electrically conducting manner of paying close attention to.Therefore, do not need between the device that transmits and receptor, this type of receptor need not any additional cable or hard wire connects.
Because signal receiver is configured to receive the signal that transmits with electrically conducting manner, so can comprising, signal receiver strides health conductive electrical communication module.Stride health conductive electrical communication module and be and be configured to receive the signal that transmits with electrically conducting manner such as the functional module by the signal of IEM emission.When needed, striding health conductive electrical communication module can be realized by high power function piece as indicated above.In some instances, striding the signal that health conductive electrical communication module is configured to receive is encoded signal, described encoded signal refers to adopt certain mode (for example, the agreement of use such as binary phase shift keying (BPSK), frequency shift keying (FSK), amplitude shift keying (ASK) etc.) through the signal of ovennodulation.In this type of example, receptor and stride health conductive electrical communication module and be configured to the encoded signal that receives is for example deciphered by the signal of Ingestible event marker emission.Receptor can be configured in low signal-to-noise ratio (SNR) environment of substantial noise for example also may be arranged except the signal of paying close attention to, and for example has in the environment of 7.7dB or lower SNR, and encoded signal is deciphered.Receptor can also be configured to not have in fact error code ground that encoded signal is deciphered.In some aspects, signal receiver has high coding gain, and for example scope at the coding gain of 8dB to 10dB, comprises the coding gain of 9dB such as scope at the coding gain of 6dB to 12dB.The signal receiver of aspect of the present invention can not have in fact error code ground, for example with 10% or less error code, comes encoded signal is deciphered.
Aspect these of the Signal coding that will receive, such as being in the situation of IEM signal of coding at the signal that receives, stride health conductive electrical communication module and can be configured to process with at least a demodulation agreement the signal of reception, wherein stride health conductive electrical communication module can be configured to utilize as required two or more, three kinds or signal more kinds of, that four kinds or more kinds of etc. different demodulation agreements are processed reception.When the different demodulation agreements that adopt two or more are processed the signal of given coding, these agreements are simultaneously or in a sequence carried out.Can process with any easily demodulation agreement the signal of reception.The demodulation agreement of paying close attention to includes but not limited to: demodulation (for example for Costas loop (Costas Loop), as be disclosed as described in the PCT patent application serial numbers PCT/US07/024225 of WO 2008/063626, its disclosure is incorporated this paper by reference into); Coherent demodulation (for example, as be disclosed as described in the PCT patent application serial numbers PCT/US07/024225 of WO 2008/063626, its disclosure is incorporated this paper by reference into); Accurate low expense iterative demodulation (for example, as be disclosed as described in the PCT patent application serial numbers PCT/US07/024225 of WO 2008/063626, its disclosure is incorporated this paper by reference into); Non-coherent demodulation; And differential coherent demodulation.
In some instances, adopt the coherent demodulation agreement.The coherent demodulation module that can adopt in aspect receptor includes but not limited to those coherent demodulation modules of describing among the PCT patent application serial numbers PCT/US2007/024225, and its disclosure is incorporated this paper by reference into.
In some instances, adopt the differential coherent demodulation agreement.Differential coherent demodulation compares the phase place at phase ortho position in binary phase shift keying (BPSK) modulation signal.For example, 11001010 8 bit binary code will produce 0101111 differential signal.Because this technology is utilized the phase contrast between the phase ortho position, so compare with the coherent demodulation scheme, it is more healthy and strong inherently to signal frequency unstability and frequency displacement.
Coherent demodulation
In certain embodiments, carry out the BPSK demodulation that has AWGN (additive white Gaussian noise), in order to use coherent demodulation that BER (bit error rate) is down to minimum.
In these embodiments, emitter makes things convenient for the coherent demodulation process of receptor by transmission preamble carrier in " forward position (the front porch) " of each burst of BPSK modulation in the body.This agreement provides the stable carrier wave of double amplitude and the fixed phase corresponding with the transmission of 0 bit.The existence in forward position gives receptor useful certification mark, and gives a large amount of carrier cycles to be used for accurately estimating carrier frequency and phase place.
Other practical application is the derivation that comes reducible data speed with carrier frequency.The signal that sends is formatted as the data clock frequency is divided exactly by carrier frequency.In case carrier acquisition is finished like this, just can realize easily and fast data clock collection.
In certain embodiments, receptor is sampled to the signal that arrives with about 4 times of speed to carrier frequency.With this signal and DDS (direct digital synthesiser) mixing that is set to nominal carrier frequency to produce complex radical band (real component and imaginary component).The output of frequency mixer is carried out low-pass filtering and extracted sampling (decimate).The low pass filter bandwidth must be enough wide in case in the frequency band due to and frequency hopping uncertain because of carrier oscillator are shaken (frequency hopping dither) capture frequency.The frequency of BPSK is near the 0Hz and have+/-20% frequency accuracy subsequently.
Receptor asks complex radical band bpsk signal square to produce strong frequency multiplication line.Rising edge signal and the modulation of BPSK subsequently all help the formation of this line.The multiple time-domain signal that uses FFT (fast fourier transform) will ask square transforms to frequency domain.The peak energy interval is identified as 2 * carrier frequency.With this frequency divided by 2 to use 1024 FFT that the estimation of the carrier shift frequency of about 0.1% precision is provided.
Then with complex baseband signal again with the deviation frequency mixing of determining.Result after the narrow-band low pass filtering is centered by 0Hz and has the multiple bpsk signal of 0.1% precision.The bandwidth of narrowband low-pass filter is corresponding with a half-band width of bpsk signal.
Then extract rising edge signal.Phase place (phi=arctan (imaginary/real)) by at first calculating all sample points in the forward position, then use the least mean square fit of straight line is estimated that phi determines this frequency shift (FS) to the slope of time.The slope of straight line is corresponding to residual frequency offset.Then for the third time the complex baseband signal mixing is higher than 0.01% precision to remove this frequency shift (FS) and to have.
Then the complex signal forward position is got average to determine average imaginary values and value of real part.Arctan (average imaginary part/average real) obtains the forward position phase place.Make on the BPSK imaginary axis ahead of the curve and rotate with 270 degree based on this phase calculation coefficient of rotary.
Then to whole rotation bpsk signal carry out getting for the second time average identifying the centers of gravity (data=1) of 90 degree, and in a similar manner with the BPSK rotation so that this center of gravity is placed on the imaginary axis.Then with empty signal wave elimination (sliced) to extract data.
Utilization by the data clock that pre-determines and the priori of the integer quotient of carrier frequency and data clock frequency dependence is derived of carrier frequency come the gating slicing data.
In the embodiment of above-mentioned agreement, suppose the persistent period of running through whole burst, carrier frequency keeps enough precision in frequency and phase place.
Include but not limited to those coherent demodulation modules of describing among the PCT patent application serial numbers PCT/US2007/024225 aspect the coherent demodulation module that can in the enforcement of receptor, adopt; Its disclosure is incorporated this paper by reference into.Accurate low expense iterative decoding
In certain embodiments, receptor comprises the interactive decoder (interactive decoder) of accurate low expense, and this paper is also referred to as the communication decoder.The communication decoder provides highly accurately communication in simple, good and cost-effective mode, although there is the significant signal distortion that causes because of noise and other factors.The communication decoder utilizes error correcting code and simple iterative process to obtain decode results.The communication decoder can make to realize cheaply high coding gain in multiple and various application.
Broadly, an embodiment of communication decoder provides the decoding ability of data communication.An embodiment of communication decoder provides the high coding gain with minimal-overhead.In some instances, communication decoder help to make message transmission rate near theoretic maximum, be shannon limit (Shannon Limit), simultaneously processing expenditure is dropped to minimum.Low expense has been guaranteed cost-benefit realization.Various embodiment of the present invention comprises hardware, software and circuit.
The various embodiment of the communication decoder of innovation of the present invention use error correcting code and simple and unique process with " impelling " measuring-signal relevant with the position of makeing mistakes towards the measuring-signal of being correlated with correct raw bits, thereby improve the probability of the destination data of identification and originating point place coded data coupling, and improve significantly the data accuracy that purpose is located in.This simple and unique process helps efficient realization.The low expense relevant with simple and unique process drops to minimum with cost.The iteration communication decoder of the application of the invention, LDPC decoding does not far have so complicated.
Generally speaking, decoder module produces the data of decoding by the modification of following technology.For each hyte of coded data, if there is no noise, one group of signal of measuring that then will be relevant with coded data are rounding near most probable measurement, for example are rounding to immediate transmitted symbol.Convert this group transmitted symbol to one group of hard code decision value.The hard code of this group decision value is carried out error detection.Result based on the error detection of this being organized hard code decision value adjusts signal of this group measurement.Take turns in the signal group of all measurements of coded data, to carry out abovementioned steps, until satisfy predetermined stop condition.Include but not limited to the accurately low expense iteration decoding module of those that describe among the PCT patent application serial numbers PCT/US2007/024225 aspect the accurate low expense iteration decoding module that can in the embodiment of receptor, adopt; Its disclosure is incorporated this paper by reference into.
Forward error correction
In certain embodiments, receptor is configured to use with emitter in the body that adopts FEC (forward error correction), so that the anti-additional gain that comes from the interference of other unwanted signal and noise to be provided.Error correction is simple in emitter and receptor, and high coding gain is provided.This function uses single-parity check product code and novel SISO (soft advance soft go out) iterative decoding algorithm to realize.
Emitter by with message by the row and column arrangement with message coding.Every row has additional parity bit, and same every row have additional parity bit.For example, 100 bit message can be arranged in 10 * 10 bit-array.Add parity check bit to create 11 * 11 final bit-array that to use subsequently BPSK to transmit at channel.For the gain that obtains to add, can use additional dimension, arrange message and check bit if for example create cube, then use three-dimensional.
Receptor deciphers to realize high coding gain by iterative process with message.Preserve to each bit sample and with " soft " form.Suppose that desirable sample (that is, the hard decision point) is-1 and+1 by being returned to format, then the bit of reception will for example fall into say-2.0 and+scope between 2.0.All samples are carried out hard decision, and carry out even-odd check.If row or column has parity error, then the sample with row or column repels from corresponding hard decision point by little increment.If row or column does not have parity error, then by little increment the sample of row or column is absorbed corresponding hard decision point.Use the appropriate increment of selecting, based on required channel SNR (signal to noise ratio), ten times iteration usually is enough to realization to the coding gain of the 8dB to 10dB of AWGN (additive white Gaussian noise).The method is easy to be embodied as program DSP or the FPGA/ASIC logic of storage.Under given specific coding speed, it also drops in the 1dB or 2dB of shannon limit of forward error correction.
Include but not limited to aspect the forward error correction block that can in the embodiment of receptor, adopt, be disclosed as those forward error correction block of describing among the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/063626; Its disclosure is incorporated this paper by reference into.
The beacon function module
Various aspects can adopt the beacon function module.In all fields, the beacon function submodule can adopt such as in the lower module one or more: the signaling module of beacon wake module, beacon signal module, ripple/frequency module, multi-frequency module and modulation.
It is relevant such as beacon communication channel, beacon agreement etc. beacon function module and beacon can be communicated by letter.For the purpose of this disclosure, the signal that normally sends as the part of message of beacon or be used for amplification message and the signal (sometimes being called " beacon signal " herein) that sends.These beacons can have the feature of good definition, such as frequency.Can easily detect beacon in noise circumstance, and beacon can be for smelling the trigger use of visiting circuit, aforesaid those are smelt the spy circuit.
In one aspect, the beacon function module can comprise the beacon wake module with arousal function.Arousal function only generally comprise during special time such as for the short time period of specific purpose just with high-power mode work so that such as the function that receives signal etc.Receptor important consideration partly for system is that it should be lower powered.This feature can be to have superiority in the receptor of implanting, in order to support the long-acting power supply that small size keeps battery simultaneously.The beacon wake module can realize these advantages in the very limited time period with high-power mode work by making receptor.This phase shorter workweek can provide optimum system dimension and energy expenditure feature.
In practice, this receptor can periodically and with low energy consumption " wake up ", in order to carry out " smell and visit function " by for example smelling the spy circuit.For purposes of this application, term " is smelt and is visited function " and refers generally to for the of short duration low power function of determining whether emitter exists.Visit Function detection to launcher signal if smell, then device can be transformed into the communication decoding mode of higher-wattage.If there is no launcher signal, then receptor can return and for example turn back to immediately park mode.In this way, when not having launcher signal, then can save energy during relatively long-time section, and when have launcher signal, high power capacity can be used for efficient decoding mode and operates during short time relatively.
Smell the spy circuit for operation, various modes and make up available.By the demand of concrete system is visited the Circnit Layout coupling with smelling, can realize the system that optimizes.
The other example of beacon function module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
The frequency hopping function module
Various aspects can adopt the frequency hopping function module.Can the frequency hopping function module is relevant with specific communication channel, frequency hopping agreement etc.Therefore, various aspects can adopt one or more frequency hopping agreement.For example, receptor can be searched for the designated frequency range that transmission may drop on, for example two or more different frequencies.When realizing a correct decoding, emitter has just been finished the task of its digital information payload being sent to receptor in the body.
The frequency uncertainty of the transmission that for example provides via module at random by random frequency hopping in some instances, can produce a plurality of benefits.An example of this communication protocol is FHSS communication (FHSS).FHSS is that a kind of use all is known pseudo-random sequences for emitter and receptor, by between a plurality of frequency channels rapidly switched carrier send the method for radio signal.For example, a such benefit for example, can easily realize at little bare chip.Illustrate, emitter carrier frequency agitator may be the agitator that is easy to coarse free-running operation that the sub-fraction at the bare chip of 1mm realizes in the body.Degree of accuracy approximately+/-20 is easy to obtain.This is because receptor proportion searching algorithm.
Another benefit like this is the service life that can prolong battery.Illustrate, the life period of emitter battery for example 3 to 10 minutes, because random frequency hopping, can improve significantly emitter at the probability of clear channel (clear channel) transmission that can be received by the receptor of frequency agility.
Another benefit is in the high power capacity environment collision event to be minimized.Illustrate, in a plurality of bodies emitter when for example Ingestible event marker may send simultaneously for example a plurality of Ingestible event markers simultaneously or the collision probability in the situation about within the very approaching time, being ingested be reduced to minimum.In other words, do not having in the situation of frequency hopping function, similar batch Ingestible event marker will send and cause in identical (or almost identical) frequency the probability possibility height of a plurality of conflicts.
In some aspects, the usable spectrum that uses in volume conduction is used is the scope from about 3kHz to 150kHz.By detailed zooscopy, found that in some environment having scope emitter (seeing above) in the body of the received signal level of 1 to 100 μ V can compete with hundreds of approximately narrow-band interference signals to thousands of μ V in same frequency spectrum.Destructiveness for the mitigate interference signal, can adopt frequency hopping channel or agreement, wherein emitter will send randomly frequency hopping of signal such as binary phase shift keying (BPSK) signal that signal that the arrowband of output sends for example modulates or fsk signal at every turn in the body.
The other example of frequency hopping module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
Functional module is avoided in conflict
Various aspects can adopt conflict to avoid functional module.Conflict can be avoided functional module relevant with specific communication channel, collision avoidance protocol etc.Therefore, various aspects can be utilized the various collision avoidance protocol technology relevant with specific communication channel.Particularly useful in the environment of collision avoidance technique emitter within for example having two or more bodies (for example a plurality of IEM of individual absorption).In this environment, if each individual interior emitter continues to send their signal, then the transmission of an emitter may mask off the transmission of emitter in all other bodies.The situation that therefore, can't detect signal may significantly increase.
Various aspects can comprise multiple method for collision avoidance individually or in the multiple combination mode.
A kind of such method adopts a plurality of transmission frequency.By the frequency of utilization selective filter, even in the situation about sending at the same time, also the emitter that sends at f1 and the emitter zone that sends at f2 can be separated.
The other example of collision avoidance module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
Physiological sensing
Except receiving the signal that transmits with electrically conducting manner, outside the signal that for example evaluator of Ingestible event marker is launched, signal receiver can also comprise one or more of different physiological parameter sensing functions.The physiological parameter sensing function refers to that sensing is following but is not limited to following physiological parameter or the ability of biomarker: electrocardiogram (ECG) data comprises heart rate and electrocardiogram (ECG) etc.; Breathing rate, temperature; Pressure; The chemical composition of fluid such as the detection of analytes in the blood, fluidised form, blood flow rate, accelerometer exercise data etc.Have at signal receiver in the situation of physiological parameter or biomarker sensing function, the different parameter that signal receiver can sensing or the quantity of biomarker can be different, such as 1 or more, 2 or more, 3 or more, 4 or more, 5 or more, 10 or more etc.Term " biomarker " refers to anatomical parameters, physiological parameter, biochemical parameter or the molecular parameter relevant with seriousness with the existence of particular disease states.Biomarker can detect and measure by the whole bag of tricks, and these methods comprise physical examination, experimental determination and medical imaging.According to specific embodiment, signal receiver can use signal receiving element, for example use the electrode of the receptor that is used for signal reception and sensing application, realize one or more of in these sensing functions, perhaps signal receiver can comprise one or more the different sensing element that is different from signal receiving element.Can exist at signal receiver the quantity of the different sensing element of (or being attached thereto at least) can be different, and can be 1 or more, 2 or more, 3 or more, 4 or more, 5 or more, 10 or more etc.
In certain embodiments, signal receiver comprises bifunctional a group 2 or the more electrode that signal reception and sensing are provided, such as 2 or 3.For example, except receiving signal, electrode also can have extra sensing function.In certain embodiments, produce ECG data with electrode.From above-mentioned data, can finish many kinds and process, for example detect various cardiac events, such as heart beating overrun, ventricular fibrillation, heart rate etc.The ECG data that obtains can be used in titration of medicines, or is used for the great change on detecting heart rate or the rhythm of the heart or warns when significantly unusual.Among some embodiment, at the heart rate that is used for monitoring the patient who does not have pacemaker, or come monitor heart rate for the patient of holter (Holter) monitor of the mancarried device of the electrical activity that may be usually need to be used for continuing to monitor in 24 hours heart or other device or cardiac event monitor as alternative, these data also are helpful.The recording period that prolongs is for finding that impalpable sporadic arrhythmia is helpful in the short period section.
As mentioned above, can adopt two or more different demodulation agreements to come the given signal that receives is deciphered.In some instances, can adopt simultaneously coherent demodulation agreement and differential coherent demodulation agreement.Fig. 2 provides according to an aspect of the present invention receptor can how to carry out the functional block diagram of coherent demodulation agreement.Should be noted that the part that receptor only is shown among Fig. 2.Determine carrier frequency (with the carrier signal that is mixed down into carrier shift) in case Fig. 2 illustrates, then signal has been mixed down into the process of base band.At frequency mixer 223 places with carrier signal 221 and 222 mixing of the second carrier signal.By the impact of the suitable narrow low pass filter 220 of bandwidth applications with minimizing border external noise.According to coherent demodulation scheme of the present invention, demodulation occurs at functional device 225 places.Determine the expansion phase place (unwrapped phase) 230 of complex signal.Optional three-mixer level be can use, in this level, the carrier frequency of calculating and the frequency differential between the practical carrier frequency developed to estimate with phase place.Then utilize the structure of described bag (packet) to determine the beginning of the encoding domain of bpsk signal at piece 240 places.Mainly, the initial border of bag is determined in the existence of---appearing as the FM edge in the amplitude signal of signal of complex demodulation---to utilize synchronization header.In case determined the starting point of bag, on IQ plane and normal bit sign at piece 250 places with signal rotation, and at piece 260 places it is deciphered at last.
Except demodulation, to stride the health communication module and can also comprise forward error correction block, this module provides additional gain to resist the interference of other unwanted signal and noise.The forward error correction function module of paying close attention to comprises those forward error correction function modules of describing among the PCT patent application serial numbers PCT/US2007/024225; Its disclosure is incorporated this paper by reference into.In some instances, forward error correction block can adopt any easily agreement, identifies and proofread and correct (in the border) decoding error such as Reed-Solomon, Golay, Hamming, BCH and Turbo agreement.
Receptor of the present invention can also adopt the beacon function module.In all fields, beacon handover module 306 can adopt such as in the lower module one or more: beacon wake module, beacon signal module, ripple/frequency module, multi-frequency module and modulation signal module.
The beacon handover module 306 of Figure 1B can communicate by letter with beacon, relevant such as beacon communication channel, beacon agreement etc.For the purpose of this disclosure, the signal that normally sends as the part of message of beacon or be used for amplification message and the signal (sometimes being called " beacon signal " herein) that sends.These beacons can have well-defined feature, for example frequency.In noise circumstance, can easily detect beacon, and beacon can be used for smelling the trigger of visiting circuit, as described below.
In one aspect, beacon handover module 306 can comprise the beacon wake module, and it has arousal function.Arousal function only generally comprise during special time (such as the short time period for specific purpose) just with high-power mode work in order to receive the function of signal etc.Receptor important consideration partly for system is that it should be lower powered.This feature can have superiority in the receptor of implanting, in order to support the long-acting power supply that small size keeps battery simultaneously.Beacon handover module 306 can be realized these advantages in the very limited time period with high-power mode work by making receptor.This phase shorter workweek can provide optimum system dimension and energy expenditure feature.
In practice, receptor 100 can periodically and with low energy consumption " wake up ", in order to carry out " smell and visit function " by for example smelling the spy circuit.For purposes of this application, term " is smelt and is visited function " and refers generally to for the of short duration low power function of determining whether emitter exists.Visit Function detection to launcher signal if smell, then device can be transformed into the communication decoding mode of higher-wattage.If there is no launcher signal, then receptor can return and for example turn back to immediately park mode.In this way, when not having launcher signal, then during the relatively long time period, can save energy, and when having launcher signal, high power capacity can be used for efficient decoding mode operation during the relatively short time period.Various patterns and combination thereof can be used for operation and smell the spy circuit.By concrete system requirements are visited the Circnit Layout coupling with smelling, can realize the system that optimizes.
Fig. 3 A illustrates beacon handover module 306, wherein smells the spy cycle 301 than transmitted signal repetition periods 303 length.Provide time function in X-axis.As shown in the figure, transmitted signal periodically repeats, and smells simultaneously and visits function also in operation.In practice, in fact, smelling the spy cycle 301 can be longer than the transmitted signal repetition period 303.In all fields, smell the relatively long time period can be arranged between the spy cycle.In this way, guarantee to smell when visiting circuit start at every turn, for example be embodied as the spy function of smelling of smelling the spy circuit and guarantee to occur to send at least one times.
With reference now to Fig. 3 B,, Fig. 3 B illustrates and provides short but smell frequently the spy cycle 305 and long hair send the beacon handover module 306 of bag 307.Smell and visit circuit with certain time point startup during sending.In this way, smell visit circuit can detection of transmitted signals and switch to the high power decoding mode.
It is to provide " smelling spy " function with continuous mode that an other beacon wakes the aspect up.Compare with method provided above, this aspect of striding health beacon transmitting channel can utilize the following fact: total energy consumption is the product of average power consumption and time.In this regard, system can drop to total energy consumption minimum owing to have very short activity cycle, in this case, the cycle meansigma methods of activity is reduced to little numerical value.Alternatively, provide the low spy activity of smelling continuously.In this case, configuration provides enough low power, is suitable level so that transmitter-receiver continuous service and total energy consumption are in for these parameters of particular system.
The functional flow diagram of the beacon handover module 306 of Figure 1B shown in Fig. 3 C.In Fig. 3 C, the beacon handover module illustrates as smelling spy module 310.Smell and visit module 310 and be configured to scan the data that are coded in the electric current that emission of ions produces.Described data by the timetable of setting for example per 20 seconds received as electrically conductive signal at the receptor place.At step 315 place, the restriction activity smell time period during the spy, for example 300 milliseconds.Thereby this relatively low working cycle allows lower mean power function to realize the system's service life that prolongs.At step 320 place, receptor determines whether signal exists and whether described signal has effective ID.If movable do not detect the signal (shown in figure arrow 320) with effective ID during smelling spy being in, then process is returned step 315, and stops to be in movable smelling and visit until the next scheduled event cycle.If at step 320 place, receive the signal with effective ID, then process moves on to step 322.At step 322 place, whether the signal that receptor is determined to receive is from the ion emitter that had before detected.If signal is from the ion emitter that had before detected, then process moves on to step 326.At step 326 place, receptor is determined the current wake-up period (time of the appointment from the ID of last report, such as 10 minutes) in counting (the individual number of times that effectively detects that in other words, has identical ID) whether greater than as the predetermined number of times (such as 50 times) of threshold counter measurement.If counting surpasses this threshold value of determining such as threshold counter, then receptor turns back to and smells the spy pattern.If counting surpasses threshold value, then process moves on to step 330, and receptor is coded in receive data in the electric current that emission of ions produced with 100% detecting pattern work with analysis.In case with the data decoding and the analysis that receive, then process turns back to step 315.If determine to be coded in data in the electric current from the effective source different from the source that had before detected at step 322 place receptor, then process moves on to step 328.At step 328 place, threshold counter is resetted.
Another view of beacon module is provided in the functional block diagram shown in Fig. 3 D.The plan explanation of summing up among Fig. 3 D a kind of technology of identifying effective beacon.Signal 360 expressions that arrive receive, carry out bandpass filtering (such as from 10KHz to 34KHz), then are digital signal from analog-converted by high frequency signaling link (comprising carrier frequency) by electrode.Then at piece 361 places signal 360 extracted sampling and at frequency mixer 362 places with it with nominal driving frequency (such as 12.5KHz, 20KHz etc.) mixing.The signal of gained is extracted sampling at piece 364 places, and is low pass filtering (such as 5KHz BW) is mixed down into carrier shift with generation carrier signal---signal 369 at piece 365 places.Signal 369 is further processed (then fast fourier transform detects two highest peak values) so that real carrier frequency signaling 368 to be provided by piece 367.This agreement allows accurately to determine the carrier frequency of the beacon that sends.
Fig. 4 illustrates beacon function, and wherein for example beacon channel is relevant with a frequency for beacon, and for example message channel is relevant with another frequency for message.This for example is configured in and has superiority when system processes a plurality of transmitted signal.Solid line represents the beacon of transmitted signal 1.Dotted line represents the beacon of transmitted signal 2.In various transmission situations, the beacon of transmitted signal 2 may be overlapping with the beacon of transmitted signal 1, as shown in the figure.Message signale 1 can be on the frequency different from they beacons separately with message signale 2.The beacon that advantage may be transmitted signal 2 fully can disturb with the message of transmitted signal 1, even they are sent simultaneously.Contain two emitters although Fig. 4 illustrates, it will be apparent to one skilled in the art that and to revise system in order to make its amplification be more emitter.The demand of concrete system has determined the concrete architecture of system to a certain extent.
The other example of beacon function module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
Various aspects can adopt the frequency hopping function module.The frequency hopping function module can be relevant with specific communication channel, frequency hopping agreement etc.Therefore, various aspects can be utilized one or more frequency hopping agreement.For example, receptor can be searched for and send the designated frequency range that falls into, for example two or more different frequencies.When realizing the correct decoding of single, emitter has been finished the task of its digital information payload being sent to receptor in the body.
In some instances, can produce a plurality of benefits by the transmission frequency uncertainty that for example provides via the random frequency hopping of module at random.For example, a such benefit is to realize at little bare chip easily.In order to illustrate, emitter carrier frequency agitator may be the agitator of inaccuracy and free-running operation in the body, and it is easy to realize at the fraction of the bare chip of 1mm.Magnitude approximately+/-20 is easy to be allowed, because receptor proportion searching algorithm.
Another benefit like this is the battery life that prolongs.Illustrate, during the emitter battery life for example 3 to 10 minutes, because random frequency hopping can improve emitter significantly at the probability that can be sent by the clear channel that the receptor of frequency agility receives.
Another benefit is in the high power capacity environment collision event to be minimized.In order to illustrate, when emitter in a plurality of bodies when for example Ingestible event marker may send simultaneously, as at a plurality of Ingestible event markers simultaneously or in the situation about being ingested within the very approaching time, collision probability is reduced to minimum.In other words, do not having in the situation of frequency hopping function, similar batch Ingestible event marker sends and causes the probability height of a plurality of conflicts in identical (or almost identical) frequency.
In some aspects, the usable spectrum that uses in the conduction of large volume is used is the scope from about 3kHz to 150kHz.By detailed zooscopy, found in some environment, to have scope emitter (seeing above) in the body of the received signal level of 1 to 100 μ V and can in same frequency spectrum, compete with hundreds of approximately narrow-band interference signals to thousands of μ V.Destructiveness for the mitigate interference signal, can adopt such frequency hopping channel or agreement, wherein emitter will send the arrowband transmitted signal of output at every turn in the body, for example such as the modulation signal of binary phase shift keying (BPSK) signal or fsk signal, and frequency hopping randomly.
The other example of frequency hopping module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
The various aspects of receptor can adopt conflict to avoid functional module.Conflict avoids the functional module can be relevant with specific communication channel, collision avoidance protocol etc.Therefore, various aspects can be utilized the various collision avoidance protocol technology relevant with specific communication channel.Particularly useful in the environment---for example individuality is taken in a plurality of IEM---of collision avoidance technique emitter within for example having two or more individualities.In this environment, if emitter continues their signal of transmission in each individuality, then the transmission of an individual interior emitter may mask off the transmission of emitter in all other bodies.The situation that therefore, can't detect signal may significantly increase.
Various aspects can comprise multiple method for collision avoidance individually or in the multiple combination mode.
A kind of such method adopts a plurality of transmission frequency.By the frequency of utilization selective filter, even in situation about being sent simultaneously, also can be distinguished at the f1 emitter of broadcasting and the emitter of broadcasting at f2.
The other example of collision avoidance module has been described among the PCT patent application serial numbers PCT/US08/85048; Its disclosure is incorporated this paper by reference into.
Other functional module of striding in the health communication module that can be included in receptor of the present invention comprises the time clock feature module, it is with special time and given signal correction, for example, described in one or more in following PCT application: PCT patent application serial numbers PCT/US08/85048; The PCT patent application serial numbers PCT/US2007/024225 that is disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/095183 and is disclosed as WO 2008/063626; The disclosure of these patent applications is incorporated this paper by reference into.
As mentioned above, stride the health electrically conductive signal and also can be the signal that intelligent non-intestinal delivery system produces, for example be disclosed as described in the PCT patent application serial numbers PCT/US2007/015547 of WO 2008/008281; Its disclosure is incorporated this paper by reference into.In these examples, can be configured to derive according to the signal that receives the information of a plurality of dissimilar relevant fluid delivery events with the related medical treatment device of health.The information type that can derive includes but not limited to: characteristic of the fluid that how many amounts of the fluid delivery event that will occur or occur, the fluid of once using is, once used etc.What those situations are the amount that is configured to definite fluid of once using for receptor be, this device can be configured to receive multiple capacity administration data, in order to be configured as the different value that receives this data field.
Receptor can provide other communication path, the data of collecting can be sent to another device from receptor through this other communication path, such as but not limited to smart phone, hospital information system etc.This other communication path is provided by " external communication " module.This external communication module can adopt multiple different agreement.The agreement of paying close attention to comprises wired communication protocol and wireless communication protocol.For example, receptor can comprise conventional RF circuit (for example working) in 405MHz medical treatment device frequency band, and the medical worker can be for example communicates with by using with data searcher such as wand (wand) or similar device.What pay close attention in certain aspects is the low power wireless communication agreement, such as BLUETOOTH TM(bluetooth) wireless communication protocol.The communication protocol that adopts in addition Multipurpose connector of paying close attention to is as hereinafter in greater detail.
When receptor was included in sv at least a portion during use, described part can have be used to the output device that audio frequency for example and/or visible feedback are provided; The example of described output device comprises audible alarm, LED, display screen etc.Described exterior section can also comprise interface port, and parts can be connected to computer to read the data that are stored in wherein via described interface port.In addition, described exterior section can comprise one or more executive component, such as button or similar structures, so that the user can related with health in some way medical treatment device carries out is manually mutual, so that such as test operability, opening device, reset apparatus etc.
In some instances, adopt external communication module to reconfigure the parameters of receptor.Therefore, communication module can be bi-directional communication modules.Reconfigurable parameter comprises data acquisition " working cycle ", for example receptor IEM is smelt how visit frequent degree, frequent degree that receptor is collected ECG or activity data how with the persistent period as how.
In one aspect, external communication module may be implemented as the power supply with oneself, in order to can be independent of other parts of device by for example microprocessor with its opening and closing.
Receptor according to instruction of the present invention can comprise the physiological sensing module that one or more are different.Physiological sensing module refers to ability or the function of following one or more physiological parameter paid close attention to of sensing or biomarker, such as but not limited to: the electrocardiogram (ECG) data that comprises heart rate, electrocardiogram (ECG) etc.; Breathing rate, temperature; Pressure; The chemical composition of fluid such as the detection of analytes in the blood, fluidised form, blood flow rate, accelerometer exercise data etc.Have in the situation of physiological parameter or biomarker sensing function at receptor, the different parameter that signal receiver can sensing or the quantity of biomarker can be different, such as one or more, two or more, three or more, four or more, five or more, ten or more etc.Term " biomarker " refers to anatomical parameters, physiological parameter, biochemical parameter or the molecular parameter relevant with seriousness with the existence of health status such as particular disease states.According to concrete aspect, described device can use its signal receiving element, for example use the electrode of the receptor that is used for signal reception and sensing application, realize one or more of in these sensing functions, perhaps receptor can comprise one or more the different sensing element (micropin as described below) that is different from signal receiving element.Can exist at signal receiver the quantity of the different sensing element of (or being attached thereto at least) can be different, can be one or more, two or more, three or more, four or more, five or more, ten or more etc.
In some aspects, receptor comprises bifunctional one group of two or more electrode that signal reception and sensing are provided, such as two or three.For example, except receiving signal, these electrodes can also have extra sensing function.In some aspects, use electrode to become ECG data next life.From described data, can finish many kinds processes, each cardiac event such as heart beating is overrun such as detecting, ventricular fibrillation, heart rate etc., detect nervous symptoms, such as outbreak (for example, as may epilepsy outbreak (referring to such as hereinafter being used in greater detail device and the module that outbreak detects)) etc.The ECG data that obtains can be used in titration of medicines, or can be used in the great change on detecting heart rate or the rhythm of the heart or warn when significantly unusual.In certain aspects, at the heart rate that is used for monitoring the patient who does not have pacemaker, when coming monitor heart rate, these data also are helpful to the patient who---is used for continuing to monitor in 24 hours mancarried device or other device of the electrical activity of heart---or for may usually needing holter (Holter) monitor or cardiac event monitor as alternative.The recording period that prolongs is for finding that impalpable sporadic arrhythmia is helpful in the short period section.
As mentioned above, can in receptor, comprise one or more extra biosensor different from electrode.For example, the accurate measurement that can adopt temperature sensor such as thermal resistor, CMOS temperature sensor, resistance temperature detector (RTD) to obtain temperature.A kind of extra biosensor can comprise LED and the photodiode that is combined in the pulse blood oxygen instrument, and pulse blood oxygen instrument can be used to measure blood oxygen, also can provide the information of closing pulse pressure.In addition, the aspect of signal receiver comprises pressure transducer, for example wherein signal receiver is implanted the tremulous pulse next door to carry out the measurement of arteriotony.In some aspects, exist deformeter with gaging pressure deflection (pressure deflection), then deformeter is connected to signal receiver.
Receptor can also comprise the detection of analytes sensor.For example, specific chemical sensor can be incorporated into signal receiver to detect existing of several formulations, described formulation example is as being ethanol, glucose, BNP (BNP, it is relevant with heart disease) etc.The sensor of paying close attention to comprises those sensors of the existence that is configured to chemical analyte in the detection of biological body fluid sample, and the chemical analyte of wherein paying close attention to includes but not limited to: blood glucose (glucose), cholesterol, bilirubin, sarcosine, various metabolic enzyme, hematochrome, heparin, hematocrit, vitamin K or other thrombin, uric acid, carcinoembryonic antigen or other tumor antigen, various reproductive hormone are such as those reproductive hormones, Drug abuse and/or its metabolite relevant with ovulation or gestation; Blood alcohol concentration etc.In some aspects, the configuration receptor material that will detect or characteristic comprise lactate (be important for the athlete), oxygen, pH, ethanol, Nicotiana tabacum L. metabolite and illicit drug (for medical diagnosis and to enforce the law all be important).Comprise at receptor in the situation of the analyte that detects sensing element, can adopt various different modes that this sensing element is configured in the receptor.For example, can provide the sensor that comprises permoselective membrane, described permeable membrane is permeated the preparation that needs detect, and the chamber of isolation is wherein arranged behind the film, and preparation penetrates described film.Then measure the change of characteristic such as the electrical characteristics of this chamber.In some aspects, adopt to be positioned on receptor one side with film across wherein little storage, and measure the circuit that is positioned at thereafter.The in addition ChemFET sensor of paying close attention to, thus it is based on analyte being attached to the variation that sensor causes electrical conductivity.In some aspects, when adopting material, such as protein analyte, when being attached on the sensor, the electrical characteristics of material (or other characteristic) are changed.Can adopt various ways to determine blood alcohol concentration, include but not limited to: analyze sensor such as the fluid sample of perspiration, optics spectroscopic sensor etc.
What pay close attention to is the receptor that comprises at least one electrocardiogram (ECG) sensor assembly.The ECG sensor assembly is the module that is configured to obtain the ECG data, and if necessary, the ECG sensor assembly is also carried out one or more in the following operation: carry out in some way date processing, storage data and forwarding data.The ECG data that can adopt receptor derive a plurality of different tolerance, and it includes but not limited to: R ripple, heart rate, heart rate variability, breathing rate etc.When receptor comprised one or more of physiological sensing function, device can also comprise and is configured to obtain and the sensing module of deal with data from these sensing functions.For example, when receptor comprised the ECG sensing function, device can comprise the suitable functional module (for example adopting the form of programming) that can operate and process the initial data that comes from these sensors.The example of the physiological sensing module of paying close attention to is ECG sensing module shown in Figure 5.
With reference now to Fig. 5,, realizes the example of the ECG sensing module of improved Hamilton and Tompkins algorithm shown in it.Fig. 5 represents a kind of possible implementation of R ripple detection algorithm according to an aspect of the present invention.As shown in Figure 5, before A/D converter 502 places converted signal to digital signal, the ECG sensing module received signal and at wave filter 501 places these signals is carried out bandpass filtering (for example 0.3 to 150Hz) via electrode.Then, this signal is sent on microprocessor 503 and the digital signal processor 504 process.For example, at piece 505 places, the data signal that DSP 504 receives (is for example carried out bandpass filtering, at 10-30Hz), and at piece 510 places to its difference, and at piece 515 places further to its filtering, in order to strengthen at piece 520 places and there is the window of QRS wave group (QRS complex) in final identification.Then applied logic is to identify the R ripple in each window.At logical block 525 places, determine that whether window width is greater than for example 140ms.Determine peak value and valley in the window, shown in logical block 530.If peak value is greater than the twice of valley, then the R ripple equals peak value.If valley is greater than the twice of peak value, then the R ripple equals valley.Otherwise the R ripple equals the ratio of peak value and the valley that occurs for the first time.Logical block 535 illustrates this point.After this, R wave-amplitude and peak time are sent to memorizer (for example, flash memory), shown in logical block 540.
The in addition accelerometer module of paying close attention to.The accelerometer module is the module that is configured to obtain accelerometer data, and if necessary, this accelerometer module is also carried out one or more in the following operation: carry out in some way date processing, storage data and retransmission data.Receptor can adopt this accelerometer module to derive a plurality of different tolerance, includes but not limited to following data: about patient's activity, mean activity, patient's position and angle, the data (wherein this data can utilize 3 axis accelerometers obtain) of Activity Type as walking, take a seat, having a rest; Then preserve the data of obtaining.What pay close attention to is analog acceleration meter and digital accelerometer.An example of the accelerometer module of paying close attention to shown in Fig. 6.
With reference now to Fig. 6,, the functional block diagram of 3 axis accelerometer modules according to an aspect of the present invention is shown, this 3 axis accelerometer module is configured to obtain and process accelerometer data from three different axles.Each axle of accelerometer is processed, to determine meansigma methods (shown in segment 601), standard deviation (shown in piece 602) and self correlation (shown in piece 603).Meansigma methods reflection accelerometer with respect to gravity towards, and standard deviation and self correlation are to describe the amplitude of observed motion and the important tolerance of frequency, for example peak correlation, related frequency, the dependency between the axle.In order to carry out meter step, with these three axle combinations, and carry out filtering at piece 635 places at piece 630 places.Make up total acceleration, shown in piece 640.Use total acceleration so that system's reply receptor with respect to experimenter's difference towards having more vigorousness.In case calculated total acceleration, standard deviation and self correlation have then been calculated, shown in piece 645.Then these values are carried out threshold process (for example, standard deviation>0.1, self correlation>0.25) to determine whether to exist significant shuttling movement, shown in piece 650.Then, shown in piece 655, if exceed threshold value, then step number is defined as the quantity of zero crossing of the total acceleration of average correction.
In some receptors, device can comprise the environmental functional module.The environmental functional module is to be configured to or whether data such as environmental aspect, the receptor of the environmental correclation of acquisition and receptor is connected to the module of skin surface etc.For example, the environmental functional module can be configured to obtain the receiver environment temperature data.The environmental functional module can be configured to determine that by for example impedance measurement electrode connects.The environmental functional module can be configured to determine cell voltage.The above-mentioned specific function of environmental functional module only is exemplary but not limits.
Receptor can be configured to process in every way the data of reception.In some respects, receptor only forwards the data to external device (ED) (for example, using conventional RF communication).Aspect other, the data that receptor process to receive to be determining whether taking certain action, as operate in the lower effector of its control, startup is visual or audible alarm, transmit control signal to the effector that is arranged in other position of health etc.Aspect more again, the data of receptor storing received are in order to follow-uply be transmitted to external device (ED) or use when processing follow-up data (for example, detecting the variation that certain parameter is passed in time).These receptors can use the data of reception to carry out the combination in any of these operations and/or other operation.
Aspect some of IEM signal receiver at receptor, the data that record on the data storage elements comprise following at least one of them, if not all: time, date and the identifier of using each IEM to the patient are (for example, globally unique serial number), wherein identifier can be adopted name or its version of code of compositions.The data that record on the data storage elements of receptor can also comprise the experimenter's that receptor is correlated with medical record information, and identification information for example is such as, but not limited to following: name, age, treatment record etc.In some aspects, the data of paying close attention to comprise the hemodynamics measurement.In some aspects, the data of paying close attention to comprise the heart tissue characteristic.In some aspects, the data of paying close attention to comprise pressure or volumetric measurement, temperature, activity, breathing rate, pH etc.
Receptor can comprise the various dissimilar power supply that working power is provided to device in some way.The characteristic of power module module may be different.In some instances, power module can comprise battery.When having battery, battery can be disposable use battery or rechargeable battery.For rechargeable battery, can come battery is charged with any easily agreement.What pay close attention to is the agreement of facilitating the multitask of the element of receptor to realize.For example, receptor of the present invention can comprise for realizing several functions---as receiving the signal that transmits with electrically conducting manner, sensing physiological data etc.---one or more electrode.Can also adopt one or more electrode (when existing) as power receiver, described power receiver can be used to rechargeable battery is charged, as further describing in the multipurpose link block part hereinafter.Alternatively, power module can be configured to receive power supply signal, and for example power module comprises the coil that can bestow power supply when receptor has been applied in suitable magnetic field to device.In other example, device can comprise the power module with the health power supply, and such as the power module of describing in the U.S. Patent Application Serial Number 11/385,986, the disclosure of this patent application is incorporated this paper by reference into.
Receptor can comprise that power supply provides module, and when its control device takes certain state in order to for example drop to the power supply use of installing minimum.For example, power supply provides module to carry out working cycle for data acquisition based on movable or other event of a period of time of one day or patient, and wherein the performed working cycle can be based on signal factors or a plurality of factor.For example, power supply provides module can make receptor obtain patient's activity data (for example by accelerometer module) when the patient walks about, rather than when patient's rest.In other side, power management module can allow receptor only gather the ECG data at night, for example uses real-time clock in the receptor only to gather ECG in scheduled time scope (for example from 9PM to 7AM).
As mentioned previously, receptor can be configured to have various states---for example holding state or one or more of active state, according to the needs of every kind of required receptor state, intermediate module circulates the high power function piece between active state and inactive state.In addition, can also be by power module other receiver element of circulation opening and closing during the different conditions of receptor.The power supply that power supply provides module can be configured to control the various circuit blocks in the medical treatment device, described circuit block is such as be the circuit block relevant with the power supply of processor, and various peripheral components (such as the wireless communication module etc.) circuit block of being correlated with and power supply thereof etc.Therefore, during every kind of state of receptor, can circulate opening and closing independently as required to the power supply of the various parts of receptor, (and the high power function piece is circulated between active state and inactive state, as discussed previously) in order to realize power-efficient.For example, in some instances, receptor can be configured to be present in two or more different active states, wherein carries out different task or a group task in every kind of different active state.Carry out IEM signal detection agreement when the receptor of paying close attention to can be configured in being present in the first active state, and carry out the physiological data detection protocol when being present in the second active state.In the receptor of these types, the all parts of opening and closing receptor as required independently can circulate, to realize that power-efficient (and makes the high power function piece circulate, as discussed previously) independently between active state and inactive state.
Power supply provides the power supply that module can comprise that one or more is single in order to start and stop using to the power supply of these all parts.For example, in one aspect, power supply provides module to comprise: to the high power handling I/O power supply of high power handling piece supply I/O power supply; With the high power handling core power supply to high power handling piece supply core power supply.In addition, power supply provides module to comprise: to the radio communication I/O power supply of wireless communication module supply I/O power supply; With the radio communication core power supply to wireless communication module supply core power supply.
Should be appreciated that, can use single power supply to power to a plurality of parts.For example, single power supply can be to high power handling piece and wireless communication module supply I/O power supply.In one aspect, power supply provides module from determining low-power processing block (for example microprocessor) reception control signal of which power supply of On/Off.
With reference now to Figure 26,, provides according to the present invention the circuit diagram of the part of the circuit of the receptor of instruction.Circuit 2600 is responsible for control to the power supply of all parts of receptor.The holding wire " VCC_EN_BAT " that Figure 26 all illustrates in two width of cloth figure is located to be connected with Figure 24, and the part of the circuit in Figure 24 works to control power supply.As shown in figure 26, translater shown in it 2610 and switch 2620 electric coupling, switch 2620 and Voltage Reference 2630 and 2640 electric coupling.Transducer 2610 is translated as signal VC_EN_BAT on its B bus with the data signal VC_ENA on its A bus.Signal VCC_EN_BAT is connected to the actuator 24155 of all parts power supply, the enable pin of 24157 and 24159 (as shown in figure 24).Therefore, data signal VCC_EN_BAT can enables/disables to the power supply of all parts of receptor.For example, actuator 24155,24157 and 24159 is respectively to DSP nuclear, DSP and radio communication I/O and the power supply of radio communication nuclear.Therefore, each in these parts can utilize the respective enable/disable data signal (VCC_EN_BT) that comes from circuit 2600 to switch on and off.
Receptor can comprise the Multipurpose connector module.The Multipurpose connector module comprises live body experimenter contact, electrode described herein (hereinafter being also referred to as " Multipurpose connector ") for example, and can be used for power supply to device and carry out periodic charge, carry out reprogramming to the control function of device and/or to the data retrieval of device.The configuration difference that this configuration all comprises independent adapter with those for each of these functions---for example different patient's adapters, power connector and device configuration adapter---.
Comprise the receptor of Multipurpose connector module can the realize target experimenter such as patient or the patient device of being correlated with and the second external device (ED) such as variable connection the between external programmer device and the external charging apparatus.Described connection can be used to promote the communication of combination of signal such as the signal of telecommunication, digital signal, optical signal, various types of signals etc.Term " variable connection " refers to the following ability of Multipurpose connector as used herein, described ability be Multipurpose connector receive with such as patient's live body experimenter be connected the link that one of external device (ED) is connected, and based on specific link, form connection such as the link that is connected with the patient or the link that is connected with the second external device (ED).Receptor also comprises multi-functional to control the signal relevant with the communication of signal via connecting.In all fields, the second external device (ED) comprises external programmer device, and this second functional device comprises the controller function piece, with the control signal relevant with communication between external programmer device and the receptor.When receptor is connected to external programmer device via Multipurpose connector, can come with programming mode control receptor with external programmer device.In all fields, the second external device (ED) comprises the external charging apparatus, and the second functional device comprises the power functions piece, with the control signal relevant with communication between external charging apparatus and the receptor.When receptor was connected to external charger via Multipurpose connector, external charger can be used to receptor is charged.In all fields, the second functional device comprises patient's interactive function piece.When receptor was connected to the patient or is connected to patient's relevant apparatus via Multipurpose connector, device can be used to carry out interactive communication with patient or patient's relevant apparatus.For example, receptor can dispose electrode, in order to stimulate or a plurality of patient parameters of sensing and physically be connected to the patient and be beneficial to realize the several functions target, for example the patient is sent pacing stimulation; Receive physiologic information etc. from the patient.
In some respects, in multi-functional at least one is configured to the signal guide device.The signal guide device can be any parts, subassembly or its combination that can carry out described function.In one embodiment, receptor is connected with signal guide implements reason, for example receptor is configured to comprise the signal guide device.This configuration can comprise one or more circuit etc.In another embodiment, the signal guide device separates with receptor physically.This configuration can comprise can be beneficial to router or other network equipment of realizing semiotic function described herein.The signal guide device can comprise and is configured to for example control element of distinguishing signal of control signal.In all fields, the signal guide device comprises at least one in software and the circuit.
Signal controlling or discriminating can be based on various standards, such as voltage, frequency, manually control, programming Control etc.The control element configuration is also correspondingly different.For example, the control element of differentiating based on voltage can be implemented as one or more diode, thermal resistor etc.The control element of differentiating based on frequency can be implemented as high pass filter or low pass filter.Provide the control element of manual control and/or programming Control to can be implemented as analog switch, relay, multiplexer etc.Various other realizations can be based on the various parameters such as light, temperature, time etc.
As mentioned above, Multipurpose connector be configured to the patient be connected the second external device (ED) such as external programmer device, external charging apparatus or external data processor the connecting element of connection be provided.Correspondingly, the structure of Multipurpose connector so that its can be directly or by another device (as mentioned below) provide receptor and patient and with being connected of another device.Correspondingly, receptor can be connected to the patient via Multipurpose connector in the very first time, and the second time that is different from the very first time via same Multipurpose connector be connected to another device so that adopt same Multipurpose connector at different time receptor to be connected to different entities.Thus, can use Multipurpose connector to be connected to the patient and to be connected at least one or more additional external device (ED) in different time one or more physics realization with the functional device of device, such as external charger, external programmer device or external data processor.
The structure of Multipurpose connector can be as required and different, and the connector construction of wherein paying close attention to includes but not limited to: IS-1 adapter, association for the advancement of medical instrumentation's electrocardiogram (AAMI ECG) wire connector and many pins of medical grade shield type adapter.In some instances, adapter comprises one or more electrode, such as two to ten electrodes, comprises three electrodes or four electrodes.
If necessary, Multipurpose connector can be configured to directly be connected with patient or other external device (ED), so that being connected between the Multipurpose connector that the electrical connector that need not to add provides receptor and patient or other external device (ED).Alternatively, Multipurpose connector can be configured to via physically different electrical connectors such as cable or be wired to the patient or other external device (ED).Physically different electric connectors can have a terminal that is configured to cooperate with Multipurpose connector and be configured to carry out another terminal of specific purpose, described specific purpose for for example be connected to patient or external device (ED), such as battery charger or external programmer device.Should be noted that when receptor is connected to the patient via different adapters such as wire device still is regarded as receptor.
In receptor of the present invention, Multipurpose connector is operably connected (such as electrical connection, light connection etc.) to multi-functional (for example two or more, three or more, four or more, five or more, seven or more, ten or more functional device), and is described such as other place of the application.
Except being configured to connect the patient, the Multipurpose connector of paying close attention to can be configured to receptor is connected to other external device (ED), and described other external device (ED) includes but not limited to external charging apparatus, external programmer device, data processing equipment, modem, keyboard, display and/or external memory etc.By using identical adapter that receptor is connected to patient and other device, avoided that the patient is connected to receptor when medical treatment device is connected to another device (such as charger).This configuration has strengthened patient's safety, thereby because this signal of having got rid of other external device (ED) such as charger, programmer, data processor etc. will be sent to the probability that the patient may hurt the patient.Come for several functions also so that the device waterproof is more easy, because the opening on the shell of device is less with single adapter.
The receptor of paying close attention to can comprise the router between in multi-functional that is arranged on Multipurpose connector and device on the function one or more." be arranged on the function ... between " refer to signal, before one that enters in multi-functional, pass through again router afterwards by Multipurpose connector such as the signal, the signal of going out or the two-way signaling that arrive first.Router can be configured to optionally allow signal by arriving some functional device according to one or more parameter.For example, router can be configured to based on the voltage distinguishing signal, and the signal that for example only allows to be higher or lower than certain threshold voltage (or in certain voltage belt) passes through; Based on the frequency distinguishing signal, the signal that for example only allows to be higher or lower than threshold frequency (or in certain frequency band) passes through; Or based on mode of operation, distinguishing signals such as charge mode, data transfer mode, patient's interactive mode.In some instances, can Multipurpose connector and only between some multi-functional function router is set.In other words, can there be one or more functional device not separate because of router and Multipurpose connector.
In some instances, router can be configured to based on the signal of paying close attention to the feature of the uniqueness of device be come distinguishing signal.Can be relatively low voltage from the signal of body measurement, 500mV or lower for example, such as 100mV or lower, or 50mV or lower.Similarly, can be relatively low-frequency from the signal of body measurement, 20kHz or lower for example, such as 5kHz or lower, or 1kHz or lower.By contrast, being used for the typical electrical source signal that the internal cell to device as external medical device charges can be relatively high voltage, such as 1V or higher, 2V or higher, or 5V or higher.The type signal that is used for transfer of data can have than the relative higher frequency of body measurement signal, 100kHz or higher for example, and such as 1MHz or higher, or 10MHz or higher.Therefore, by distinguishing based on frequency and voltage, router can optionally be routed to signal one or more suitable functional device.Router can come distinguishing signal based on any feature of signal, and the feature of signal includes but not limited to voltage, frequency and the combination of the two.In other example, router can be based on the mode of operation signal that comes route to enter of device, and the mode of operation of device can be arranged by other circuit, software or hand switch or instruction.
In some instances, the signal that router is configured to certain type is routed to the specific function piece, isolates simultaneously the signal of one or more other functional device.For example, if expect patient's signal is carried out the high impedance measurement, then the Low ESR of isolated power functional device may be important.In this case, router can be arranged between power functions piece and the Multipurpose connector, and its signal that only allows to be higher than certain voltage passes through.Therefore, the signal of the relatively low voltage of measuring from patient body will with the isolation of power functions piece, patient's interactive function piece can correctly be measured this signal.
But, in some instances, may be unimportant with untapped other functional device isolation with specific.Therefore, in some instances, can be not so that one or more specific function piece and signal disconnect with configuration of routers.That is, in these examples, the signal of arrival will always pass through the specific function piece.But in some cases, functional device can only respond the signal of some type, such as frequency or the voltage signal of certain scope, and will can not be damaged when being exposed to other signal.This selective response can be effective as the route means.
Can be comprised of a plurality of function route pieces such as router used herein itself, each function route piece is arranged between one or more apparatus function piece and the Multipurpose connector in function.Thus, the individual router piece can come distinguishing signal based on different parameters, thereby allows dissimilar signals to arrive corresponding apparatus function piece.
Router can be inherently, on one's own initiative or the combination by intrinsic and active technique signal is routed to suitable circuit.In some instances, router can be differentiated the signal that enters based on voltage.For example, the router that is arranged on the function between Multipurpose connector and the one or more functional device can only allow to be higher than the signal of certain voltage threshold by arriving these functional devices.In some instances, this can utilize one or more diode to realize.In some instances, these diodes can be set to commutator, such as half-wave rectifier, full wave rectifier, three-phase rectifier etc.In other example, router can only allow to be lower than the signal of certain threshold voltage by arriving related functional device.
In other example, router can come the route signal based on frequency.For example, be arranged on the function signal that Multipurpose connector and router between one or more functional device can only allow to be higher than certain frequency by arriving these related functional devices.In other example, router can only allow to be lower than in certain frequency, certain frequency band or certain out-of-band signal passes through.The router of differentiating based on frequency can comprise wave filter, such as low pass filter, high pass filter or band filter.Wave filter can have any easily design, and the feature of the signal that can distinguish as required of filter characteristic and difference.
In some respects, router can comprise one or more controlled switch that signal is routed to suitable functional device.Switch can include but not limited to analog switch, multiplexer, relay etc. or their combination in any.Switch can be by detecting the signal existence and correspondingly other circuit of its route being controlled.Alternatively, switch can be controlled by software.In other side, switch can be controlled by the user.For example, the device shell on or on the peripheral control unit user interface can be arranged.User interface can include but not limited to one or more switch, one or more button, touch screen etc., and by user interface, the user can select suitable mode of operation, and the router switch can correspondingly be set.In some instances, can be based on from the signal of Multipurpose connector input and by the mode of operation of internal circuit or software modification device.Possible mode of operation can include but not limited to: patient's interactive mode, charge mode, data-transmission mode etc.Then can be according to these switches of mode of operation route.
To send via Multipurpose connector in some examples of data or processing instruction, may expect to select the signaling protocol with patient's connecting circuit compatibility.Be the compliant requirement, patient's electrical connection may have the safety condenser of the electrical connection of being connected to and avoid the dc voltage injury with the protection patient.In these areas, may expect to select not represent i.e. 1 or 0 the communication protocol of data bit based on the DC level.On the contrary, can select to represent the data communication protocol of data based on conversion or frequency modulation(PFM).In other example, not necessarily to avoid using the DC data protocol, and can use any easily data protocol.
The block diagram that comprises the receptor of Multipurpose connector shown in Figure 16 wherein installs with patient's interactive mode and illustrates.Receptor 1601 is connected to patient 1603 via Multipurpose connector 1605.Multipurpose connector 1605 is positioned on the shell 1607 and is connected to router one 609.Router one 609 is connected to internal electric source 1611, signals collecting piece 1613, energy output piece 1615 and/or controller and data I/O piece 1617.As shown in the figure, receptor 1601 is connected to patient 1603, so router one 609 passes the signal along to signals collecting piece 1613 via connecting 1619.Energy output piece 1615 can be delivered to the patient with energy via connecting 1621.Connect 1621 can with or can be not with is connected 1619 shared same electric wires.
Identical receptor shown in Figure 17, device is in charge mode shown in it.External power source 1723 is connected to receptor 1701 via Multipurpose connector 1705.Multipurpose connector 1705 is connected to router one 709.The signal that router one 709 identifies arrival is charging signals, and correspondingly via connecting 1725 signal is routed to internal electric source 1711, thereby to internal electric source 1711 chargings.
Figure 18 illustrates the receptor 1801 when device is in data communication mode.External control and data communication equipment 1827 are connected to receptor 1801 via Multipurpose connector 1805.Multipurpose connector 1805 is connected to router one 809.The signal that router one 809 identifies arrival is control and/or data traffic signals, and correspondingly via connection 1829 signal is routed to control and data I/O piece 1817.External control and data communication equipment 1827 then can be with control signal and/or Packet Generation to control and data I/O pieces 1817 or from controlling and data I/O piece 1817 transmitted signal request datas.Control is connected and can be comprised that wireless connections send to external control and data communication equipment 1827 with data by identical connection 1829 or by different connections with data I/O piece.
The embodiment of the router that can in receptor of the present invention, adopt shown in Figure 19 A and Figure 19 B.Figure 19 A has described the router based on the voltage level distinguishing signal.The signal that only exceeds the threshold voltage of router one 931 is delivered to bus 1935 from bus 1933.This principle simple embodiment shown in Figure 19 B, wherein diode 1937 is as the signal guide device, such as router one 909.Only the signal greater than the threshold voltage of diode 1937 is delivered to bus 1941 from bus 1939.
Figure 20 A and Figure 20 B illustrate the embodiment of the router of differentiating based on the frequency of the signal that arrives.Figure 20 A illustrates based on the principle of frequency by means of the router of arrival signal bus 2043 and functional device bus 2045 and 2047.Element 2049 has the impedance that increases with frequency, and forms high pass filter with resistor 2050.The signal that only is higher than the design frequency of high pass filter is delivered to bus 2045 from bus 2043.Element 2051 has the impedance that reduces with frequency, and forms low pass filter with resistor 2052.The signal that only is lower than the design frequency of low pass filter is delivered to bus 2047 from bus 2043.High pass filter can have with low pass filter or can not have different design frequencies.Figure 20 B illustrates the simple embodiment of this principle.The high pass filter that capacitor 2053 and resistor 2054 form between bus 2057 and the bus 2059, and the low pass filter between inducer 2055 and resistor 2056 formation buses 2057 and the bus 2061.Only have those signals that are higher than cut-off frequency to be allowed to be delivered to bus 2059 from bus 2057, and only have those signals that are lower than cut-off frequency to be allowed to be delivered to bus 2061 from bus 2057.
Figure 20 C illustrates another embodiment of the router of differentiating based on the frequency of the signal that arrives.High pass filter 2056 has the gain that reduces when being lower than certain design frequency.The signal that only is higher than this design frequency will be delivered to bus 2060 from bus 2058.Low pass filter 2062 has the gain that reduces when being higher than the second design frequency.The signal that only is higher than this design frequency will be delivered to bus 2064 from bus 2058.
Figure 21 illustrates an aspect of the router that adopts active switch.Bus 2163 is separated with 2169 with bus 2165,2167 with 2175 by switch 2171,2173. Bus 2165,2167 and 2169 is connected to one or more functional device of outside receptor separately.Can come gauge tap 2171,2173 and 2175 by other circuit, software and/or by the user, in order to open on demand or close so that bus 2163 is connected with corresponding functional device or disconnects.
Receptor of the present invention can be incorporated the circuit that is connected with Multipurpose connector into, described circuit is routed to fairing, power conversion device with the AC voltage that is higher than certain threshold value that applies inherently, then is routed to use energy to the battery charger circuit of internal cell charging.Data acquisition circuit in the receptor is not subjected to the AC voltage influence that applies of appointment.Receptor also detects the existence of this voltage and can change its mode of operation based on this information.
Figure 22-24 illustrates the embodiment of circuit of an aspect of receptor.Figure 22 illustrates the multipurpose electrode and connects SNAP_E1 2277, SNAP_E2 2279 and SNAP_E3 2281, and via signal receiving amplifier input 22121 and 22123 electrode is connected to the switch 22113,22115 and 22117 that signal receives piece.Diode 2283,2285 and 2287 protects these circuit to avoid the damage that causes because of static discharge ( ESD).Inducer 2289,2291 and 2293 reduces electromagnetic interference ( EMI).Capacitor 2295,2297 and 2299 is by preventing that any dc voltage is applied to electrode 2277,2279 and 2281 and protects the patient.Circuit ChargeInACI 22101, ChargeInAC2 22103 and ChargeInAC3 22105 are connected to the internal electric source shown in the subsequent drawings with input.Capacitor 22107,22109 and 22111 prevents that any dc voltage is applied to signal receiving amplifier.Select three electrodes 2277,2279 and 2281 combination in any to link two signal receiving amplifiers input V+diff 22121 and V-diff 22123 with switch 22113,22115,22117 and 22119.
In device shown in Figure 22, it is impossible that signal is received that piece disconnects fully.If electrode is applied charging signals, then charging signals will and arrive in the amplifier input by switch.But the amplifier input is designed to avoid the impact of relatively large voltage, so needn't receive piece by cut-off signal.
In alternative arrangements, when receiving the signal of non-data signal at electrode, can receive piece by cut-off signal.This can be for example by realizing with other switch and/or different switch arrangement.
Figure 23 illustrates the battery charger input of internal electric source functional device.The circuit ChargeInACI 22101 of Figure 22, ChargeInAC2 22103 and ChargeInAC3 22103 are connected to the power supply function piece at ChargeInACI 23125, ChargeInAC2 23127 and ChargeInAC3 23129 places respectively.Diode 23131-23136 forms three-phase rectifier.When device was connected to external charger, commutator received the charging signals of the square wave that can be alternating current, for example 100kHz, and converted thereof into the DC current on the network C hargerIn 23139.When these exist voltage in input less than about 0.6V, for example when device is connected to the patient, this nonpassage of signal over commutation device, and ChargerIn node 23139 with input 23125,23127 and 23129 disconnections.In the time need to carrying out the high impedance measurement of signal to the patient, with Low ESR and the electrode isolation of ChargerIn node 23139.Booster converter 23141 is increased to required charging voltage with the voltage on the clean ChargerIn 23139, for example about 5V.The voltage that increases is delivered to battery charger via node 23143.Diode 23145 is holding circuit when being higher than required voltage and being placed on the ChargerIn node 23139.
An aspect of battery charger circuit shown in Figure 24.The output node 23143 of Figure 23 is connected with battery charger circuit among Figure 24 at battery charger input node 24147 places.Battery charger input 24147 is connected to integrated circuit of battery charger 24149.In this regard, battery charger input 24147 is configured at battery pad 24151 and 24153 places battery lithium cell charging for example.The remainder of circuit shown in Figure 24 comprises actuator 24155,24157 and 24159, and its regulating cell voltage uses for the remainder of the circuit in the device.
Between the operating period, receptor can be operably connected to the live body experimenter via Multipurpose connector, such as patient or another external device (ED).Other external device (ED) that can connect includes but not limited to external charging apparatus, external programmer device, external data processing device.Receptor can also be operably connected to another medical treatment device via Multipurpose connector, comprises the outer portion near end of the medical treatment device that is connected to implantation.When via Multipurpose connector patient or another device being connected to the external medical device, router (when existing) can come the opening and closing signal path based on the type of signal or the feature of signal.Discuss as mentioned, can be inherently, carry out route on one's own initiative or by the combination of these and other technology.
Figure 25 provide can have Multipurpose connector aspect the sketch map of the components/functions relation that realizes.Sketch map for example provides signal guide device 2500.Signal guide device 2500 comprises control element 2502.Control element 2502 can control or response voltage 2504, frequency 2506, manually/programming instruction 2508 and other standard 2510.Can come discriminating voltage 2504 via one or more diode 2512, thermal resistor 2514 etc.Can differentiate frequency 2506 by high pass filter 2516, low pass filter 2518 etc.Can by send via analog switch 2520, relay 2522, multiplexer 2524 etc. manually/programming instruction 2508 is with manual mode and/or programming mode control signal.Other standard 2510 that is used for signal controlling/response can comprise such as light, temperature, time etc.
Also comprise with the method for Multipurpose connector operative installations of the present invention receptor and one of patient or above-mentioned other device are disconnected, and via Multipurpose connector this device operationally is coupled to any in these two of one of patient or other device.Router in the receptor (when existing) can be different from route and come from the mode incoming road of signal of the first device that connects by the signal that comes from the second device that connects.In addition, the mode of operation of external medical device can respond the signal that comes from the second device that connects and change.
The relevant U.S. Provisional Patent Application serial number 61/122,723 that can comprise the receptor of Multipurpose connector of the present invention and use the further details of their using method to submit in 15th referring in Decembers, 2008; Its disclosure is incorporated this paper by reference into.
Impedance (EZ) measurement module
Receptor of the present invention can comprise the impedance measurement module, and for example wherein these devices are configured to the impedance at least one pair of electrode two ends of measuring device.The impedance measurement module can be configured to determine the loop circuit impedance of the tandem compound of two electrodes and resistive load (for example therebetween tissue provides).The impedance measurement module is included in the current source piece that the electrode two ends provide electric current, and the voltage processing block of the voltage signal at measuring resistance load two ends and definite electrode impedance.For example, receptor can be configured to apply at described two electrode two ends the square wave current of 2 μ App (the RMS amplitude is 1 μ Arms).This enough detects the electrode that breaks away from.Application can include but not limited to: the receptor diagnostic application, for example wherein adopt the impedance of measuring to determine whether electrode disconnects with the patient and/or whether electrode is working; Patient monitoring is used, and determines one or more physiological parameter etc. as wherein adopting impedance.
Figure 27 provides according to an aspect of the present invention the circuit diagram of drive scheme 2700 modelings that realized by the current source piece.Shown in this respect, can drive to derive bipolar current from unipolar logic, wherein there is not " DC " component in the drive scheme.Generate two electric currents " EZ_Carrier " 2720 and " EZ_Balance " 2730, and provide electrode current lez 2710 at two electrode two ends." EZ_Carrier " 2720 and " EZ_Balance " 2730 can be generated by for example low-power processor (for example microprocessor), and by connect to realize (unknown electrode impedance) with capacitor 2740 and resistor 2750.
Voltage processing block measurement electrode two ends (being resistive load-resistor 2710 two ends) by electrode current lez 2710 produce voltage signal 2760.Then the voltage processing block can determine electrode impedance with voltage signal 2710.For example, can at first press [gain=287] amplifies voltage signal 2710, limit tape handling with the reduction noise by 5KHz HPF and 33KHZ LPF to it, and it is put on A/D converter input (12 A/D converters of for example sampling at the 500KHz place) in order to the digit data stream that comes from voltage signal is provided.For example, DSP can process digit data stream to determine electrode impedance.For example, DSP can EZ carrier frequency (for example 20KHz) locate will input data flow and sinusoidal wave mixed frequency, Hogenauer (" CIC ") wave filter is used in the low pass filter, and data flow is extracted sampling (for example extracting by 16).This first-harmonic with carrier energy moves on to 0Hz.DSP then can calculating data the absolute value (value) of stream, on 1 second time period, it is got average, then use following formula to convert thereof into impedance:
Zelectrode=(Vc/ (lez * gain))-300
Wherein: Vc is in the amplitude that lez carrier frequency (20KHz) records at A/D converter.Gain arranges G3...G0=0000; Use 287 to calculate as yield value.300 ohm of Tare resistance (electrode impedance) that this obtains connecting with tested electrode.
The circuit diagram that Figure 28 provides the electrode impedance of use 3 line ohmmeters according to an aspect of the present invention to measure.Current source piece generation EZ carrier wire 2820 and EZ balanced line 2830 are to provide the electrode current (lez) 2810 of the ohmic load of flowing through (electrode resistance En 2850).Utilize Kelvin to connect, and no current electrode (impedance) Em 2860 that flows through, the voltage of being observed by the first order 2870 will be lez * (300+En).Electrode current lez 2810 can be 2 μ App=1 μ ARMS for example.
The impedance measurement module comprises control module and processing module and electrode.Impedance measurement is the example that can utilize the sensing function that any two electrodes of receptor realize.Except the function and deployment thereof of determining device, for example whether electrode is being worked as required and/or is being connected to the experimenter, can derive the physiological data of paying close attention to from the impedance of measuring.For example, the impedance of measurement will have certain component relevant with breathing of determining by striding the breast impedance.In this way, can adopt impedance data to obtain experimenter's breathing rate.Electrode 2860 can also be used as the sensor of experimenter's fluidised form.Pass in time, especially for the heart failure patient of diuretic, fluidised form is very important amount.The fluidised form that obtains can be used in carries out titrimetry to medicine and measures and/or give the alarm.Except measuring fluidised form, impedance measurement can also be used for measuring body fat.
Module realizes
In all fields, above-mentioned module, such as high power-low power module, intermediate module, stride one of health conductive electrical communication module, physiological sensing module, power module, memory module, external communication module etc. and/or their parts or the combination, can be implemented as software, such as digital signal processing software; Hardware, for example circuit; Or their combination.Therefore, other element that can exist in signal receiver includes but not limited to: demodulator of PM signal PM, and for example being used for will be from the signal interpretation of IEM emission; Signal projector for example is used for transmitting to external position from signal receiver; Data storage elements, such as the data that are used for the relevant signal that receives of storage, physiological parameter data, medical records data etc.; The clock element for example is used for special time is related with event (as receiving signal); Prime amplifier; Microprocessor is such as the one or more of difference in functionalitys that are used for coordinating signal receiver, band filter etc.
In some aspects, the module of receptor of the present invention is present on the integrated circuit, and wherein integrated circuit comprises a plurality of different functional devices.In given receptor, at least some in the module for example two or more, comprising that whole modules may reside in the single integrated circuit in the receptor (for example, adopts the form of SOC(system on a chip) or SOC) at most.Single integrated circuit refers to comprise the single circuit structure of all difference in functionality pieces.Therefore, integrated circuit is monolithic integrated optical circuit (being also referred to as IC, microcircuit, microchip, silicon, computer chip or chip), and described monolithic integrated optical circuit is the lip-deep microminiaturized electronic circuit (can comprise semiconductor device and passive component) that is manufactured on thin semiconductive material substrate.The integrated circuit of some aspect of the present invention can be hydrid integrated circuit, and they are the microminiaturized electronic circuits that consist of by being combined in each semiconductor device on substrate or the circuit board and passive component.
Fig. 7 provides the functional block diagram of the integrated circuit components of signal receiver according to an aspect of the present invention.In Fig. 7, receptor 700 comprises electrode input 710.What be electrically coupled to electrode input 710 is to stride health conductive electrical communication module 720 and physiological sensing module 730.In one aspect, stride health conductive electrical communication module 720 and be implemented as high frequency (HF) signal chains, and physiological sensing module 730 is implemented as low frequency (LF) signal chains.CMOS temperature sensing module 740 (for detection of ambient temperature) and 3 axis accelerometers 750 also are shown.Receptor 700 also comprises processing engine 760 (for example microcontroller and digital signal processor), nonvolatile memory 770 (being used for the data storage) and wireless communication module 780 (being used for installing the transmission of data in for example data upload action to another).
Fig. 8 provides the more detailed block diagram of the circuit of the functional block diagram that is configured to according to an aspect of the present invention to realize receptor shown in Figure 7.In Fig. 8, receptor 800 comprises electrode e1, e2 and e3 (811,812 and 813), and they for example receive the signal that transmits with electrically conducting manner by IEM emission, and/or sensing physiological parameter or the biomarker paid close attention to.By multiplexer 820 electrode 811,812 and 813 signals that receive are carried out multiplexedly, multiplexer 820 is electrically coupled to electrode.
Multiplexer 820 is electrically coupled to high bandpass filter 830 and low band pass filter 840.High-frequency signal chain and low frequency signal chain provide programmable gain to cover level or the scope of expectation.In this particular aspects, high bandpass filter 830 passes through the frequency in 10KHz to the 34KHz frequency band, and filters to carry the noise of outer frequency.This high frequency band can change, and can comprise for example scope of 3KHz to 300KHz.The frequency of passing through was amplified by amplifier 832 before converting thereof into digital signal by transducer 834, in order to be input to high-power processor 880 (being depicted as DSP), high-power processor 880 is electrically coupled to the high-frequency signal chain.
The lower frequency that illustrates in the scope that low band pass filter 840 makes 0.5Hz to 150Hz passes through, and filters the outer frequency of band.This frequency band can change, and for example can comprise less than 300Hz, such as less than 200Hz, comprise the frequency less than 150Hz.Amplify the frequency signal that passes through by amplifier 842.The accelerometer 850 that is electrically coupled to the second multiplexer 860 also is shown.Multiplexer 860 in the future the self-acceleration meter signal and carry out multiplexed from the amplifying signal of amplifier 842.Then be digital signal by transducer 864 with multiplexed conversion of signals, transducer 864 also is electrically coupled to low-power processor 870.
In one aspect, can substitute accelerometer 850 with digital accelerometer (such as the digital accelerometer of Ya De promise quasiconductor (Analog Devices) company manufacturing).Use digital accelerometer can realize various advantages.For example, because the signal that digital accelerometer produces has been number format, so the right open transformation device 864 of digital accelerometer, and be electrically coupled to low-power microcontroller 870,---in this case, no longer need multiplexer 860.Digital signal can also be configured to open its oneself when detecting motion, thereby further saves power.In addition, can also carry out the lasting meter step.Digital accelerometer can comprise that fifo buffer is to help control to send to the data flow of low-power processor 870.For example, can with data buffer storage in FIFO until full, at this moment, can trigger processor to wake up from holding state and receive data.
Low-power processor 870 can be the MSP430 microcontroller of company of Texas Instrument (Texas Instruments) for example.The low-power processor 870 of receptor 800 keeps holding state, and as mentioned previously, this needs minimal current consumption---for example 10 μ A or less, or 1 μ A or less.
High-power processor 880 can be the VC5509 digital signal processor of for example Texas Instruments.High-power processor 880 executive signal during active state is processed action.As previously mentioned, these actions need to be than the more substantial electric current of holding state---30 μ A or larger for example, such as 50 μ A or larger---and can comprise the signal that transmits with electrically conducting manner such as scanning, when the action that receives the signal that transmits with electrically conducting manner and then process the signal that transmits with electrically conducting manner, obtain and/or process physiological data etc.
Receptor can comprise that hardware accelerator module is with process data signal.Can come alternative such as DSP with hardware accelerator module.As more special-purpose computing unit, to compare with more general DSP, this computing unit is with some aspects of still less transistor (more low-cost and power) executive signal Processing Algorithm.The piece of these hardware can be used for the execution of " acceleration " important specific function.Some structures of hardware accelerator can be " programmable " by microcode or VLIM assembly.During use, can be by calling of function storehouse being visited their function.
Hardware accelerator (HWA) module comprises that the HWA input block is to receive input signal to be processed and for the treatment of the instruction of this input signal; And the HWA processing block is with according to the instruction process input signal that receives and generate as a result output signal.Can send as required as a result output signal by the HWA IOB.
Figure 30 provides the block diagram of HWA module according to an aspect of the present invention.As shown in the figure, input block 3001 is coupled to processing block 3002, and processing block 3002 is coupled to IOB 3003.Input block 3001 receives input signal 3001 and/or instruction 3015.HWA module 300 can for example be striden health conductive electrical communication signal and/or receive physiological data signals from one or more physiological sensing module from striding the reception of health conductive electrical communication module.
The HWA module can receive analogue signal, and comprise A/D converter take with conversion of signals as digital signal, maybe can receive digital input signals (for example from A/D converter or microprocessor).For example, the HWA module can be electrically coupled to A/D converter and microprocessor, and it has direct state machine from the A/D converter image data.In another embodiment, hardware accelerator can only be connected to the microprocessor by the microprocessor instruction deal with data.
Can be for example internally memorizer, external memory storage or receive instruction 3015 by microprocessor.On the one hand, HWA module and microprocessor shared storage (for example, via dual-ported memory or multiplexer).On the other hand, the HWA module is via DMA port swap data.
HWA processing block 3002 is processed input signal 3010 according to the instruction 3015 that receives.Can realize extracting such as DCO (digital controlled oscillator), DDC (digital downconverter), FIR wave filter, CIC by this hardware accelerator the function of sampling.It is optimum that these functions are processed for the IEM coherent signal, and also applicable to general data acquisition, impedance measurement, ECG signal processing (Hamilton and Tomkins), accelerometer etc.Can be sent as required by HWA IOB 3003 output signal 3020 of the gained of HWA processing block 3002 generations.
HWA module 3000 can also comprise that HWA power block 3030 is with the power supply of enables/disables to HWA module 3000.For example, HWA module 3000 can be configured to be de-energized and switch on, or is configured to that the clock that drives it is carried out gate (gating) and comes disabled etc.Realize its required number of transistors relatively less (about the scope of 10k to 100k door), wherein by the relevant most of static powers of memorizer/buffer depletion.Therefore hardware accelerator can realize low-power consumption.
Fig. 8 also illustrates the flash memory 890 that is electrically coupled to high-power processor 880.On the one hand, flash memory 890 can be electrically coupled to the low-power processor 870 that better power efficiency can be provided.
Wireless communication unit 895 is shown is electrically coupled to high-power processor 880, and can comprise for example BLUETOOTH TMWireless communication transceiver.On the one hand, wireless communication unit 895 is electrically coupled to high-power processor 880.On the other hand, wireless communication unit 895 is electrically coupled to high-power processor 880 and low-power processor 870.And, wireless communication unit 895 can be embodied as and have its oneself power supply, so that it can switch on and off by other parts that for example microprocessor is independent of receptor.
Fig. 9 provides the view of the block diagram of hardware relevant with the high-frequency signal chain in according to an aspect of the present invention the receptor.In Fig. 9, receptor 900 comprises the receptor probe that is electrically coupled to multiplexer 920 (for example with electrode 911,912 and 913 form).High pass filter 930 and low pass filter 940 also are shown so that the band filter of eliminating the outer frequency of any band to be provided.Shown in aspect, provide the band of 10KHz to 34KHz to pass to the carrier signal that drops in this frequency band passed through.Exemplary carrier frequency can include but not limited to 12.5KHz and 20KHz.Can there be one or more carrier wave.In addition, receptor 900 comprises analog-digital converter 950---the analog-digital converter of for example sampling with 500KHz.After this, DSP can processing digital signal.The device of DMA to DSP in this respect 960, it sends to digital signal the private memory of DSP.The benefit that direct memory access provides is to allow the remainder of DSP to remain on low-power mode.
The exemplary configuration of various states
As mentioned previously, for each receptor state, the high power function piece is circulated between active state and inactive state.For each receptor state, each receiver element of receptor (such as the power domain in circuit block, the processor etc.) also can be configured to by power module its independently circulation between switching on and off.Therefore, receptor can have different configurations for every kind of state in order to realize power efficiency.For example, Figure 29 illustrates receptor and has holding state and active state---for example holding state 110, smell spy state 130, separate the decoding state 140 that is in harmonious proportion, gather ECG and accelerometer state 120 and transmission state 160.Should notice that as mentioned previously beacon signal module can realize polytypely smelling the number of making inquiries about and realizing low power efficiency, thereby will smell for following embodiment that to visit status packet be inactive state.
Consider state shown in Figure 29, below paragraph the exemplary configuration of receptor parts shown in Figure 8 according to an aspect of the present invention during the various states of receptor is provided.Should be appreciated that, can realize the configuration that substitutes according to required application.
In state 110, receptor consumes minimum electric current.Configuration receptor 800 is so that low-power processor 870 is in inactive state (such as holding state) and high-power processor 880 is in inactive state (such as holding state), and the circuit block relevant with peripheral circuit and the power supply that needs during the comings and goings state thereof remain open (for example, wireless communication module 895 and AFE (analog front end)).For example, low-power processor can make the 32KHz agitator be in activity, and can consume the electric current of several μ A or still less, comprises 0.5 μ A or still less.In holding state, low-power processor 870 for example waiting signal is converted to active state.Described signal can be outside, such as interrupt signal, or the signal that is produced in inside such as intervalometer by one of peripheral hardware of device.During the holding state of high-power processor, high-power processor can for example run on outside the 32KHz clock crystal.High-power processor for example waiting signal is converted to active state.
When receptor is in when smelling the spy state, low-power processor 870 is in holding state, and high-power processor 880 is in holding state.In addition, the AFE (analog front end) required with smelling spy function circuit block relevant, that comprise A/D converter is (in other words, being the high-frequency signal chain) of opening.As mentioned previously, beacon signal module can realize polytypely smelling the number of making inquiries about and realizing low power efficiency.
When detecting the signal of transmission, can enter the solution mediation decoding state of higher-wattage.When receptor was in solution mediation decoding state, low-power processor 870 was in active state, and high-power processor 880 is in active state.High-power processor 880 can for example be moved from 12MHz or near crystal oscillator, and the clock speed that 108MHz is provided for device based on the clock multiplier of PLL.Low-power processor 870 can for example run on scope outside the R-C agitator of the inside of 1MHz to 20MHz, and each MHz clock speed consumes scope at 250 to 300uA power during active state.Active state allows to process and carry out any possible subsequent transmission.Required transmission can trigger wireless communication module to be recycled to unlatching from closing.
When receptor was in collection ECG and accelerometer state, the circuit block relevant with accelerometer and/or ECG Signal Regulation chain opened.During gathering, high-power processor 880 is in holding state, and between processing and transmission period, high-power processor 880 (for example is in active state, from 12MHz or near crystal oscillator operation, and the clock speed that 108MHz is provided for device based on the clock multiplier of PLL).During this state, low-power processor 870 is in active state, and the scope that can run on is outside the R-C agitator of the inside of 1MHz to 20MHz, and each MHz clock speed consumes scope at 250 to 300uA power.
Other state of receptor
Except the duty that receptor circulates between holding state and active state, receptor can also comprise other duty.Receptor can comprise storage configuration, for example presents low-down current drain 10 μ A or lower, such as 1 μ A or lower and comprise 0.1 μ A or lower.Under storage configuration, receptor for example can be configured to so that low-power processor is in holding state, and high-power processor is closed, and other receiver element as with active state during the relevant circuit block of required peripheral circuit close.Figure 29 illustrates the store status 170 of receptor.Receptor can change non-storage configuration into from store status according to a plurality of inputs, a plurality of being input as such as predetermined time table or the excitation that applies wherein, the manual operation that for example responds receptor (is for example pressed " unlatchings " button or from leave behind draw ring (tab) or respond " unlatching " signal that is sent to receptor of receptor.As shown in Figure 1, receptor can change holding state 110 into from store status 170.
Receptor can also be configured to comprise charged state, is charged state 150 shown in Figure 29.When receptor was in charged state, only low-power processor was opened, and for example is in holding state.The circuit block relevant with the power supply of high-power processor and all peripheral hardwares closed.
Receptor can also be configured to comprise transmission state 160, wherein can for example transmit data by using wireless communication protocol that data are sent to receptor with another device outside and/or from receptor and another device outside.High-power processor is in active state, and low-power processor is in active state, and opens such as other receiver element of the circuit block relevant with wireless communication module.
Receptor can also be configured to comprise " diagnosis " state.In diagnostic state, the operation of the one or more of functions that receptor can test receiver, such as signal receive, physiological data obtains and/or processing etc., in order to determine whether in correct these functions of carrying out.Receptor also can be configured to such as via signal (its can be can listen, visual, be forwarded to the 3rd device etc.) to the result of user report test.For example, receptor can be configured to all in normal operation or one or more of function problem is arranged to the user report all functions.In some respects, receptor changes diagnostic state into and leaves diagnostic state according to different inputs, described being input as such as predetermined time table (for example being provided by the receptor programming) or the excitation that applies, as mentioned above.
Communication via serial peripheral interface bus
Low-power processor (for example, MSP shown in Figure 8) and high-power processor (for example, DSP shown in Figure 8) can use any easily communication protocol to communicate each other.In some instances, these two elements (when existing) communicate each other via serial peripheral interface bus (hereinafter referred to as " spi bus ").The following description content description send signaling and the message transfer scheme that message realizes for making high-power processor and low-power processor communicate and to come and go along spi bus.For the following description of the communication between the processor, use respectively " LPP " and " HPP " replacement " low-power processor " with " high-power processor " so that maintenance is consistent with Fig. 8.But its discussion goes for other processor except shown in Fig. 8 those.
Interface configuration is main equipment for making LPP, and HPP is slave unit, and only by LPP side drive link.HPP can only respond LPP via SPI.In addition, SPI requires HPP at once to respond LPP.HPP is not waiting for these data, then loss of data if LPP sends data.According to an aspect of the present invention, signaling and the message of hereinafter describing interface transmit configuration, in order to overcome these limitations.
Signaling
In order to overcome above-mentioned limitation, in signaling protocol, realize three " outside the band " signals.LPP has it and can assert and cancel " attention " signal of asserting that HPP has " attention " and " allowance " signal.
Send data (for example, the message that LPP initiates) for LPP to HPP, LPP asserts its LPP attention.Then it waits until that HPP is by till asserting that HPP allowance signal responds.This has guaranteed that both sides all are that SPI gets ready alternately and data can not lost.At this moment, HPP can be from the LPP receipt message.If the current message that can't receive from LPP the LPP initiation then makes HPP can receive the message that LPP initiates.HPP keeps " online " until LPP asserts to its LPP attention cancellation.HPP asserts by its HPP allowance signal cancellation is asserted to respond this cancellation.At this moment, HPP can't be from the LPP receipt message.Because can receive the message that LPP initiates from LPP, so forbidding HPP receives the message that LPP initiates.In this case, system responds to level variation and the level itself of these signals.In other words, the request that system is considered as the signal of asserting to move, and system is considered as the level of this signal the indication that continues to move.Because HPP need not to carry out any operation before LPP asserts its LPP attention, HPP can enter low-power standby state.In this case, the LPP attention is not only asked the SPI link, and wakes HPP up.
Send for the data (for example HPP initiate message) to LPP for HPP, HPP asserts its HPP attention.This is asserted has data to LPP notice HPP.Asserting of HPP attention is the content of asserting of prompting LPP, but not the cancellation of HPP attention is asserted.HPP only needs this signal cancellation is asserted, then it just can assert this signal again.In case LPP sees the attention of HPP and asserts, then at last will according to hereinafter 1) respond.Do not require LPP at once to respond.In this case, important just asserting of signal.System never considers the existing level of this signal.
Message sends:
Because the reason of the master/slave genus appointment of spi bus, HPP can only respond LPP message.It can't inquire problem to LPP.In order to realize two-way data flow, above-mentioned signaling is embodied as with two types message transmits combination, as mentioned below.
Message for the LPP that mails to HPP initiates can adopt situation 1 above) come to send message to HPP.This type of message is not from requiring the response message of HPP.The example of a message can be that instruction " is processed this ECG ".Message informs that HPP expection has the ECG data, and then LPP a series of message that will comprise the ECG data send to HPP.Another example can be when LPP sends instruction to HPP and inform that it is that the IEM signal that transmits becomes and smells spy.
The message of initiating for HPP sends, and these message still must originate from LPP.In order to realize the communication of this direction, use above situation 2) inform that LPP inquiry HPP obtains message.Before HPP asserted the HPP attention, it prepared Query Information (that is, the message that HPP initiates), so that it can respond LPP at once.LPP sends a series of message to obtain inquiry from HPP.LPP inquires query length, and carries out this operation by sending " query length " message to HPP.The message that then LPP asks HPP to initiate with this length.Because LPP inquires query length, so knowing exactly, LPP to extract how many data from HPP.LPP is by sending query response message answer HPP " problem " to HPP.Because HPP is embodied as and once only has not finish an inquiry, so knowing, it to expect this response.
Should also be noted that for above-mentioned sequence, because LPP is that the SPI link " provides clock ", so LPP always knows to extract how many data from HPP exactly.In addition, in this regard, because LPP always inquires problem, and HPP always prepares to reply any problem from LPP, so do not guarantee that HPP always obtains " query length " message from LPP when HPP wants to send inquiry.
On the one hand, can for example realize error detection and correction with the Fletcher checksum algorithm.Retransmit because when detecting mistake, carry out, so for any message that needs execution action (smelling spy (pill sniff) etc. such as pill), this action is until whole situation 1 above) just carry out when finishing.This is important, because be correct data and LPP may detect mistake at HPP.Final confirm to finish and correct transfer of data is above situation 1) finish.
Global positioning system (GPS) module
Receptor of the present invention can comprise global positioning system (GPS) module.The GPS module is the module that receives signal and definite geographical position from the global positioning system of satellite as used herein.Any easily GPS module all may be utilized.
The receptor configuration
The medical treatment device related with health of paying close attention to comprises external device (ED) and implantable device.Aspect externally, receptor is external, this refers to that this device is present in outside the health between the operating period.Under receptor is outside situation, can adopt any easily mode to dispose them, wherein in some aspects, they are configured to related with required skin position.Therefore, in some aspects, outside receptor is configured to it is contacted with experimenter's local skin position.The configuration of paying close attention to includes but not limited to: paster, wrist strap, jewelry (such as wrist-watch, earrings and bracelet), clothes, associate member are such as belt and footwear, glasses etc.In some instances, these receptors for example are configured to by using suitable binding agent that it is adhered to skin part, and are as mentioned below.In some instances, these receptors are configured to contact with skin part, but do not adhere to it, for example wherein this device is configured to wrist strap, jewelry (such as wrist-watch, earrings and bracelet), clothes, associate member (such as belt and footwear) and a pair of glasses.In other other example, these receptors can be configured to remain in certain definition distance of skin surface, in 1cm, comprise in the 0.5cm.
In some aspects, receptor is implantable parts.Implantable this receptor that refers to for example is designed namely to be configured to based on semipermanent or permanently be implanted in the subject.In these areas, receptor is in vivo during use.Implantable refer to these receptors are configured to be present in physiological environment---comprising high salt, high humidity environment common in the health body---more than two days or two days, according to appointment one all or longer, approximately around longer, about six months or longer, about 1 year or longer for example about 5 years or more long time keep functional.In some aspects, implantable receptor be configured to when implant the physiological location place continue scope about 1 year to about 80 years or longer time period, as from about 5 years to about 70 years or longer, comprise scope from about 10 years to about 50 years or during the longer time period maintenance functional.For implantable aspect, receptor can have any easily shape, includes but not limited to: capsule shape, disc etc.Receptor can be configured to be placed in various position, such as abdominal part, lower back, shoulder (such as the position of placing implantable pulse generator) etc.Some implantable aspect, receptor is independent device, because it is not connected to the implantable device of any other type physically.In other other side, this receptor can be connected to the second implantable device physically, for example be used as the device of the platform of one or more biosensor, wherein device can be wire, such as the cardiovascular wire, wherein in these areas certain some aspect, the cardiovascular wire comprises the biosensor that one or more are different, and for example wherein this wire is multisensor wire (MSL).The implantable device of paying close attention to also includes but not limited to: implantable pulse generator (such as ICD), nerve stimulator, implantable flammentachygraph etc.
Receptor can comprise the signal receiver element, and it be used for to receive the signal that transmits with electrically conducting manner, such as the signal of the marker emission of Ingestible event marker.Signal receiver can comprise various dissimilar signal receiver elements, and wherein the character of receiver element is different according to the character necessity ground of the signal of signal generating element generation.In some aspects, the signal receiver element can comprise one or more electrode for detection of the signal of signal generating element emission, such as two or more electrodes, three or more electrodes etc.In some aspects, acceptor device will be provided with two or three electrodes that scatter by certain distance each other.This distance makes electrode can detect differential voltage.This distance can change, and in some aspects, its scope is at 0.1cm to 1.0m, and such as 0.1cm to 5cm, such as 0.5cm to 2.5cm, wherein in some instances, this distance is 1cm.
The embodiment of the external signal receptor aspect of the receptor of paying close attention to shown in Figure 10.Figure 10 illustrates receptor 1000, and it is configured to be placed on experimenter's the external partial position such as chest region.Receptor comprises top plating 1010 (such as can be by suitable polymeric material manufacturing), and comprise action button 1020 and the state identifier LED 1030 that can manually press, state identifier LED 1030 can be used for passing on the information that receptor is being worked to the observer.The action button 1020 that can manually press can be by manual control to change receptor into non-storage mode from storage mode.When receptor was in storage mode, the microcontroller of receptor can remain on the active state of low duty cycle always, processing the input from on/off buttons, and with digital signal processor (DSP) outage of receptor.When pressing on/off buttons so that receptor is switched on, it is moving and DSP switched on to enter its holding state that microprocessor controls will be inputted debounce.Under storage mode, device can consume the electric current less than 10 μ A, comprises the electric current of 5 μ A or less, such as 1 μ A or less, comprises 0.1 μ A or less.This configuration makes device deposit the available battery (there is the battery of 250mAH in supposition) that keeps in one month the situation greater than 90%.Can also adopt this button to come for other function.For example, can adopt this button to indicate receptor to obtain the data of some type.As additional or alternative, can adopt this button manually to indicate receptor that data are sent to another device.
Figure 11 provides the decomposition view of receptor shown in Figure 10.As shown in figure 11, receptor 1000 comprises top plating 1010, rechargeable battery 1100, integrated circuit components 1120 and bottom coverboard 1130.Bottom coverboard 1130 snaps in the top plating 1010 in order to battery and integrated circuit components 1100 and 1120 are sealed in the fluid-tight housing.Interact although snapping is shown, can adopt any easily coordinated scheme, so that top plating and bottom coverboard can interact by interlock slot, can be fixed together by suitable binding agent, can weld together etc.In some instances, can be with electric parts mold in top plating and/or bottom coverboard.Adhesive patch 1140 also is shown, and it snaps into top plating 1010 and comprises conductive pole 1141 to 1143, these posts as electrode at receptor between the operating period and Body contact.In receptor, post 1141 to 1143 electrically contacts via for example wire or other conductive member and the integrated circuit components 1120 related with upper case 1010.In an example, top plating 1010 comprises conductive member, and these conductive members are configured to hold the post 1141 to 1143 that is coupled to the wire (not shown), and wire provides to the electrical connection of integrated circuit components 1120.
Figure 12 provides the decomposition view of adhesive patch 1140.Adhesive patch 1140 comprises upper prop 1141,1142 and 1143, as mentioned above.These posts and contact skin post 1151,1152 and 1153 electrically contact.Be positioned on contact skin post 1151,1152 and 1153 its skin-side surface is conductive hydrogel layer 1154.Be positioned at each post 1151, around 1152 and 1153 be non-conductive hydrogel 1155 and contact adhesive 1156 parts.In this part, can adopt any easily physiologically acceptable binding agent.In some instances, the excitation of adopting response to apply changes its adhesive binding agent.For example, can adopt the binding agent that cohesiveness becomes lower when applying light (for example UV light) or chemicals, in order to keep strong cohesiveness when needing receptor to keep related with health, still its cohesiveness dies down easily and is beneficial to remove receptor from health as required.Be positioned on the non-skin side of each contact skin post is dried electrode material such as Ag/AgCl layer.Being positioned on the upper surface of this dried electrode material layer is porous layer, such as carbon ethylene (carbon vinyl) layer.Backing layer 1180 also is shown.Although not shown, upper prop 1141 to 1143 electrically contacts by backing layer 1180 (for example polyurethane and polyethylene) and dried electrode and contact skin post, these dried electrodes and contact skin post are positioned at the below of each upper prop.As shown in the figure, these posts with enough increases any two give between the fixed column dipole size mode, along the outer peripheral direction of the paster dried electrode layer off-center with respect to them.In addition, as required, figure that can be by for example changing porous layer 1170 and/or the composition of revising dried electrode layer are relevant with each post with electric conduction gradient.What pay close attention in aspect this type of is that electric conduction gradient increases progressively part along the outer peripheral direction of paster in conductivity.
Figure 13 A to 13E provides alternative outer paster to dispose a plurality of views of 1300, and outer paster configuration 1300 comprises two electrodes 1310 and 1320 in the flexible structure with cohesive bandage configuration.Paster 1300 comprises the flexible outer support part 1330 in top and lower flexible support member 1350, and its fitting together shown in Figure 13 E is in order to surround integrated circuit/battery component 1360 and electrode 1310 and 1320.Shown in Figure 13 D, electrode 1310 and 1320 basal surface expose.Shown in Figure 13 E, electrode 1310 and 1320 comprises lead elements and production method thereof 1375 and 1370, and lead elements and production method thereof 1375 and 1370 provides electrically contacting between electrode and the integrated circuit/battery component 1360.Can adopt any easily binder parts, as indicated above those.
Figure 14 A to 14B provides the block diagram that may reside in the exemplary hardware arrangement in the receptor shown in Figure 13 A to 13E.But, should be appreciated that these exemplary hardware arrangement are not limited to the aspect shown in Figure 13 A to Figure 13 E.
Figure 14 A provides the block diagram that can be included in the exemplary hardware arrangement in receptor such as the receptor 1300 according to an aspect of the present invention.As shown in the figure, hardware system 1400 comprises the first electrode 1310 and the second electrode 1320 that is electrically coupled to Analog ASIC 1410.ASIC 1410 can comprise for example AFE (analog front end) of hardware system 1400 (for example, high-frequency signal chain, low frequency signal chain etc.).As can realize AFE (analog front end) in ASIC, customized logic can substitute DSP.Show Digital ASIC 1420 and be electrically coupled to Analog ASIC 1410, and carry out digital Signal Regulation and processing.Show accelerometer 1430 such as three axis accelerometer and be electrically coupled to Digital ASIC 1420.On the one hand, accelerometer 1430 is electrically coupled to Analog ASIC 1410.It is also understood that, can realize digital accelerometer.Show microprocessor 1440 and be electrically coupled to Digital ASIC 1410 and flash memory 1450.In addition, show microprocessor 1440 and be electrically coupled to radio device 1460 such as wireless transceiver.
Figure 14 B provides the block diagram that can be included in another exemplary hardware arrangement in receptor such as the receptor 1300 according to an aspect of the present invention.In hardware system 1490, show electrode 1310 and 1320 and be electrically coupled to optional low-noise amplifier (LNA) 1461.Show Analog ASIC 1462 and be electrically coupled to LNA 1461, and Analog ASIC 1462 can comprise for example AFE (analog front end) of hardware system 1490.Show Digital ASIC 1463 and be electrically coupled to Analog ASIC 1462, and carry out digital Signal Regulation and processing.In this regard, Digital ASIC 1463 also comprises microprocessing unit 1464, and microprocessing unit 1464 can be any easily microprocessing unit, such as the CORTEX-M3 of ARM company TM Microprocessing unit.Accelerometer 1430 is electrically coupled to Analog ASIC 1462, but as mentioned previously, accelerometer 1430 may be implemented as and is electrically coupled to Digital ASIC 1463 and digital accelerometer.What be electrically coupled to Digital ASIC 1463 is radio device 1460.
Figure 14 C provides the block diagram that can be included in another exemplary hardware arrangement in receptor such as the receptor 1300 according to an aspect of the present invention.In hardware system 1480, two ASIC among single SOC(system on a chip) (SOC) 1470 alternate figures 14A and the 14B.For example, SOC 1470 with the ASIC 1410 shown in the alternate figures 14A and 1420 or Figure 14 B shown in ASIC 1462 and 1463 (in this case not shown optional LNA 1460).In this case, radio device 1460 is electrically coupled to SOC 1470.
Figure 14 D provides the block diagram that can be included in another exemplary hardware arrangement in receptor such as the receptor 1300 according to an aspect of the present invention.In hardware system 1499, optional LNA 1461 is electrically coupled to electrode 1310 and 1320.Show SOC 1482 and be electrically coupled to optional LNA 1461, accelerometer 1430, temperature sensor 1494 and radio device 1498 (wireless communication module that for example, comprises transceiver).SOC 1492 comprises processor 1492, electrode input 1484, AFE (analog front end) 1486 (for example, striding health conductive electrical communication module and physiological sensing module) and software defined radio device 1488.In addition, temperature sensor 1496 also can be included in single ASIC 1470 and/or the radio device 1498 (sensor is not shown).
As required, one or more parts of receptor can be applied the conformal atresia sealant of describing in the U.S. Patent Application Serial Number 12/296,654 for example, the disclosure of this application is incorporated this paper by reference into.Conformal atresia sealant can be characterized by " thin film " coating, because its thickness makes it can significantly not increase the cumulative volume of the structure of associated, wherein can be about by any increase on the caused device volume of this layer volume 10% or still less, as be about volume 5% or still less, comprise be about volume 1% or still less.According to aspects of the present invention, the thickness of conformal atresia sealant such as in the scope of 0.3 to 3.0 μ m thickness, and is included in the scope of 1.0 to 2.0 μ m thickness in the scope of 0.1 to 10.0 μ m thickness.According to aspects of the present invention, can use plane treatment agreement (planar processing protocol) to apply conformal atresia sealant, described plane treatment agreement for for example plasma reinforced chemical vapour deposition, physical vapour deposition (PVD), sputter, evaporation, cathodic arc deposition (referring to for example U.S. Patent Application Serial Number 12/305,894, its disclosure is incorporated this paper by reference into), low-pressure chemical vapor deposition and other this type of technique.When existing, conformal atresia sealant can comprise various different materials.On the one hand, this layer comprises carborundum to produce the highly corrosion resistant sealing.Alternatively, this layer can comprise silicon dioxide, oxycarbide, carbon nitrogen oxide, such as the metal of noble metal and alloy thereof such as platinum, rhodium, iridium and alloy thereof, metal silicide, nitride, tungsten carbide or other carbide such as silicon nitride, carboritride, aluminium nitride, titanium nitride.This layer can be monolayer or be made of the multilamellar of same material or different materials.When adopting multiple material, can also calculate thermal coefficient of expansion and it is designed so that these materials can not affect the receptor parts of associated negatively.In some instances, conformal atresia sealant covers at least a portion (if not covering whole outer surface) of the outer surface of receptor.In this type of example, be electrically connected the telecommunication may reside in the sealant with between the external environment condition that parts in the receptor and receptor are provided.
Activating agent is sent
Receptor of the present invention can comprise that activating agent sends parts.Activating agent is sent parts (when existing) and can be changed.In some instances, activating agent is sent the different parts that parts can be receptors, and wherein these parts can comprise the surfactant composition source.Surfactant composition can change, and comprises the one or more of activating agents of being combined with carrier compositions, and wherein this carrier compositions can be the liquid or solid compositions, and can be configured to the delivery characteristics that provides as required controlled.The activating agent of paying close attention to is sent parts and is included but not limited to: solid delivery form, such as patch and ointment delivery form, and fluid is introduced form, such as the ionophoresis form with adopt the form of micropin parts, as more detailed description hereinafter.For implantable receptor, can adopt any easily activating agent to send form.The example that the activating agent of paying close attention to is sent form includes but not limited to: those activating agents of describing in 11/897,931 are sent form; Its disclosure is incorporated this paper by reference into.Decide on concrete form, send parts can comprise provides a certain amount of surfactant composition from the device feature of sending from medicament source to the patient.Device feature can change in large scope, and wherein the example of device feature comprises selective membrane, pump, electric field source, micropin etc.In some instances, activating agent can be sent parts is combined with other parts of receptor.For example, comprise in the situation of binder parts at receptor that the adhesive composition of binder parts can comprise one or more of activating agents as required, wherein this adhesive composition can be filled a prescription as providing any required activating agent to send characteristic.In comprising the situation that activating agent is sent, receptor can be configured to respond reception dose signal, respond one or more physiological parameter that detects (for example, device is configured to the closed loop activating agent and sends device) etc. and according to the predetermined dosage active agent delivery course for the treatment of.
Micropin
Receptor of the present invention can comprise the micropin parts, and the micropin parts can be configured to send for detection of analytes and/or activating agent, for example more detailed description hereinafter.The micropin parts of paying close attention to be configured to for Wicresoft, painless and easily mode biological fluid is sent to another position (for example external position) from the physiology source.The micropin parts can be configured to allow in the body sensing or from health as from skin or see through skin and extract biological fluid, and to damage, the pain of tissue or stimulate minimum or do not have.
The micropin parts can comprise one or more micropin (wherein can any easily form such as cubical array form dispose a plurality of micropins), connect the substrate of one or more micropin, fluid chamber and/or the sensor that communicates with one or more micropin.
Micropin can be configured to play the effect of conduit, sensing element or their combination.The conduit micropin can have the bar of porous or hollow.As used herein, aperture or hole that term " porous " expression has at least a portion of the microneedle configuration of passing, enough large and abundant interconnection transmits to allow liquid and/or solid material to pass micropin.As used herein, term " hollow " expression has hole or the passage of one or more general toroidal of the inside of the microneedle configuration of passing, and it has enough large diameter to allow liquid and/or solid to pass the micropin transmission.In case of necessity, looping pit can the direction along needle point to base extend through whole needle body or its part, extends or in the side branch of needle body or form outlet in the direction that is parallel to needle body.Solid or porous micropin can be hollow.As required, can apply to one or more micropin (if solid, porous or hollow) and/or use at least in part sensitivity or diffusional modification (diffusion-modifying) Material Filling (if porous or hollow).
Micropin can by various material structures, comprise metal, pottery, quasiconductor, Organic substance, polymer and composite.The building material of paying close attention to includes but not limited to: alloy, silicon, silicon dioxide and the polymer of pharmaceutical grade rustless steel, gold, titanium, nickel, ferrum, stannum, chromium, copper, palladium, platinum, these or other metal.The biodegradable polymer of paying close attention to includes but not limited to: hydroxy acid polymer such as lactic acid and glycolic polylactic acid, polyglycolide, polylactic acid-polyglycolic acid lactide copolymer and with the copolymer of PEG, poly-anhydride, poe, polyurethane, poly-butanoic acid, poly-valeric acid and lactide caprolactone copolymer.The not biodegradable polymer of paying close attention to includes but not limited to: Merlon, polymethylacrylic acid, ethylene-vinyl acetate, politef and polyester.
Micropin can be configured to have is that circular cross section or described cross section can be non-circular bars in the vertical direction.For example, the cross section of micropin can be polygon (such as star, square, triangle), ellipse or other shape.Described bar can have one or more hole.Described cross sectional dimensions can change, and in some instances, its scope is between 1 μ m and 500 μ m, between 10 μ m and 100 μ m.Its external diameter and internal diameter also can change, and wherein in some instances, its external diameter scope is between 10 μ m and 100 μ m, and in some instances, its inside diameter ranges is between 3 μ m and 80 μ m.The length of micropin also can change, and in some instances, its scope between 100 μ m and 500 μ m, comprises between 150 μ m and the 350 μ m between 10 μ m and 1mm.
The substrate of device can be by various material structures, and described various materials comprise metal, pottery, quasiconductor, Organic substance, polymer and composite.Substrate comprises micropin pedestal accompanying or that form with micropin.As required, the substrate of micropin parts can be combined with another parts of receiver architecture.
Fluid chamber's (being configured to fluid acquisition chamber or activating agent apotheca) and/or sensor can be attached to substrate or be formed the part of substrate (for example, as) for directly to communicate with the pedestal of micropin.
Fluid chamber's (when existing) can optionally be connected with hole or the aperture of micropin, so that biological fluid can be crossed micropin from micropin flow of tissue on every side, and flow to fluid chamber, perhaps surfactant composition can flow through micropin and flows in the subject from this chamber.As required, fluid chamber is attached to substrate or be attached in the substrate.Fluid chamber can be basically rigidity maybe can hold yielding.Fluid chamber can being combined to form by one or more of polymer, metal, pottery, quasiconductor or they.In one aspect, fluid chamber comprises porous or adsorbing material such as sponge, gel or paper or polymer belt.Fluid chamber can comprise the fluid surfactant composition, and it comprises the one or more of activating agents of being combined with carrier formulation.Therefore, as required, this fluid chamber can be empty at first, or can air inclusion or the one or more of reagent of any form (such as the liquid or solid granule) or activating agent etc.
As required, the micropin parts can comprise one or more sensor.These sensors can be arranged in micropin or device body (for example fluid chamber).These sensors can or be attached to one or more micropin in one or more micropin, be attached in the substrate or be positioned at fluid chamber or communicate with it.The sensor of paying close attention to comprises pressure transducer, temperature sensor, chemical sensor, pH sensor and/or emf sensor.The sensor of paying close attention to comprises those sensors of the existence that is configured to chemical analyte in the detection of biological body fluid sample, and the chemical analyte of wherein paying close attention to includes but not limited to: blood glucose (glucose), cholesterol, bilirubin, sarcosine, various metabolic enzyme, hematochrome, heparin, hematocrit, vitamin K or other thrombin, uric acid, carcinoembryonic antigen or other tumor antigen, various reproductive hormone are such as those reproductive hormones relevant with ovulation or gestation, medicine and/or its metabolite of abuse; Blood alcohol concentration etc.In some aspects, the configuration material that detects of receptor or characteristic comprise lactate (be important for the athlete), oxygen, pH, ethanol, Nicotiana tabacum L. metabolite and illicit drug (all be important for medical diagnosis and law enforcement).Sensor (when existing) can with micropin sensor function module communication, micropin sensor function module can comprise software and/or hardware component and exist only in the micropin parts and/or be attached at least to a certain degree in the other parts of receptor.
System
In some aspects, receptor is the system related with health of device or the part of network, described device such as sensor, signal receiver and can be inner and/or other outside device alternatively, these devices provide final various dissimilar information by processor such as ppu collection and processing, and then processor can provide relevant live body experimenter such as patient's venation data as output.For example, receptor can be the member in the interior network of the body of device, and it can be provided to the output that comprises the data of relevant IEM absorption, one or more physiological sensing parameter, implantable device operation etc. the external collector of data.Then the external collector of data, such as the form that adopts medical network server etc., the data that this receptor is provided and the combinations such as relevant patient's other related data such as weight, weather, medical records data, and can process this isomeric data with the data of patient's special use that height specific aim and venation are provided.
In some aspects, system of the present invention comprises signal receiver aspect and one or more IEM of receptor.The IEM that pays close attention to comprises those that describe in the following patent documentation: the PCT patent application serial numbers PCT/US2006/016370 that is disclosed as WO/2006/116718; Be disclosed as the PCT patent application serial numbers PCT/US2007/082563 of WO/2008/052136; Be disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO/2008/063626; Be disclosed as the PCT patent application serial numbers PCT/US2007/022257 of WO/2008/066617; Be disclosed as the PCT patent application serial numbers PCT/US2008/052845 of WO/2008/095183; Be disclosed as the PCT patent application serial numbers PCT/US2008/053999 of WO/2008/101107; Be disclosed as the PCT patent application serial numbers PCT/US2008/056296 of WO/2008/112577; Be disclosed as the PCT patent application serial numbers PCT/US2008/056299 of WO/2008/112578; And the PCT patent application serial numbers PCT/US2008/077753 that is disclosed as WO/2009/042812; The disclosure of these applications is incorporated this paper by reference into.
In some aspects, system comprises the external device (ED) that is different from receptor (it is implantable or local applying in some aspects), and wherein this external device (ED) provides several functions.This external device (ED) can comprise the ability that feedback and suitable clinical adjustment are provided to the patient.This device can adopt any in the various ways.For example, this device can be configured to be positioned on the bed on patient next door, for example bedside monitor.Other form includes but not limited to PDA, smart phone, home computer etc.
System of the present invention embodiment shown in Figure 15 A.In Figure 15 A, system 1500 comprises the pharmaceutical composition 1510 that contains IEM.Also there is signal receiver 1520 in the system 1500, the signal receiver as shown in Figure 10 to Figure 12.Signal receiver 1520 is configured to detect the signal from the marker emission of IEM 1510.Signal receiver 1520 also comprises the physiological sensing ability such as ECG, and the moving sensing ability.Signal receiver 1520 is configured to data are sent to patient's external device (ED) or PDA 1530 (device that enables such as smart phone or other radio communication), and then described external device (ED) or PDA 1530 are sent to server 1540 with data.Server 1540 can be configured to for example provide the license of patient's Intentionality as required.For example, server 1540 can be configured to allow home care person 1550 to participate in patient's treatment plan, for example via interface (such as network interface), thereby allow alarm that home care person's 1550 monitor servers 1540 generate and trend and for the patient provides support, shown in arrow 1560.Server 1540 can also be configured to directly provide response to the patient, and such as the form with patient alarm, patient's stimulation etc., shown in arrow 1565, these responses are transmitted to the patient via PDA 1530.Server 1540 can also with the medical professional (for example, RN, doctor) 1555 mutual, the measurement that medical professional 1555 can the usage data Processing Algorithm obtains patient health and compliance, for example, health index report, alarm, intersection patient's benchmark (cross-patient benchmark) etc., and provide clinical communication and the support of informing to the patient, shown in arrow 1580.
Another embodiment of system of the present invention shown in Figure 15 B.Figure 15 B has described a kind of system that comprises syringe 15107, receptor 15105, blood glucose meter 15110, radio communication device 15115, communication link 15150B-E and Dose Manager 15160.System generally is provided for the intelligent mechanism that control is sent by the dosage of syringe 15107 (for example, the cassette joint of subcutaneous injection inserting needle or the built-in access to plant of vein (luer connection)).Described control example as can comprise detect syringe 15107 whether near the patient, measure syringe 15107 administrations dosage, metrical information is sent to other device such as receptor 15105, blood glucose meter 15110, wireless device 15115 and/or Dose Manager 15160, and one or more device in these devices provides feedback information.In some implementations, feedback information can prevent from using to patient's dosage, for example uses the interlocking on the syringe 15107 to avoid supplying dosage.Syringe 15107 can not indicated and this dosage should be administered to the patient based on feedback output visual indication (for example light emitting diode (LED)) or audible signal.For example, mutual interlocking gear, LED and/or the sound on the syringe 15107 can signal the medicine of the positive acceptance error type of patient, at wrong time acceptable dose and/or the medicine of acceptance error consumption.
In some implementations, syringe 15107 can be configured to the interlocking pattern and as default setting to prevent dispenser, until Dose Manager 15160 provides feedback information that syringe 15107 releases are just allowed to use medicament or medicine.
In addition, in certain embodiments, syringe 15107 can comprise that measuring mechanism is to provide the metrical information of expression dosage.When the case, Dose Manager 160 can use this metrical information together with other patient information, when controls and/or how much dosage is offered the patient such as blood pressure, blood sugar level, heart rate, Ingestible event marker (IEM) data etc.In addition, when syringe 15107 during near patient body (for example enter or close), syringe 15107 can start measuring mechanism (it provides metrical information), at this moment, by signal with metrical information and out of Memory, be carried to other device such as the identifier relevant with syringe 15107, patient's identifier etc., such as receptor 15105, blood glucose meter 15110 and/or wireless device 15115, in order to be sent to Dose Manager 15160.In addition, these other devices can be monitored the time by syringe 15107 dispensers.Therefore, Dose Manager 15160 can receive the precise time of when dispenser, but not depends on the spraying time that the user provides.Therefore, system can carry event for assessment of the particular fluid between injection fluid delivery device such as syringe 15107 and the patient.
Aspect some of system of the present invention, comprise that the receptor of the present invention of Multipurpose connector is operably connected to patient or another equipment via Multipurpose connector.Repeat as mentioned, other device that receptor operationally is attached thereto includes, but not limited to external charging apparatus, external programmer device, external data processing device etc.In some instances, system can comprise operationally be directly connected to the patient or be operably connected to the device related with the patient, such as the receptor of the outer portion near end of the medical treatment device implanted.
Be operably connected at receptor in the situation of external device (ED), it can be directly connected to external device (ED), or via one or more different electrical connector, is connected to external device (ED) such as cable, electric wire or similar structures.The example of an external device (ED) is external programmer device.Programmer can be configured to change the setting of receptor.For example, programmer can be changed the work setting of receptor, such as persistent period of the frequent degree of the parameter of relevant patient's signal measurement, measurement, measurement, be used for the electrode measured etc.Programmer can also be changed the mode of operation of receptor.Programmer can also send data to receptor, such as medical records or about other data of patient.Programmer can be any device that is applicable to this purpose.The programmer of paying close attention to comprises, but be not limited to, have computer, personal digital assistant (PDA), smart phone, information transfer device or other hand-held device etc. of monitor built-in or peripheral hardware (as being found in bedside monitor or health information system).
System of the present invention can also comprise the external data processor that is configured to from the receptor receive data.External data processor can be directly receives electrical signal data from receptor, or receives electrical signal data via data forwarding device (as from the signal receiver receive data related with health, then with the data retransmission that the receives device to the vitro data processor).External data processor can be configured to come receive data via any easily wired or wireless agreement as required.Some external data processors of paying close attention to can be by being connected to Multipurpose connector from the receptor receive data.The external data processor of paying close attention to is can receive electrical signal data and process these data to produce those of useful information.External data processor can also store data simply so that subsequent treatment or check.Can the data of processing be exported to the user by any easily medium, these media as data are write on the paper, via graphical user interface for the data of user's display process etc.Can adopt any useful form such as figure, table or signal to come arranging data.The external data processor of system of the present invention can adopt various configurations, such as the computer with monitor built-in or peripheral hardware (for example, embedding bedside monitor or health information system), personal digital assistant (PDA), smart phone, information transfer device etc.
Dynamical feedback and the treatment circulation of the suggestion that system of the present invention allows to follow the tracks of administration time and level, measurement therapeutic response and provides change dosage based on physiology and the molecular characterization of individual patient.For example, symptomatic heart failure patient takes multi-medicament every day, and main purpose is for the workload that alleviates heart and improves Quality of Life.The primary treatment medicine comprises angiotensin converting enzyme (ACE) inhibitor, beta-blocker and diuretic.For so that Drug therapy takes effect, key is that the patient will observe its prescribed treatment plan, takes required dosage in the suitable time.Multinomial studies show that in the clinical literature: the II class above 50% and III class heart failure patient are not accepted the treatment that guide is recommended; And carried out the patient of suitable titrimetry for wherein some, only the patient of 40-60% has observed treatment plan.By this thematic system, can monitor heart failure patient to the situation of deferring to for the treatment of, and can connect to help doctor's optimizing therapeutic regimen with crucial physiological measurements with deferring to performance.
In some aspects, can adopt system of the present invention to obtain to comprise the information aggregate of sensing data and dispenser data.For example, people can combine heart rate, breathing rate, multiaxis expedited data, the information of relevant fluidised form and the information of relevant temperature, then derive and will inform the index of relevant experimenter's overall activity, these indexs can be used for generating physical signs, such as activity indicators.For example, when temperature raise, heart rate will rise a bit, and breathed and accelerate, and this can be used as the indication of activity of this person.By calibrating this category information, can determine that this person is in the amount calories of burning at that moment.In another embodiment, one group of particular rhythm pulse or multiaxis expedited data can indicate a people going on a flight of stairs, and people can infer that they are consuming how much energy thus.On the other hand, body fat can be measured (for example according to impedance data) and be combined to generate physical signs with the activity indicators of the combination producing of tested biomarker device, to be used for weight management or cardiovascular health plan.This information and cardiac performance index can be combined to obtain the fine status of holistic health, it can be combined with Drug therapy dispenser data.On the other hand, people may find that for example specific medication is relevant with small size rising or the Electrocardiographic variation of body temperature.People can develop the pharmacophore model for drug metabolism, and use from the information of receptor and estimate the level in the serum that actually exists in the experimenter is provided more accurately with the free parameter in this model of match necessarily.This information can be fed back to the dosage treatment plan.On the other hand, for as high risk pregnancy monitoring, people can be in conjunction with measuring uterine contraction (for example, adopting strain-ga(u)ge measurement) and also monitoring the information of the sensor of fetal heart frequency.
In some aspects, can will use experimenter's specific information of system acquisition of the present invention to send to certain position, in this position with this information be combined to provide data acquisition system from one or more other individual data, described data acquisition system is from two or more, comprehensive such as five or more, ten or more, 25 or more, 50 or more, 100 or more, 1,000 or the individual data that gather such as more.Then can process described synthetic data, for example according to various criterion it is classified, and make it available to one or more dissimilar grouping, such as patient's grouping, medical personnel's grouping etc., wherein the processing of data can be so that the access rights of any given grouping be made as the data type that this grouping can be accessed.For example, can be from suffering from identical disease and taking image data 100 Different Individual of same medicine.Can to these data process and with its develop be easy to defer to for the patient to the situation of deferring to of drug rehabilitation program and the demonstration of general health.The patient member of this grouping can access this information and check their situation of deferring to and other patient member's of this grouping comparable situation, and whether they have enjoyed the benefit that other people is experiencing.On the other hand, the access right that can also authorize integrated data processing to the doctor is with the patient that checks them and other doctor's patient's comparable situation, and obtains relevant actual patient to the useful information of the reaction of given treatment plan.Can provide additional function to the grouping of Internet access synthetic data, wherein this type of function can include, but are not limited to: the ability of annotation data, chat feature, confidentiality privilege etc.
These receptors can be the parts of the system described in the following patent application: PCT patent application serial numbers PCT/US08/85048; Be disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/095183; The PCT patent application serial numbers US2006/016370 that is disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/063626 and is disclosed as WO 2006/116718; The disclosure of these patent applications is incorporated this paper by reference into.
According to a further aspect in the invention, receptor can be realized in every way, comprise implantable device, such as half implantable device of subcutaneous device and the outside device (such as individual signal receiver) that applies or locate, and each device all can use with the dosage delivery system.The receptor that the example of the receptor configuration of paying close attention to includes, but are not limited to describe in the following patent application disposes: the PCT patent application serial numbers PCT/US08/85048 that is disclosed as WO 2009/070773; Be disclosed as the PCT patent application serial numbers PCT/US2007/052845 of WO 2008/095183; The PCT patent application serial numbers US2006/016370 that is disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/063626 and is disclosed as WO 2006/116718; The disclosure of these patent applications is incorporated this paper by reference into.An example of the individual signal receiver that uses with the dosage delivery system is to adhere to removedly user's skin or " paster " receptor on the clothes.Other enforcement comprises wrist strap or IV access device.In some implementations, the personal health signal receiver that receptor may be embodied as related with health (for example being positioned at body or extremely approaching with health), and can be configured to decipher from the body transmitter receipt signal that is positioned at body and to signal.
Receptor according to instruction of the present invention can also be configured to receive information from other source, such as intelligent event flag device (IEM) data.In this case, receptor 105 can detect the data relevant with the IEM event, such as using the medicine that contains the radio frequency identifiers shape, can process these data and it is forwarded to another device, such as blood glucose meter 110 and/or wireless device 115, in order to further process and forward it to Dose Manager 160.
In some aspects, system also comprises the element for storage data, i.e. data storage elements.Data storage elements can be computer readable medium.Term " computer readable medium " refers to participate in provide instruction and/or any physical store or the transmission medium of data to be used for carrying out and/or processing to computer as used herein.The example of storage medium comprises floppy disk, tape, CD-ROM, hard disk drive, ROM or integrated circuit, magneto-optic disk or computer-readable card (such as pcmcia card etc.), and no matter such device is inner or outside for computer.Can be with the file " storage " of inclusion information on computer readable medium, wherein " storage " refer to recorded information so that it afterwards can be by computer access and retrieval.With regard to computer readable medium, " permanent memory " refers to be nonvolatil memorizer.Permanent memory can not stop because of the power supply of computer or processor being wiped free of.Computer hard disc driver ROM (that is, not being used as the ROM of virtual memory), CD-ROM, floppy disk and DVD are all examples of permanent memory.Random access memory (RAM) is the example of volatile memory.File in the permanent memory can be editable and rewritable.
The present invention also is provided for carrying out the computer executable instructions (i.e. programming) of said method.Computer executable instructions is present on the physical computer-readable media.Correspondingly, the invention provides comprise for detection of with the computer readable medium of processing by the programming of the signal of compositions of the present invention (for example, as above repeating) generation.
As above repeat, pay close attention to some aspect, receptor comprises the quasiconductor support component.When making receiver architecture and parts thereof, can adopt in the various different agreements any.For example, can adopt molded, deposition and material to remove, for example the plane treatment technology such as Micro Electro Mechanical System (MEMS) manufacturing technology, comprises face micro-processing technology and body micro-processing technology.Making the deposition technique that can adopt in some aspect of these structures includes, but are not limited to: plating, cathodic arc deposition, plasma spray, sputter, electron beam evaporation plating, physical vapour deposition (PVD), chemical vapour deposition (CVD), plasma strengthening chemical vapour deposition (CVD) etc.Material removal technique includes, but are not limited to: reactive ion etching, anisotropy chemistry etching, isotropism chemistry etching, complanation (such as by chemically mechanical polishing), laser ablation, discharge processing (EDM) etc.The in addition photoetching agreement (lithographic protocol) of paying close attention to.What pay close attention in some aspect is to use the plane treatment agreement, wherein uses the multiple different materials that is applied in a sequential manner substrate to remove agreement and deposit agreement to make up structure and/or remove structure on one or more surface of the substrate on initial plane.The exemplary manufacture method of paying close attention to has more detailed description in common unsettled PCT patent application serial numbers PCT/US2006/016370; Its disclosure is incorporated this paper by reference into.
In some aspects, can adopt the off-the-shelf parts to make these receptors or its parts.For example, can adopt the instrumentation amplifier for the off-the-shelf that input is amplified, for example adopt the bare chip form.Can use the customized logic of carrying out demodulator, memorizer, microprocessor function and total interface function, FPGA or ASIC.Emitter can be the chip of getting permission for the off-the-shelf of medical embedded for example mixed communication band.Clock can be clock independently, or device can have the microprocessor that contains onboard clock.
Aspect of the present invention also comprises the method for using receptor.In the method for receptor, receptor receives input signal in some way, and wherein input signal can be different.The example of input signal includes, but are not limited to: stride the signal (as receiving from IEM or intelligent non-intestinal delivery apparatus) of health conduction reception, signal such as physiological parameter and/or the ambient signal etc. that the device sensor obtains.Various aspects of the present invention comprise that also the device response receives input signal and moves in some way, such as forwarding a signal to the second device, bioactive agent delivery is delivered to and installing related experimenter etc.
In certain methods of the present invention, as optional step, emitter (such as IEM) conduction transmitted signal in the body at first.Then the signal that receive to be sent by receptor wherein can be stored into memorizer with it, and it is re-send to another receiver, such as directly or via the 3rd device, export to user etc. such as outside PDA.Emitter is that IEM uses by absorption as required in the inventive method of IEM in the body therein.
It is found that method of the present invention can be used for treating various disease, comprise the symptom application.The specific symptoms of available combination treatment of the present invention is difference with the type that can be present in the activating agent in the compositions of the present invention.Therefore, symptom includes, but are not limited to: cardiovascular disease, cell breeding disease (such as tumor disease), autoimmune disease, hormone abnormal diseases, infectious disease, pain control, nervous system disease (such as epilepsy) etc.
Treatment refers to improve at least the symptom relevant with the symptom that torments the experimenter, wherein broadly improvement be used to refer to the parameter relevant with the pathological state for the treatment of for example symptom reduce at value at least.Therefore, treatment also comprise wherein fully and suppressing, for example prevent or stop (for example stopping) pathological state or with relevant at least symptom so that the experimenter no longer suffers pathological state or characterizes at least the torment of the symptom of this pathological state.Correspondingly, " treatment " of disease comprise and prevent disease this is sick but not yet experience or show in the animal of this sick symptom and (prophylactic treatment) occurs, suppress disease (slow down or stop its development), alleviate symptom or side effect (comprising palliative treatment) and palliate a disease (the impelling disease to disappear) of disease may easily suffering from.
Can treat various experimenters according to the inventive method woods.Generally speaking, this type of experimenter is " mammal " or " mammal ", wherein these terms broadly are used for describing the organism that belongs to Mammalia, (for example comprise Carnivora (for example Canis familiaris L. and cat), Rodentia, home mouse, Cavia porcellus and mouse) and Primates (for example, people, chimpanzee and monkey).Aspect representational, the experimenter will be the people.
In some aspects, as mentioned above, method of the present invention is in the section of time expand for example, as one all or longer, one month or longer, six months or longer, 1 year or longer, 2 years or longer, 5 years or longer etc. in the method for management symptom.Can adopt method of the present invention in conjunction with one or more other disease control agreement, described agreement comprises the agreement based on electricity irritation in for example cardiovascular disease management, such as pace-making agreement, heart synchronous protocol etc. again; Life style is such as diet and/or the exercise treatment plan for multiple different symptoms; Etc..
In some aspects, these methods comprise based on the data adjustment treatment plan of obtaining from compositions.For example, can obtain and comprise that relevant patient is to the data of the information of the situation of deferring to of prescribed treatment plan.Can for example adopt as required suitable decision tool, employing contains or does not contain additional physiological data and (for example uses one or more sensor, for example can adopt above-described sensor to obtain) data, in order to make and keep given treatment plan or in some way it is made amendment, described mode is for for example by revising drug rehabilitation program and/or implanting the activity therapy plan.Therefore, method of the present invention comprises the method based on the modification of signal treatment plan of obtaining from compositions.
In some aspects, also provide the method for the history of determining compositions of the present invention, wherein said composition comprises activating agent, evaluator element and the medicinal carrier of accepting.In some aspects, the evaluator response is inquired about and is transmitted, and for example inquires about marker to obtain signal by wand or other suitable inquiry unit.Then adopt the signal that obtains to determine the historical information of relevant compositions, such as source, Chain of Custody etc.In some aspects, this determining step can comprise the data base of the storage history of accessing said composition or similarly collect.
Receptor of the present invention can be used for various application.Medical aspect of the present invention provides an important new tool in its a complete set of therapeutic equipment to the clinician: the automatically pharmaceutical preparation of detection and Identification actual delivery in the body.The application of this fresh information device and system is multiple.Application includes but not limited to: (1) monitoring patient is to the situation of deferring to of prescribed treatment plan; (2) defer to situation customization treatment plan based on the patient; (3) monitoring patient's the situation of deferring in clinical experiment; (4) purposes of monitoring controlled substance etc.In these different exemplary application each all has more detailed repetition in following patent application: PCT patent application serial numbers PCT/US08/85048; Be disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/095183; The PCT patent application serial numbers US2006/016370 that is disclosed as the PCT patent application serial numbers PCT/US2007/024225 of WO 2008/063626 and is disclosed as WO 2006/116718; The disclosure of these patent applications is incorporated this paper by reference into.
Find that also the receptor of paying close attention to can use to sending of experimenter with the combined treatment fluid.What pay close attention to is that receptor is combined with the intelligent injection delivery apparatus, as is disclosed as and describes among the PCT patent application serial number PCT/US2007/015547 of WO 2008/008281; Its disclosure is incorporated this paper by reference into.When with this type of fluid delivery device (such as the intelligent injection device) when being combined with, this receptor can be configured to receive the data of the actual amount of the relevant treatment fluid of having used.This receptor can be configured to this particular data and other related data (such as analyte testing data, physiological data etc.) combination, wherein can adopt the check (such as special home-use analyte verifying attachment etc.) of receptor or another kind of type to obtain the data of these addition type.In addition, this receptor can be configured to include but not limited to based on one or more action of information and executing that receives: forward the data to the second device, revise treatment plan etc.
The receptor that wherein do not use in addition of paying close attention to receives the application of signal from IEM or intelligent non-intestinal delivery system.This type of application of paying close attention in receptor of the present invention is to detect in the epilepsy outbreak.Such device comprises epilepsy outbreak detection module, and this module is configured to adopt the data of the reception of one or more types to determine the torment whether experimenter shown effect by epilepsy.Correspondingly, in these are used, adopt receptor to obtain the physiological data of one or more types, and process these data to determine whether the experimenter will or suffer the torment of epilepsy outbreak.In other words, receptor adopts the physiological data that obtains to make the outbreak prediction or detects the generation that shows effect.The physiological data that can obtain in these are used and use comprises electroencephalograph (EEG) data, accelerometer data, heart rate (ECG) data etc.Can obtain one type data and maybe can obtain and process two or more dissimilar data to determine that the experimenter is the torment that will or suffer the epilepsy outbreak.In some instances, the data that receptor can be obtained be combined from the data in other source and process these data and determine.Data for example can comprise, the unique signature of accelerometer or change rate of heartbeat.Can integrate sensing data as the part of system or as auxiliary input from EEG as required.Adopt a plurality of data flow, people can detect " fire-lighter ", i.e. one group of event that causes showing effect.In this type of example, can adjust medical treatment based on the outbreak state as required.The neuroregulation device can adapt to these demands---and measure EEG or adjust therapeutic scheme.
Receptor can be configured to use any easily agreement to make this decision.Can adopt one or more of algorithms, it is the decision that will show effect or show effect that these algorithms are made relevant with the physiological data that obtains.The example of this type of algorithm includes, but are not limited to: the algorithm (for example published U.S. Patent number 20070213786 is described) that is used for realizing automatization's outbreak warning (ASWA); The algorithm that changes for detection of the class temporal frequency of warbling in the EEG signal is (such as calculating and the mathematical method of the people such as Sen in the medical science of " Analysis of Seizure EEG in kindled epileptic rats ", December was published on the 4th in 2007, the 8th volume is described in the 225th page to the 234th page etc.).
In this used, prediction or the detection of epilepsy outbreak can cause a plurality of additional actions.In some instances, receptor can be configured to produce and send alarm signal.Alarm signal can be detectable for the experimenter or can not be detectable.For example, can adopt can be by the form of listening of detecting of experimenter or optical signal in alarm signal.This alarm signal can also be the signal that sends to healthcare givers or other personnel via for example wireless communication protocol.Can multiple different mode adopt this alarm signal to come such as the reminding medical personnel assistance to be provided, to encourage or to revise treatment plan etc. to the experimenter.
In some instances, receptor is configured to the therapy equipment of " closed loop " epilepsy, and wherein receptor comprises epilepsy treatment parts, such as Drug therapy parts or electricity treatment parts.In these examples, receptor can adopt the prediction of epilepsy outbreak or detection (for example by active agent delivery and/or electricity irritation or by instruct another device carry out this type of action in one or more) encourage the epilepsy treatment.Perhaps, can revise existing epilepsy treatment agreement at aspects such as dosage, persistent period based on prediction or the outbreak that detects.
Receptor of the present invention also is used for following the tracks of using, and wherein monitors one or more personnel in the given time period, such as patient, soldier etc.The receptor that adopts in these aspects can comprise a plurality of different physiology and/or environment sensing module, and for example above-described accelerometer and ECG sensing module are so that experimenter's health status is passed in monitoring in time.These data can be combined with the position data that for example GPS module provides, in order to follow the tracks of the experimenter with respect to the position as time function.
It is tracking individuals that the tracking of a kind of particular type of paying close attention to is used, and the staff in the active operation environment for example is such as the medical personnel in the army personnel in the battlefield surroundings, fire fighting in the fire hazard environment and rescue personnel, the hospital etc.In this type of was used, receptor of the present invention can comprise the functional module for some common physiological status of the environment of determining to pay close attention to.For example, can there be functional module for some physiological status of determining common battlefield situation.The example of this type of functional module comprises above-described accelerometer and ECG functional module, because these specific functional modules provide the useful data about mobile and vital movement.When one or more physiological status of paying close attention to reaches one or more critical limit (for example the soldier is no longer mobile and/or vital sign is movable no longer enough), receptor can be configured to send alarm signal to commanding officer/medical officer unit, thereby the indication soldier needs immediately nursing.For example, if the temperature sensor of receptor indication cold weather and soldier's body temperature has begun to drop to below the specified minimum, then receptor can inform that this soldier may suffer hypothermia from trend commanding officer/medical officer unit and the signalling of commander unit.The personnel of the commanding officer of signalman official/medical officer unit or medical officer or operation central control unit then can notify other soldier in this zone or healthcare givers to treat this soldier for this situation as soon as possible.Similarly, can monitor the order of severity of the symptom of wounded soldier and the condition of the injury or lose blood after the situation of fainting.
In these are used, can customize each receptor for specific wearer.Therefore, given receptor can comprise relevant individual information, such as drug allergy and other important medical information for this individual medical worker for the treatment of.In addition, it is historical that receptor can be preserved of short duration physiology, such as nearest four hours or certain At All Other Times body temperature, heart rate, position, blood pressure, blood oxygen saturation and the situation of movement of section.Can on request this information be transmitted to floor manager official/medical officer unit or commander unit.This can realize by the telecommunication system of receptor, or realizing direct connection the between receptor and the commanding officer/medical officer unit when arriving to treat the user by the medical officer in commanding officer/medical officer unit.
In these were used, receptor or commanding officer/medical officer unit can comprise be used to the software/firmware that provides guide and medical decision making to support.In addition, can also programme to control patient's fluid infusion, administration and ventilator support to the microprocessor in the set or receptor wherein, thereby even under the situation of battlefield, also can effectively treat.Receptor can be communicated by letter with for example commanding officer/medical officer unit or commander unit constantly or in of short duration burst by multiple predetermined scheme, finds this soldier in order to prevent enemy combat forces from following the tracks of communication.These bursts can be based on the appearance of property dispatching cycle ground or by commanding officer/medical officer unit or commander's indicated appearance in unit.
In these were used, commanding officer/medical officer unit can be that medical officer and other commanding officer wear so that can monitor separately the personnel's that they are responsible for mancarried device.Commanding officer/medical officer unit can comprise for the communication system of receptor and commander's unit communication, and/or can comprise and make the user monitor the position of personnel on the battlefield and/or to check the display of the physiological situation of each soldier in this commanding officer's the command structure with diagramatic way.Commanding officer/medical officer unit can receive the information of the position of relevant wounded soldier, and can receive medical information when medical officer is deployed to this soldier's site.When medical officer used, this element made medical officer can check vital sign and the out of Memory of wounded soldier before this soldier of actual inspection.Therefore, medical officer can draw the initial evaluation to wounded soldier in the way of the position of going to this soldier.In addition because receptor also with commander's unit communication, so be arranged in the medical worker of central command post can be when medical officer goes to the way of interim treatment institute just relevant diagnosis and treat possibility and indicate medical officer.By position and the state that continues to monitor the soldier, can realize the greatly reduction of casualty rate.In addition, can revise a little the technology used among the present invention when greatly reducing cost, in civilian medical use, to keep the nursing of high level.
Although in that above description is provided aspect the tracking army personnel, can adopt these receptors when following the tracks of the staff of any type, personnel are arranged in the personnel of the active operation environment of fixed position with the time period that prolongs especially therein.
Also provide the inoperative personnel tracking to use.Can in hospital environment, adopt receptor to carry out patient's tracing and managing.Need not the nurse and follow the tracks of the patient to obtain their vital sign, nurse or other medical personnel can adopt receptor to determine patient's position and their vital sign.If the information that receives indication has problem to exist, then can easily determine patient's position.Therefore, in the nursing that high level more is provided, can use the nurse of smaller amounts.
The test kit of implementing the inventive method also is provided.Test kit can comprise one or more receptor of the present invention, as mentioned above.In addition, test kit can comprise one or more of dosage compositions, for example adopts the form of IEM compositions.The dosage of the one or more of pharmaceutical preparatioies that provide in the test kit can enough once be used or more times application.Correspondingly, aspect some of test kit of the present invention, there is the pharmaceutical preparation of single dose, in some other side, can has the pharmaceutical preparation of a plurality of dosage in the test kit.Aspect those of the pharmaceutical preparation with a plurality of dosage, can at intermediate package such as single pipe, bottle, phial of single container, perhaps can pack respectively one or more dosage, so that certain test kit can have the pharmaceutical preparation of a more than container.
In some aspects, test kit can also comprise the external monitoring device, and for example as mentioned above, it can provide the communication with remote location (for example, doctor's office, central facilities etc.), and it obtains and process the data of the purposes of the relevant compositions of obtaining.
Test kit of the present invention can also comprise the operation instruction of parts enforcement the inventive method of how using test kit.These operation instructions can be recorded on the suitable recording medium or substrate.For example, operation instruction can be printed on substrate such as paper or the plastics etc.Therefore, operation instruction can be used as package insert and is placed in the test kit, and the containers labels (namely related with packing or minute packing) that is placed on test kit or its parts is medium.In other side, these operation instructions are present in suitable computer readable storage medium as the Electronic saving data file, such as on CD-ROM, the disk etc.In some other sides, actual operation instruction is not placed in the test kit, but is provided for obtaining from remote source by for example the Internet the method for operation instruction.Example in this respect is to comprise the test kit that wherein can check operation instruction and/or can download from it the network address of operation instruction.The same with operation instruction, be recorded in suitable substrate for the measure of obtaining operation instruction.
The some or all of parts of test kit of the present invention can be packaged in the suitable encapsulation in order to keep aseptic.Aspect test kit of the present invention a lot, the parts of test kit can be packaged in the test kit potted component to consist of single easy-to-handle unit, test kit potted component wherein, for example box or similar structures, can be sealed container or can not be sealed container, for example with the aseptic of the some or all of parts of further maintenance test kit.
Should be appreciated that, the invention is not restricted to described concrete aspect, therefore may be different.Scope of the present invention should also be understood that term used herein only is for the purpose of describing concrete aspect, and is not to be intended to limit, because will only be limited by claims.In the situation of the scope that value is provided, should understand, unless outside the context clear, to lower limit unit 1/10th, the value of the upper limit of this scope and the intermediate value between the lower limit and any other statement and should the statement scope in intermediate value all be encompassed in the present invention.Any limit value of clearly getting rid of in the scope of stating, these upper and lower bounds more among a small circle can be included in independently these more among a small circle in, and also be encompassed in the present invention.In the scope of stating comprises one or both situation in the limit value, do not comprise that any one or the two scope is also contained among the present invention in these contained limit values.Unless otherwise defined, otherwise all technical terms used herein all have the identical implication of implication of knowing together with those skilled in the art in the invention with scientific terminology.Although implementing or testing among the present invention and also can use and those similar or equivalent any method and materials described herein, what describe now is to represent illustrative methods and/or material.This paper is all incorporated in all open and patent applications that present patent application is quoted by reference into, open and patent application is pointed out to incorporate into by reference specially and individually as each, and these incorporate by reference that this paper is intended to that combination quotes into disclose the described method of disclosure and description and/or material.Any disclosed quoting all is open before submitting to day, admits that the present invention haves no right owing to before invented and mention before this open date and should not be construed as.And the open date that provides may be different from the open date of reality, thereby need to confirm respectively.
It should be noted that as used in this paper and the claims, unless context points out separately that clearly otherwise singulative " its ", " being somebody's turn to do " and " described " comprise a plurality of things that refer to.It shall yet further be noted that and claim can be drafted as getting rid of any optional key element.Therefore, this statement is intended to as quoting in conjunction with the claim key element that to use such as the exclusiveness term of " only ", " only having " etc. or use " negate " the in advance basis of restriction.After having read the disclosure, those skilled in the art it is evident that, the separative parts of aspect tool and structure that each that describe herein and illustrate is independent, under the prerequisite that does not deviate from scope of the present invention or spirit, can easily from the structure of any other several aspects, isolate parts and the structure of these separation, or with its combination.Any method of quoting can be implemented by the order of quoting event or by possible any other order in logic.Although be convenient to understand thorough purpose, aforementioned invention is described in more detail by the mode that illustrates and give an example, but according to instruction of the present invention, those skilled in the art it is evident that, in the situation of the spirit or scope that do not deviate from claims, can carry out some modifications and changes to it.Therefore, preamble has only illustrated principle of the present invention.To understand, those skilled in the art can be susceptible to multiple layout, although do not describe clearly in this article or illustrate, they can embody principle of the present invention and comprise within the spirit and scope of the present invention.And all examples that this paper quotes and conditional statement mainly are intended to help the reader understanding to invent artificial propelling prior art and principle of the present invention and the concept contributed, and are interpreted as being not limited to example and the condition of this type of specific reference.And all statements of quoting principle of the present invention, aspect and particular instance thereof herein are intended to contain its 26S Proteasome Structure and Function equivalent.In addition, this type of equivalent refers to comprise at present known equivalent and the equivalent of exploitation in the future, namely carries out identical function and any element how to develop of tubular construction not.Therefore, scope of the present invention is not to be intended to be subject to shown in this paper and the illustrative aspects of describing.Exactly, scope and spirit of the present invention are embodied by claims.

Claims (14)

1. the physiology communication sink on the skin that can be fixed in removedly the experimenter, described receptor comprises:
Shell;
Power supply, described power supply are fixed in the described shell;
Processing unit, described processing unit are electrically coupled to described power supply and are fixed in the described shell; And
At least two electrodes, described at least two electrodes be electrically coupled to described processing unit and be fixed in described shell periphery so that described electrode will with described experimenter's contact skin,
Wherein said processing unit is configured to receive with in the frequency range of 3kHz to 300kHz and through the data of the alternating current form coding of experimenter's bodily tissue conduction, wherein said at least two electrodes are configured to detect differential voltage therebetween, described differential voltage is corresponding with the alternating current of experimenter's bodily tissue between described at least two electrodes conduction, and wherein said alternating current is by the device generation of described experimenter inside.
2. receptor according to claim 1, wherein, described processing unit is configured to also to receive the physiologic information as the coding of the physiological signal form of the frequency in 0.5Hz to the 150Hz scope of described experimenter's bodily tissue conduction, and wherein said physiological signal is associated with described experimenter's physiological function.
3. receptor according to claim 2, also comprise the communication module that is electrically coupled to described processing unit, wherein, described communication module allows the radio communication between the device of described receptor and described experimenter outside, so that described receptor can provide physiologic information to the device of described experimenter outside.
4. receptor according to claim 3, wherein, described communication module is configured to use FHSS communication protocol to communicate.
5. receptor according to claim 2, also comprise the communication module that is electrically coupled to described processing unit, wherein, described communication module allows the radio communication between the device of described receptor and described experimenter outside, so that described receptor can provide control information to the device of described experimenter outside, and wherein said control information is to derive from the data with the alternating current form coding that the device with described experimenter inside provides.
6. receptor according to claim 5, wherein, the described device of described experimenter outside is the control device related with drug delivery system, described drug delivery system comprises pharmaceutical preparation and can change the dosage delivered of pharmaceutical preparation.
7. receptor according to claim 6, wherein, described drug delivery system comprises the fluid containment unit, the piston that described fluid containment unit has the chamber that is configured to containing fluid and is fixed in described fluid containment unit, wherein said piston is controlled based on the control information that described receptor provides by described control unit.
8. receptor according to claim 7, wherein, described fluid containment unit is the intravenous medicated bag of containing fluid.
9. receptor according to claim 1, also comprise power management module, described power management module is electrically coupled to described power supply and described processing unit, so that described power management module is to controlling to the power of described processing unit output from described power supply, and wherein said receptor uses the beacon handover module, described beacon handover module is configured to the alternating current of recognition coding data and produces such signal, described signal so that when described beacon handover module recognizes the alternating current of described coded data described power management module described processing unit is switched to active state from inactive state.
10. receptor according to claim 9, wherein, described power management module comprises:
High power operation module, described high power operation module are controlled the high power of exporting to described processing unit from described power supply when described processing unit is in active state;
Middle power operational module, described middle power operational module are controlled the middle power of exporting to described processing unit from described power supply when described processing unit is in the activity off working state; And
Low-power operation module, described low-power operation module are controlled when described processing unit is in inactive state from the low-power of described power supply output.
11. receptor according to claim 10, wherein, described beacon handover module is configured to described middle power operational module transmitted signal to allow described processing unit to switch to described activity off working state.
12. receptor according to claim 9, wherein, described power management module comprises described beacon handover module, and wherein said beacon handover module comprises:
Enumerator;
Beacon signal generator, described beacon signal generator are coupled to described enumerator with for generation of a plurality of beacon signals; And
Memory cell, described memory cell is coupled to described beacon signal generator, wherein said memory cell is configured to stored algorithm, and wherein said beacon signal generator is configured to move described algorithm to determine the time lag between each in described a plurality of beacon signals.
13. receptor according to claim 1 also comprises:
Router, described router is coupled to described power supply; And
Multipurpose connector, described Multipurpose connector is electrically coupled to described router, be electrically connected the path between the device that wherein said router is configured to be controlled at described experimenter outside and the described power supply, and wherein said Multipurpose connector is configured to be connected to the device of described receptor and described experimenter outside.
14. receptor according to claim 13, wherein, the signal of telecommunication of the described device of described experimenter outside is from the external power source that the power supply in the described receptor is charged.
CN2009801566979A 2008-12-15 2009-12-15 Body-associated receiver and method Active CN102316795B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210324259.2A CN102885615B (en) 2008-12-15 2009-12-15 The receptor associated with health and method

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12272308P 2008-12-15 2008-12-15
US61/122,723 2008-12-15
US16028909P 2009-03-13 2009-03-13
US61/160,289 2009-03-13
US24057109P 2009-09-08 2009-09-08
US61/240,571 2009-09-08
US25108809P 2009-10-13 2009-10-13
US61/251,088 2009-10-13
PCT/US2009/068128 WO2010075115A2 (en) 2008-12-15 2009-12-15 Body-associated receiver and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201210324259.2A Division CN102885615B (en) 2008-12-15 2009-12-15 The receptor associated with health and method

Publications (2)

Publication Number Publication Date
CN102316795A CN102316795A (en) 2012-01-11
CN102316795B true CN102316795B (en) 2013-10-30

Family

ID=42288378

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2009801566979A Active CN102316795B (en) 2008-12-15 2009-12-15 Body-associated receiver and method
CN201210324259.2A Active CN102885615B (en) 2008-12-15 2009-12-15 The receptor associated with health and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201210324259.2A Active CN102885615B (en) 2008-12-15 2009-12-15 The receptor associated with health and method

Country Status (14)

Country Link
US (3) US8114021B2 (en)
EP (2) EP2358271A4 (en)
JP (3) JP5143290B2 (en)
KR (1) KR101146555B1 (en)
CN (2) CN102316795B (en)
AU (1) AU2009330321B2 (en)
CA (3) CA2747156C (en)
ES (1) ES2962610T3 (en)
HK (2) HK1162903A1 (en)
IL (2) IL213491A (en)
MY (2) MY172069A (en)
SG (1) SG172165A1 (en)
TW (2) TWI503101B (en)
WO (1) WO2010075115A2 (en)

Families Citing this family (375)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
SI1889198T1 (en) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
WO2007028035A2 (en) 2005-09-01 2007-03-08 Proteus Biomedical, Inc. Implantable zero-wire communications system
CN101496042A (en) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 Patient customized therapeutic regimens
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
ES2930588T3 (en) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Ingestible Event Marker Systems
KR101528748B1 (en) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 In-body power source having high surface area electrode
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
WO2008154504A2 (en) * 2007-06-08 2008-12-18 William Marsh Rice University System and method for intra-body communication
DK2192946T3 (en) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
SG190590A1 (en) 2007-11-27 2013-06-28 Proteus Digital Health Inc Transbody communication systems employing communication channels
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
ES2840773T3 (en) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Multimode Communication Ingestible Event Markers and Systems
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
WO2010014686A1 (en) 2008-07-30 2010-02-04 Aleva Neurotherapeutics, S.A. Apparatus and method for optimized stimulation of a neurological target
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
WO2010055421A1 (en) 2008-11-12 2010-05-20 Aleva Neurotherapeutics, S.A. Microfabricated neurostimulation device
JP5258521B2 (en) * 2008-11-14 2013-08-07 トヨタ自動車株式会社 Power supply system
CN102271578B (en) 2008-12-11 2013-12-04 普罗秋斯数字健康公司 Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
WO2010132331A2 (en) 2009-05-12 2010-11-18 Proteus Biomedical, Inc. Ingestible event markers comprising an ingestible component
US8160725B2 (en) * 2009-05-20 2012-04-17 Vega Grieshaber Kg Energy saving control for a field device
US10098572B2 (en) * 2009-07-20 2018-10-16 Koninklijke Philips N.V. Method for operating a monitoring system
US8134502B2 (en) * 2009-08-13 2012-03-13 Sirf Technology, Inc. Method and apparatus for reducing power consumption in GNSS receivers
EP2467707A4 (en) 2009-08-21 2014-12-17 Proteus Digital Health Inc Apparatus and method for measuring biochemical parameters
US8823515B2 (en) 2009-09-15 2014-09-02 Bella Technologies, Llc Computer implemented animal management system
US20110257563A1 (en) * 2009-10-26 2011-10-20 Vytronus, Inc. Methods and systems for ablating tissue
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
US8396538B2 (en) * 2009-11-30 2013-03-12 Biotronik Crm Patent Ag Method and apparatus for improving signal to noise ratio of ECG signals to facilitate cardiac beat detection
WO2011067297A1 (en) 2009-12-01 2011-06-09 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Microfabricated neurostimulation device and methods of making and using the same
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
US8909332B2 (en) * 2010-01-26 2014-12-09 Stmicroelectronics S.R.L. Method and device for estimating morphological features of heart beats
MX2012008922A (en) 2010-02-01 2012-10-05 Proteus Digital Health Inc Data gathering system.
US20110201898A1 (en) * 2010-02-17 2011-08-18 Benco David S Wireless healthcare smart grid
US9549708B2 (en) 2010-04-01 2017-01-24 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
AU2011237612B2 (en) 2010-04-07 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US8831732B2 (en) 2010-04-29 2014-09-09 Cyberonics, Inc. Method, apparatus and system for validating and quantifying cardiac beat data quality
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
US8904214B2 (en) * 2010-07-09 2014-12-02 Zoll Medical Corporation System and method for conserving power in a medical device
US10493289B2 (en) 2010-07-09 2019-12-03 Zoll Medical Corporation System and method for conserving power in a medical device
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
US9017256B2 (en) 2010-09-22 2015-04-28 Milieu Institute, Llc System and method for physiological monitoring
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US9571925B1 (en) * 2010-10-04 2017-02-14 Nortek Security & Control Llc Systems and methods of reducing acoustic noise
US8588687B2 (en) * 2010-10-15 2013-11-19 Roche Diagnostics Operations, Inc. Coexistence of multiple radios in a medical device
EP2629602B1 (en) 2010-10-19 2018-07-11 ST Reproductive Technologies, LLC Animal monitoring system
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
US9704385B2 (en) 2010-11-24 2017-07-11 St. Jude Medical Ab Implantable medical device adapted for radio frequency telemetry with frequency hopping
US9220826B2 (en) 2010-12-20 2015-12-29 Abiomed, Inc. Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system
US8766788B2 (en) 2010-12-20 2014-07-01 Abiomed, Inc. Transcutaneous energy transfer system with vibration inducing warning circuitry
EP2654878B1 (en) 2010-12-20 2019-05-15 Abiomed, Inc. Transcutaneous energy transfer system with multiple secondary coils
ES2366219B1 (en) * 2010-12-24 2012-09-27 Fico Mirrors, S.A. METHOD AND SYSTEM OF MEASUREMENT OF PHYSIOLOGICAL PARAMETERS.
MX2013007643A (en) * 2010-12-29 2014-01-24 Proteus Digital Health Inc Wirelesss energy sources for integrated circuits.
US9392956B2 (en) * 2011-01-28 2016-07-19 Neurosky, Inc. Dry sensor EEG/EMG and motion sensing system for seizure detection and monitoring
GB201101858D0 (en) * 2011-02-03 2011-03-23 Isansys Lifecare Ltd Health monitoring
US9195799B2 (en) * 2011-02-08 2015-11-24 Aulisa Medtech International, Inc. Wireless patient monitoring system
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US9439599B2 (en) * 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
EP3485819B1 (en) 2011-04-14 2022-09-07 Abiomed, Inc. Transcutaneous energy transfer coil with integrated radio frequency antenna
US8725239B2 (en) 2011-04-25 2014-05-13 Cyberonics, Inc. Identifying seizures using heart rate decrease
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
US20120277619A1 (en) * 2011-04-29 2012-11-01 Medtronic, Inc. Detecting food intake based on impedance
US20130194066A1 (en) * 2011-06-10 2013-08-01 Aliphcom Motion profile templates and movement languages for wearable devices
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
MX340001B (en) 2011-07-21 2016-06-20 Proteus Digital Health Inc Mobile communication device, system, and method.
ES2797448T3 (en) 2011-08-01 2020-12-02 Bio Rad Laboratories Cell capture system
WO2013019997A1 (en) 2011-08-02 2013-02-07 Emotiv Lifesciences Inc. Methods for modeling neurological development and diagnosing a neurological impairment of a patient
US9924907B2 (en) 2011-09-30 2018-03-27 Google Technology Holdings LLC Method and system for identifying location of a touched body part
US10206591B2 (en) 2011-10-14 2019-02-19 Flint Hills Scientific, Llc Seizure detection methods, apparatus, and systems using an autoregression algorithm
WO2013059832A1 (en) * 2011-10-21 2013-04-25 Incube Labs, Llc Implantable oximetric measurement apparatus and method of use
WO2013070705A1 (en) * 2011-11-07 2013-05-16 Battelle Memorial Institute Medicinal patch and injector system
US9235683B2 (en) * 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US20130129869A1 (en) 2011-11-23 2013-05-23 Hooman Hafezi Compositions comprising a shelf-life stability component
US9002468B2 (en) * 2011-12-16 2015-04-07 Abiomed, Inc. Automatic power regulation for transcutaneous energy transfer charging system
US8634914B2 (en) 2012-01-27 2014-01-21 Medtronic, Inc. Pacemaker event queue to control device processor operating power
AU2013221336B2 (en) * 2012-02-17 2017-08-17 University Of Virginia D/B/A University Of Virginia Licensing & Ventures Group Energy harvesting and control for sensor node
US20130245469A1 (en) * 2012-03-19 2013-09-19 Cardiomems, Inc. Pulmonary Arterial Hemodynamic Monitoring for Chronic Obstructive Pulmonary Disease Assessment and Treatment
JP6047907B2 (en) * 2012-04-04 2016-12-21 株式会社オートネットワーク技術研究所 Communication apparatus and communication system
JP2015513104A (en) * 2012-04-04 2015-04-30 ユニバーシティ・オブ・シンシナティ Sweat simulation, collection and sensing system
US9274578B2 (en) 2012-05-09 2016-03-01 Apple Inc. Enable power from an accessory to a host device based on whether the accessory is able to alter an electrical characteristic of the power path
US10448839B2 (en) 2012-04-23 2019-10-22 Livanova Usa, Inc. Methods, systems and apparatuses for detecting increased risk of sudden death
US9681836B2 (en) 2012-04-23 2017-06-20 Cyberonics, Inc. Methods, systems and apparatuses for detecting seizure and non-seizure states
WO2013177592A2 (en) 2012-05-25 2013-11-28 Emotiv Lifesciences, Inc. System and method for providing and aggregating biosignals and action data
US9763592B2 (en) 2012-05-25 2017-09-19 Emotiv, Inc. System and method for instructing a behavior change in a user
US9622660B2 (en) 2012-05-25 2017-04-18 Emotiv Lifesciences Inc. System and method for enabling collaborative analysis of a biosignal
RU2015105699A (en) 2012-07-23 2016-09-10 Протеус Диджитал Хелс, Инк. METHODS FOR PRODUCING INGESTED EVENT MARKERS CONTAINING AN INGESTED COMPONENT
KR20150112923A (en) * 2012-07-26 2015-10-07 아디 매쉬아취 Internal resonance matching between an implanted device and an external device
US9907967B2 (en) 2012-07-26 2018-03-06 Adi Mashiach Transcutaneous power conveyance device
US11737896B2 (en) * 2012-07-31 2023-08-29 Purdue Research Foundation Wirelessly-powered implantable EMG recording system
US8761717B1 (en) 2012-08-07 2014-06-24 Brian K. Buchheit Safety feature to disable an electronic device when a wireless implantable medical device (IMD) is proximate
US9294732B2 (en) * 2012-08-14 2016-03-22 Good Sleep Llc Systems and methods for sleep monitoring
US20140081155A1 (en) * 2012-09-14 2014-03-20 Scott R. Coggins Methods And Apparatus for Wireless Electrode Having Power Conservation
CN203252647U (en) * 2012-09-29 2013-10-30 艾利佛公司 Wearable device for judging physiological features
US10413251B2 (en) 2012-10-07 2019-09-17 Rhythm Diagnostic Systems, Inc. Wearable cardiac monitor
US10610159B2 (en) 2012-10-07 2020-04-07 Rhythm Diagnostic Systems, Inc. Health monitoring systems and methods
USD850626S1 (en) 2013-03-15 2019-06-04 Rhythm Diagnostic Systems, Inc. Health monitoring apparatuses
US10244949B2 (en) 2012-10-07 2019-04-02 Rhythm Diagnostic Systems, Inc. Health monitoring systems and methods
JP5869736B2 (en) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス, インコーポレイテッド Apparatus, system, and method for adaptively optimizing power dissipation and broadcast power in a power supply for a communication device
EP2922465A4 (en) 2012-11-21 2016-07-06 Cardiomems Inc Devices, systems, and methods for pulmonary arterial hypertension (pah) assessment and treatment
US20140171751A1 (en) * 2012-12-19 2014-06-19 Robert L. Sankman Electronic bio monitoring patch
US10220211B2 (en) 2013-01-22 2019-03-05 Livanova Usa, Inc. Methods and systems to diagnose depression
TWI659994B (en) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 Highly-swellable polymeric films and compositions comprising the same
US9855110B2 (en) * 2013-02-05 2018-01-02 Q-Core Medical Ltd. Methods, apparatus and systems for operating a medical device including an accelerometer
US20140273829A1 (en) * 2013-03-13 2014-09-18 Motorola Mobility Llc Communicating via a body-area network
US9319778B2 (en) 2013-03-13 2016-04-19 Google Inc. Communicating via a body-area network
WO2014151929A1 (en) * 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス, インコーポレイテッド Metal detector device, system and method
WO2014145712A1 (en) 2013-03-15 2014-09-18 Cardiomems, Inc. Methods for the treatment of cardiovascular conditions
RU2652788C2 (en) * 2013-04-04 2018-05-03 Конинклейке Филипс Н.В. Receiver, transceiver, transceiver module for a body coupled communication device, a body coupled communication system and a method of waking-up a body coupled receiver of a body coupled communication device
US20160088132A1 (en) * 2013-05-15 2016-03-24 Vladimir Kranz Mobile Phone With Enhanced Functions
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
JP2015020050A (en) * 2013-07-20 2015-02-02 株式会社Cu Electrocardiograph
WO2015017563A1 (en) 2013-07-30 2015-02-05 Emotiv Lifesciences, Inc. Wearable system for detecting and measuring biosignals
US9427592B2 (en) * 2013-08-28 2016-08-30 Pacesetter, Inc. Systems and methods for low energy wake-up and pairing for use with implantable medical devices
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9596650B2 (en) * 2013-09-11 2017-03-14 Microsemi Corporation Radio wake-up system with multi-mode operation
EP3047618B1 (en) 2013-09-20 2023-11-08 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
WO2015044722A1 (en) 2013-09-24 2015-04-02 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9619660B1 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Computer-implemented system for secure physiological data collection and processing
US10736529B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable electrocardiography monitor
US10165946B2 (en) 2013-09-25 2019-01-01 Bardy Diagnostics, Inc. Computer-implemented system and method for providing a personal mobile device-triggered medical intervention
US10736531B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection
US9655537B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US10820801B2 (en) 2013-09-25 2020-11-03 Bardy Diagnostics, Inc. Electrocardiography monitor configured for self-optimizing ECG data compression
US9700227B2 (en) 2013-09-25 2017-07-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US9717433B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US10888239B2 (en) 2013-09-25 2021-01-12 Bardy Diagnostics, Inc. Remote interfacing electrocardiography patch
US9775536B2 (en) 2013-09-25 2017-10-03 Bardy Diagnostics, Inc. Method for constructing a stress-pliant physiological electrode assembly
US10667711B1 (en) 2013-09-25 2020-06-02 Bardy Diagnostics, Inc. Contact-activated extended wear electrocardiography and physiological sensor monitor recorder
US9737224B2 (en) 2013-09-25 2017-08-22 Bardy Diagnostics, Inc. Event alerting through actigraphy embedded within electrocardiographic data
US9717432B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrocardiography patch using interlaced wire electrodes
US9655538B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Self-authenticating electrocardiography monitoring circuit
US20190167139A1 (en) 2017-12-05 2019-06-06 Gust H. Bardy Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring
US9433367B2 (en) * 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Remote interfacing of extended wear electrocardiography and physiological sensor monitor
US10799137B2 (en) 2013-09-25 2020-10-13 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US9615763B2 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation
US11723575B2 (en) 2013-09-25 2023-08-15 Bardy Diagnostics, Inc. Electrocardiography patch
US9408551B2 (en) 2013-11-14 2016-08-09 Bardy Diagnostics, Inc. System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US9364155B2 (en) 2013-09-25 2016-06-14 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US10433748B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US10624551B2 (en) 2013-09-25 2020-04-21 Bardy Diagnostics, Inc. Insertable cardiac monitor for use in performing long term electrocardiographic monitoring
US10251576B2 (en) 2013-09-25 2019-04-09 Bardy Diagnostics, Inc. System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US11213237B2 (en) 2013-09-25 2022-01-04 Bardy Diagnostics, Inc. System and method for secure cloud-based physiological data processing and delivery
US9504423B1 (en) 2015-10-05 2016-11-29 Bardy Diagnostics, Inc. Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer
US10433751B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data
WO2015048194A1 (en) 2013-09-25 2015-04-02 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US10806360B2 (en) 2013-09-25 2020-10-20 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US9408545B2 (en) 2013-09-25 2016-08-09 Bardy Diagnostics, Inc. Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor
US9730593B2 (en) 2013-09-25 2017-08-15 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
US10463269B2 (en) 2013-09-25 2019-11-05 Bardy Diagnostics, Inc. System and method for machine-learning-based atrial fibrillation detection
CA2926112A1 (en) * 2013-10-23 2015-04-30 Michael R. Girouard Detecting seizures including loose electrode monitoring
ES2537351B1 (en) * 2013-11-04 2015-12-03 Universidad De Sevilla Intelligent bioimpedance sensor for biomedical applications
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10925503B2 (en) * 2013-11-19 2021-02-23 The Regents Of The University Of California Saturation-tolerant electrophysical recording interface
US9295403B1 (en) * 2013-12-19 2016-03-29 Verily Life Sciences Llc Multipurpose wearable electrical contact
CN106068141B (en) 2014-01-10 2019-05-14 心脏起搏器股份公司 System and method for detecting cardiac arrhythmia
ES2661718T3 (en) 2014-01-10 2018-04-03 Cardiac Pacemakers, Inc. Methods and systems to improve communication between medical devices
TWI552722B (en) * 2014-01-13 2016-10-11 國立中興大學 R-wave detection algorithm using enhanced so and chan method
US20150196224A1 (en) * 2014-01-16 2015-07-16 Dermal Therapy (Barbados) Inc. Implantable Sensor and Method for Such Sensor
EP3741424B1 (en) 2014-02-24 2022-05-04 Element Science, Inc. External defibrillator
US9289614B2 (en) * 2014-03-18 2016-03-22 Pacesetter, Inc. System and method for communicating with an implantable medical device
US10492850B2 (en) 2014-04-04 2019-12-03 Covidien Lp Systems and methods for calculating tissue impedance in electrosurgery
WO2015173787A1 (en) 2014-05-16 2015-11-19 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
JP6110340B2 (en) * 2014-06-18 2017-04-05 日本電信電話株式会社 Biological information measuring device and biological information measuring method
US9818279B2 (en) * 2014-07-23 2017-11-14 The Boeing Company Blast sensor and mobile communication device
CN104146709B (en) * 2014-07-29 2016-05-11 中国科学院合肥物质科学研究院 A kind of multifrequency point bio-electrical impedance fast acquiring method
US9757570B2 (en) 2014-08-06 2017-09-12 Cardiac Pacemakers, Inc. Communications in a medical device system
US9694189B2 (en) 2014-08-06 2017-07-04 Cardiac Pacemakers, Inc. Method and apparatus for communicating between medical devices
ES2562810B1 (en) * 2014-08-06 2016-12-27 Universidad De Sevilla Bioimpedance measurement system for real-time and wireless monitoring of cell cultures based on an oscillation test using integrated circuits
US9808631B2 (en) 2014-08-06 2017-11-07 Cardiac Pacemakers, Inc. Communication between a plurality of medical devices using time delays between communication pulses to distinguish between symbols
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
CN107073275B (en) 2014-08-28 2020-09-01 心脏起搏器股份公司 Medical device with triggered blanking period
CA2998709A1 (en) 2014-09-17 2016-03-24 Canary Medical Inc. Devices, systems and methods for using and monitoring medical devices
US10037026B2 (en) * 2014-09-25 2018-07-31 General Electric Company Systems and methods for fault analysis
NZ730560A (en) * 2014-09-29 2020-05-29 Zogenix International Ltd Control system for control of distribution of medication
FR3028744A1 (en) * 2014-11-25 2016-05-27 Impeto Medical ELECTROPHYSIOLOGICAL DATA COLLECTION DEVICE WITH INCREASED RELIABILITY
US10736510B2 (en) 2014-12-19 2020-08-11 Koninklijke Philips N.V. Medical bracelet standard
JP2016126897A (en) * 2014-12-26 2016-07-11 株式会社東芝 Fitting apparatus and electronic device
AU2016206546C1 (en) * 2015-01-16 2018-07-05 Becton Dickinson France Drug storage and dispensing system for pre-filled containers
WO2016121337A1 (en) 2015-01-26 2016-08-04 パナソニックIpマネジメント株式会社 Electrode device
US10639633B2 (en) 2015-01-30 2020-05-05 Hewlett-Packard Development Company, L.P. Signal transmission bandwidth allocation on a microfluidic chip
US9669230B2 (en) 2015-02-06 2017-06-06 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
CN107206242B (en) 2015-02-06 2020-10-30 心脏起搏器股份公司 Systems and methods for safe delivery of electrical stimulation therapy
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016133813A1 (en) * 2015-02-19 2016-08-25 The Trustees Of Princeton University Vibration-based secure side channel for medical devices
US10108264B2 (en) 2015-03-02 2018-10-23 Emotiv, Inc. System and method for embedded cognitive state metric system
EP3265172B1 (en) 2015-03-04 2018-12-19 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
US20160278702A1 (en) * 2015-03-23 2016-09-29 Zentan Technology Co., Ltd. Physiological signal monitoring belt
US9983565B2 (en) 2015-03-27 2018-05-29 Intel Corporation Technologies for bio-chemically controlling operation of a machine
CN107431542B (en) * 2015-03-30 2021-03-05 索尼公司 Method and apparatus for body area network communication
CN107529985B (en) 2015-03-31 2020-03-31 加州理工学院 Biocompatible encapsulation for long-term implantable sensors and electronics
US10231644B2 (en) 2015-06-12 2019-03-19 St Reproductive Technologies Llc Calf bolus
KR20170008043A (en) * 2015-07-13 2017-01-23 엘지전자 주식회사 Apparatus and method for measuring heart beat/stree of moble terminal
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US9706269B2 (en) * 2015-07-24 2017-07-11 Hong Kong Applied Science and Technology Research Institute Company, Limited Self-powered and battery-assisted CMOS wireless bio-sensing IC platform
EP3337559B1 (en) 2015-08-20 2019-10-16 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
US9853743B2 (en) 2015-08-20 2017-12-26 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
ES2946910T3 (en) 2015-08-26 2023-07-27 Element Science Inc Portable defibrillation devices
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US10159842B2 (en) 2015-08-28 2018-12-25 Cardiac Pacemakers, Inc. System and method for detecting tamponade
EP3341076B1 (en) 2015-08-28 2022-05-11 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
WO2017062806A1 (en) 2015-10-08 2017-04-13 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
TWI565446B (en) * 2015-12-14 2017-01-11 準訊生醫股份有限公司 Long term physiological signal sensing patch
US10306868B2 (en) 2015-12-15 2019-06-04 St Reproductive Technologies, Llc Animal environmental and physiological monitoring system
US20190005397A1 (en) * 2015-12-16 2019-01-03 The Regents Of The University Of California Energy-efficient, modularized uncertainty quantification and outcome prediction in mobile devices
US10063369B1 (en) * 2015-12-16 2018-08-28 Verily Life Sciences Llc Time synchronization of multi-modality measurements
CN108472490B (en) 2015-12-17 2022-06-28 心脏起搏器股份公司 Conducted communication in a medical device system
US20170174614A1 (en) 2015-12-22 2017-06-22 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
IL286391B (en) 2015-12-22 2022-08-01 Zogenix International Ltd Fenfluramine compositions and methods of preparing the same
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
FR3046344A1 (en) * 2016-01-05 2017-07-07 Visiomed Group DEVICE FOR OBTAINING AT LEAST ONE PHYSIOLOGICAL PARAMETER
US10583303B2 (en) 2016-01-19 2020-03-10 Cardiac Pacemakers, Inc. Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device
WO2017134587A1 (en) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Treatment of autoimmune diseases with deep brain stimulation
WO2017136548A1 (en) 2016-02-04 2017-08-10 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
US10542075B2 (en) * 2016-02-24 2020-01-21 Nokia Technologies Oy Method and apparatus for configuration for monitoring patient information
AU2017237099B2 (en) 2016-03-23 2022-05-26 Canary Medical Inc. Implantable reporting processor for an alert implant
US11191479B2 (en) * 2016-03-23 2021-12-07 Canary Medical Inc. Implantable reporting processor for an alert implant
EP3436142A1 (en) 2016-03-31 2019-02-06 Cardiac Pacemakers, Inc. Implantable medical device with rechargeable battery
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
WO2017220328A1 (en) 2016-06-20 2017-12-28 Koninklijke Philips N.V. Medical coupling unit and sensor-side connector
JP6764956B2 (en) 2016-06-27 2020-10-07 カーディアック ペースメイカーズ, インコーポレイテッド Cardiac therapy system that uses subcutaneously sensed P-waves for resynchronization pacing management
WO2018006087A1 (en) 2016-07-01 2018-01-04 University Of Cincinnati Devices with reduced microfluidic volume between sensors and sweat glands
US11207527B2 (en) 2016-07-06 2021-12-28 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
BR112019000861B1 (en) * 2016-07-22 2020-10-27 Proteus Digital Health, Inc electronic device
US20180028071A1 (en) * 2016-07-29 2018-02-01 VivaLnk Inc. Wearable patch for measuring temperature and electrical signals
US10849541B2 (en) * 2016-08-08 2020-12-01 Hexacheck Inc. Portable complex sensor device for measuring multiple items of biometric information, and measurement method
EP3500342B1 (en) 2016-08-19 2020-05-13 Cardiac Pacemakers, Inc. Trans-septal implantable medical device
EP4201427A1 (en) 2016-08-24 2023-06-28 Zogenix International Limited Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
CN109640809B (en) 2016-08-24 2021-08-17 心脏起搏器股份公司 Integrated multi-device cardiac resynchronization therapy using P-wave to pacing timing
US10870008B2 (en) 2016-08-24 2020-12-22 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
DE202016005183U1 (en) * 2016-08-24 2017-11-27 Raumedic Ag Transmission device for transmission of brain parameter sensor data
US20180063784A1 (en) * 2016-08-26 2018-03-01 Qualcomm Incorporated Devices and methods for an efficient wakeup protocol
JP6815404B2 (en) 2016-08-26 2021-01-20 テルモ株式会社 Medical equipment
WO2018050913A1 (en) * 2016-09-19 2018-03-22 Resmed Sensor Technologies Limited Apparatus, system, and method for detecting physiological movement from audio and multimodal signals
WO2018057626A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Implantable cardiac monitor
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
WO2018081133A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
WO2018081225A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
US10463305B2 (en) 2016-10-27 2019-11-05 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
CN109890457B (en) 2016-10-27 2023-07-04 心脏起搏器股份公司 Use of a separate device for managing pacing pulse energy of a cardiac pacemaker
US10765871B2 (en) 2016-10-27 2020-09-08 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081721A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
WO2018081713A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment
CN109952129B (en) 2016-11-09 2024-02-20 心脏起搏器股份公司 System, device and method for setting cardiac pacing pulse parameters for a cardiac pacing device
US11147979B2 (en) 2016-11-21 2021-10-19 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
CN109963618B (en) 2016-11-21 2023-07-04 心脏起搏器股份公司 Leadless cardiac pacemaker with multi-mode communication
US10894163B2 (en) 2016-11-21 2021-01-19 Cardiac Pacemakers, Inc. LCP based predictive timing for cardiac resynchronization
US10663479B2 (en) 2016-12-20 2020-05-26 Blackberry Limited Determining an open/close status of a barrier
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
WO2018136592A2 (en) 2017-01-18 2018-07-26 Tc1 Llc Systems and methods for transcutaneous power transfer using microneedles
US20180206729A1 (en) * 2017-01-24 2018-07-26 VivaLnk, Inc. Wearable patch comprising three electrodes for measurement and charging
CN108344524B (en) * 2017-01-24 2021-08-06 维瓦灵克有限公司 Wearable patch for measuring temperature and electric signals
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
AU2018213326B2 (en) 2017-01-26 2020-09-10 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
EP3573708B1 (en) 2017-01-26 2021-03-10 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
CN108498083A (en) * 2017-02-24 2018-09-07 深圳市迈迪加科技发展有限公司 A kind of physiologic information monitoring device and method
WO2018154710A1 (en) * 2017-02-24 2018-08-30 三菱電機株式会社 Radar signal processing device and radar system
EP3606605B1 (en) 2017-04-03 2023-12-20 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
WO2018208401A1 (en) 2017-05-12 2018-11-15 California Institute Of Technology Implantable extracompartmental pressure sensor
US10861050B2 (en) * 2017-07-07 2020-12-08 Hand Held Products, Inc. Low-energy alert beacons and methods of using the same
JP2019016925A (en) * 2017-07-07 2019-01-31 ソニーセミコンダクタソリューションズ株式会社 Communication device, communication method and communication system
EP3668592B1 (en) 2017-08-18 2021-11-17 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
WO2019036568A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
EP3684463A4 (en) 2017-09-19 2021-06-23 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
WO2019060302A1 (en) 2017-09-20 2019-03-28 Cardiac Pacemakers, Inc. Implantable medical device with multiple modes of operation
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
US11260216B2 (en) 2017-12-01 2022-03-01 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker
WO2019108837A1 (en) 2017-12-01 2019-06-06 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
WO2019108830A1 (en) 2017-12-01 2019-06-06 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
WO2019108482A1 (en) 2017-12-01 2019-06-06 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11931138B2 (en) 2017-12-14 2024-03-19 Applied Biosensors, LLC Hydrogel sensor assembly
US11529053B2 (en) * 2017-12-20 2022-12-20 PercuSense, Inc. System and method for disease risk assessment and treatment
WO2019133997A1 (en) 2017-12-31 2019-07-04 Neuroenhancement Lab, LLC System and method for neuroenhancement to enhance emotional response
US10874861B2 (en) 2018-01-04 2020-12-29 Cardiac Pacemakers, Inc. Dual chamber pacing without beat-to-beat communication
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
JP6377290B1 (en) * 2018-03-01 2018-08-22 学校法人南山学園 Communications system
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
US11235159B2 (en) 2018-03-23 2022-02-01 Medtronic, Inc. VFA cardiac resynchronization therapy
EP3768160B1 (en) 2018-03-23 2023-06-07 Medtronic, Inc. Vfa cardiac therapy for tachycardia
EP3768369A1 (en) 2018-03-23 2021-01-27 Medtronic, Inc. Av synchronous vfa cardiac therapy
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
EP3790537A1 (en) 2018-05-11 2021-03-17 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
CN112955064A (en) 2018-06-15 2021-06-11 普罗秋斯数字健康公司 Repeatedly wearable physiological monitoring device
US20210251510A1 (en) * 2018-06-15 2021-08-19 Otsuka America Pharmaceutical, Inc. Monitoring a receiver for strip replacement
JP7267311B2 (en) * 2018-06-15 2023-05-01 大塚製薬株式会社 Low power receiver for in vivo channel detection and ingestible sensor detection at fluctuation frequencies
US11202578B2 (en) 2018-07-24 2021-12-21 Welch Allyn, Inc. Patch-based physiological sensor
US11039751B2 (en) 2018-07-24 2021-06-22 Baxter International Inc. Physiological sensor resembling a neck-worn collar
US11058340B2 (en) 2018-07-24 2021-07-13 Baxter International Inc. Patch-based physiological sensor
US11116410B2 (en) 2018-07-24 2021-09-14 Baxter International Inc. Patch-based physiological sensor
US11045094B2 (en) 2018-07-24 2021-06-29 Baxter International Inc. Patch-based physiological sensor
US10842392B2 (en) 2018-07-24 2020-11-24 Baxter International Inc. Patch-based physiological sensor
US11064918B2 (en) 2018-07-24 2021-07-20 Baxter International Inc. Patch-based physiological sensor
US11096590B2 (en) 2018-07-24 2021-08-24 Baxter International Inc. Patch-based physiological sensor
US11026587B2 (en) 2018-07-24 2021-06-08 Baxter International Inc. Physiological sensor resembling a neck-worn collar
CN109363674B (en) * 2018-08-22 2020-07-17 西安电子科技大学 Biological impedance measuring system
US11172882B2 (en) * 2018-09-05 2021-11-16 Vital Connect, Inc. Monitoring system
CN113382683A (en) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 System and method for improving sleep
WO2020065582A1 (en) 2018-09-26 2020-04-02 Medtronic, Inc. Capture in ventricle-from-atrium cardiac therapy
CN109445514B (en) * 2018-09-26 2022-03-15 电子科技大学 High-precision random frequency hopping DDS frequency synthesizer
AU2019357613B2 (en) * 2018-10-10 2021-12-09 Element Science, Inc. Wearable medical device with disposable and reusable components
TWI724340B (en) * 2018-10-29 2021-04-11 巧連科技股份有限公司 Physiological detection module and wearable electronic apparatus
CN111134636A (en) * 2018-11-05 2020-05-12 巧连科技股份有限公司 Physiology detection module and wearable electronic device with same
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11109800B2 (en) 2019-01-04 2021-09-07 Enable Injections, Inc. Medical fluid injection apparatus and method with detachable patch and monitoring
CN113613616A (en) 2019-01-04 2021-11-05 因内博注射剂公司 Medical fluid injection device and method with detachable patch and monitoring
WO2020160326A1 (en) * 2019-01-30 2020-08-06 The Regents Of The University Of Colorado, A Body Corporate Health sticker: a modular adhesive platform monitoring vital signals
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11346938B2 (en) 2019-03-15 2022-05-31 Msa Technology, Llc Safety device for providing output to an individual associated with a hazardous environment
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
FR3094198B1 (en) * 2019-03-29 2022-07-29 Rubix S&I Portable device for measuring the state of health of a user
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US11116451B2 (en) 2019-07-03 2021-09-14 Bardy Diagnostics, Inc. Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities
US11696681B2 (en) 2019-07-03 2023-07-11 Bardy Diagnostics Inc. Configurable hardware platform for physiological monitoring of a living body
US11096579B2 (en) 2019-07-03 2021-08-24 Bardy Diagnostics, Inc. System and method for remote ECG data streaming in real-time
US11737689B2 (en) 2019-08-02 2023-08-29 Bionime Corporation Physiological signal monitoring device
US11717198B2 (en) 2019-08-02 2023-08-08 Bionime Corporation Physiological signal monitoring device
TWI735138B (en) * 2019-08-02 2021-08-01 華廣生技股份有限公司 Physiological signal sensing device
CA3088621C (en) 2019-08-02 2024-04-02 Bionime Corporation Physiological signal monitoring device
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11903700B2 (en) 2019-08-28 2024-02-20 Rds Vital signs monitoring systems and methods
US11537190B2 (en) * 2019-09-11 2022-12-27 Silicon Laboratories Inc. Dual processor system for reduced power application processing
JP2023506713A (en) * 2019-12-16 2023-02-20 ニューロスティム テクノロジーズ エルエルシー Noninvasive nerve activator using booster charge delivery
US11701504B2 (en) 2020-01-17 2023-07-18 California Institute Of Technology Implantable intracranial pressure sensor
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US20210275805A1 (en) * 2020-03-03 2021-09-09 Advanced Neuromodulation Systems, Inc. Diagnostic circuitry for monitoring and mitigating electromagnetic interference (emi) in an implantable pulse generator
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
KR102263585B1 (en) * 2020-07-28 2021-06-10 주식회사 에이티센스 Bio-Signal Monitoring Device
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation
US11806503B2 (en) * 2020-10-29 2023-11-07 Medtronic Minimed, Inc. Removable wearable device and related attachment methods
KR102568423B1 (en) * 2021-01-26 2023-08-18 울산과학기술원 Method and apparatus for stimulating human body based on human body communication
US11307728B1 (en) 2021-04-26 2022-04-19 Inguran, Llc Computerized systems and methods for livestock management
CN117957029A (en) * 2021-09-24 2024-04-30 赛诺菲 Electronic device with battery life optimization provided for a drug delivery device or a drug delivery add-on device
TWI809825B (en) * 2022-04-18 2023-07-21 吳宗儒 System for diagnosing and monitoring abnormal lung rales as well as establishing method of the system
WO2024040201A1 (en) * 2022-08-19 2024-02-22 Celdara Medical Llc Improved method and system for cell therapy

Family Cites Families (690)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607788A (en) 1967-11-20 1971-09-21 Robert J Adolph Liquid electrode material
US3642008A (en) * 1968-09-25 1972-02-15 Medical Plastics Inc Ground electrode and test circuit
US3679480A (en) 1969-05-08 1972-07-25 Dow Chemical Co Electrical cell assembly
US3682160A (en) 1969-10-16 1972-08-08 Matsushita Electric Ind Co Ltd Physiological signal transmitter for use inside the body
US3719183A (en) * 1970-03-05 1973-03-06 H Schwartz Method for detecting blockage or insufficiency of pancreatic exocrine function
US3837339A (en) 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US3828766A (en) 1972-08-14 1974-08-13 Jet Medical Prod Inc Disposable medical electrode
US3989050A (en) 1972-09-19 1976-11-02 Gilbert Buchalter Process for utilizing certain gel compositions for electrical stimulation
US4106348A (en) 1974-02-20 1978-08-15 U.S. Philips Corporation Device for examination by means of ultrasonic vibrations
US4077397A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
ZA755785B (en) * 1974-10-07 1976-08-25 Baxter Laboratories Inc Diagnostic electrode assembly
US4090752A (en) * 1974-10-07 1978-05-23 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4067014A (en) 1976-10-04 1978-01-03 Hazeltine Corporation Correlation receiver for doppler microwave landing system
US4185172A (en) 1976-12-17 1980-01-22 Cselt - Centro Studi E Laboratori Telecomunicazioni S.P.A. Method of and means for detecting digitized multi frequency-coded signals
US4129125A (en) 1976-12-27 1978-12-12 Camin Research Corp. Patient monitoring system
GB1594214A (en) 1977-01-21 1981-07-30 Cardio Tech Body electrodes
US4082087A (en) * 1977-02-07 1978-04-04 Isis Medical Instruments Body contact electrode structure for deriving electrical signals due to physiological activity
JPS5469905A (en) * 1977-11-10 1979-06-05 Deikutoran Internatl Corp Answering system for call signal of automatic answering telephone set
US4239046A (en) 1978-09-21 1980-12-16 Ong Lincoln T Medical electrode
US4345588A (en) 1979-04-23 1982-08-24 Northwestern University Method of delivering a therapeutic agent to a target capillary bed
US4269189A (en) * 1979-07-09 1981-05-26 Consolidated Medical Equipment Inc. Skin conducting electrode assembly
DE2928477C3 (en) * 1979-07-14 1982-04-15 Battelle-Institut E.V., 6000 Frankfurt Device for the release of substances at defined locations in the digestive tract
US4333150A (en) 1980-01-28 1982-06-01 Westinghouse Electric Corp. Signal receiving apparatus and method
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4578061A (en) * 1980-10-28 1986-03-25 Lemelson Jerome H Injection catheter and method
US4418697A (en) 1981-08-17 1983-12-06 Francine Tama Electrode attachment method
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4513385A (en) 1983-01-31 1985-04-23 Motorola, Inc. Apparatus and method for suppressing side lobe response in a digitally sampled system
US4559950A (en) 1983-11-25 1985-12-24 Graphic Controls Corporation Disposable biomedical and diagnostic electrode
GB8422876D0 (en) 1984-09-11 1984-10-17 Secr Defence Silicon implant devices
FR2571603B1 (en) 1984-10-11 1989-01-06 Ascher Gilles PORTABLE ELECTROCARDIOGRAM RECORDER
JPS6172712U (en) 1984-10-12 1986-05-17
US4654165A (en) * 1985-04-16 1987-03-31 Micro Tracers, Inc. Microingredient containing tracer
US4763659A (en) 1985-08-21 1988-08-16 Spring Creek Institute, Inc. Dry electrode system for detection of biopotentials
US4669479A (en) 1985-08-21 1987-06-02 Spring Creek Institute, Inc. Dry electrode system for detection of biopotentials
US4635641A (en) * 1985-10-16 1987-01-13 Murray Electronics Associates Limited Multi-element electrode
US4725997A (en) * 1986-08-22 1988-02-16 Aprex Corporation Contingent dosing device
US4784162A (en) 1986-09-23 1988-11-15 Advanced Medical Technologies Portable, multi-channel, physiological data monitoring system
US4896261A (en) * 1986-11-24 1990-01-23 Motorola Inc. System for scheduling serial message transmission on a bus which is adoptable for rescheduling prioritized messages using a doubly-linked list
DE3723310A1 (en) * 1987-07-15 1989-01-26 John Urquhart PHARMACEUTICAL PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
US4975230A (en) 1988-06-17 1990-12-04 Vapor Technologies Inc. Method of making an open pore structure
US4844076A (en) 1988-08-26 1989-07-04 The Johns Hopkins University Ingestible size continuously transmitting temperature monitoring pill
DE3831809A1 (en) 1988-09-19 1990-03-22 Funke Hermann DEVICE DETERMINED AT LEAST PARTLY IN THE LIVING BODY
DE58908945D1 (en) * 1989-04-10 1995-03-09 Pacesetter Ab Implantable medical device with means for the telemetric transmission of data.
US5281287A (en) * 1989-07-21 1994-01-25 Iomed, Inc. Method of making a hydratable bioelectrode
US4987897A (en) * 1989-09-18 1991-01-29 Medtronic, Inc. Body bus medical device communication system
US6749122B1 (en) 1990-05-25 2004-06-15 Broadcom Corporation Multi-level hierarchial radio-frequency system communication system
US6359872B1 (en) 1997-10-28 2002-03-19 Intermec Ip Corp. Wireless personal local area network
US5167626A (en) 1990-10-02 1992-12-01 Glaxo Inc. Medical capsule device actuated by radio-frequency (RF) signal
US6605046B1 (en) 1991-06-03 2003-08-12 Del Mar Medical Systems, Llc Ambulatory physio-kinetic monitor with envelope enclosure
JPH0523323A (en) * 1991-07-22 1993-02-02 Nippon Zeon Co Ltd Intracorporeal information monitoring apparatus
GB9123638D0 (en) 1991-11-07 1992-01-02 Magill Alan R Apparel & fabric & devices suitable for health monitoring applications
US5176626A (en) * 1992-01-15 1993-01-05 Wilson-Cook Medical, Inc. Indwelling stent
JPH05228128A (en) 1992-02-25 1993-09-07 Olympus Optical Co Ltd Capsule for medical treatment
ATE197761T1 (en) 1992-04-03 2000-12-15 Micromedical Ind Ltd ARRANGEMENT FOR MONITORING PHYSIOLOGICAL PARAMETERS
US5263481A (en) 1992-05-21 1993-11-23 Jens Axelgaard Electrode system with disposable gel
US5283136A (en) * 1992-06-03 1994-02-01 Ramot University Authority For Applied Research And Industrial Development Ltd. Rechargeable batteries
US5318557A (en) 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
US5261402A (en) 1992-07-20 1993-11-16 Graphic Controls Corporation Snapless, tabless, disposable medical electrode with low profile
US7758503B2 (en) 1997-01-27 2010-07-20 Lynn Lawrence A Microprocessor system for the analysis of physiologic and financial datasets
US5406945A (en) 1993-05-24 1995-04-18 Ndm Acquisition Corp. Biomedical electrode having a secured one-piece conductive terminal
US5394882A (en) * 1993-07-21 1995-03-07 Respironics, Inc. Physiological monitoring system
US5458141A (en) 1993-08-04 1995-10-17 Quinton Instrument Company Abrasive skin electrode
DE4329898A1 (en) 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5402793A (en) 1993-11-19 1995-04-04 Advanced Technology Laboratories, Inc. Ultrasonic transesophageal probe for the imaging and diagnosis of multiple scan planes
WO1997004836A1 (en) 1994-03-21 1997-02-13 Dusa Pharmaceuticals, Inc. Patch, controller, and method for the photodynamic therapy of a dermal lesion
US5925066A (en) * 1995-10-26 1999-07-20 Galvani, Ltd. Atrial arrythmia sensor with drug and electrical therapy control apparatus
IE70735B1 (en) 1994-08-15 1996-12-11 Elan Med Tech Orally administrable delivery device
IL111396A (en) 1994-10-25 1997-07-13 Ness Neuromuscular Electrical Stimulation Systems Ltd Electrode system
US5485841A (en) * 1995-02-14 1996-01-23 Univ Mcgill Ultrasonic lung tissue assessment
US5778882A (en) 1995-02-24 1998-07-14 Brigham And Women's Hospital Health monitoring system
US6374670B1 (en) * 1995-03-13 2002-04-23 University Of Washington Non-invasive gut motility monitor
US5845265A (en) 1995-04-26 1998-12-01 Mercexchange, L.L.C. Consignment nodes
US5645063A (en) 1995-06-05 1997-07-08 Quinton Instrument Company Skin electrode having multiple conductive center members
US5720771A (en) 1995-08-02 1998-02-24 Pacesetter, Inc. Method and apparatus for monitoring physiological data from an implantable medical device
USD377983S (en) 1995-09-13 1997-02-11 Mohamed Sabri Cardiac monitor
US5802467A (en) 1995-09-28 1998-09-01 Innovative Intelcom Industries Wireless and wired communications, command, control and sensing system for sound and/or data transmission and reception
GB9522872D0 (en) 1995-11-08 1996-01-10 Oxford Medical Ltd Improvements relating to physiological monitoring
US8092224B2 (en) 1995-11-22 2012-01-10 James A. Jorasch Systems and methods for improved health care compliance
SE9504258D0 (en) * 1995-11-28 1995-11-28 Pacesetter Ab Device and method for generating a synthesized ECG
US5596302A (en) * 1996-01-17 1997-01-21 Lucent Technologies Inc. Ring oscillator using even numbers of differential stages with current mirrors
US5868136A (en) * 1996-02-20 1999-02-09 Axelgaard Manufacturing Co. Ltd. Medical electrode
US20010044588A1 (en) 1996-02-22 2001-11-22 Mault James R. Monitoring system
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
US5864578A (en) 1996-04-29 1999-01-26 Golden Bridge Technology, Inc. Matched filter-based handoff method and apparatus
US5800421A (en) * 1996-06-12 1998-09-01 Lemelson; Jerome H. Medical devices using electrosensitive gels
JP3636826B2 (en) * 1996-07-01 2005-04-06 積水化学工業株式会社 Bioelectrical impedance measuring device
WO1998007364A1 (en) 1996-08-16 1998-02-26 Roche Diagnostics Gmbh Monitoring system for the regular intake of a medicament
US5792048A (en) 1996-09-03 1998-08-11 Schaefer; Guenter Indentification pill with integrated microchip: smartpill, smartpill with integrated microchip and microprocessor for medical analyses and a smartpill, smartbox, smartplague, smartbadge or smartplate for luggage control on commercial airliners
US5857994A (en) * 1996-10-01 1999-01-12 Becton, Dickinson And Company Awakenable iontophoretic/delivery device for reducing electrical sensation upon application thereof
US6394953B1 (en) 2000-02-25 2002-05-28 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6364834B1 (en) * 1996-11-13 2002-04-02 Criticare Systems, Inc. Method and system for remotely monitoring multiple medical parameters in an integrated medical monitoring system
US5928142A (en) 1996-12-17 1999-07-27 Ndm, Inc. Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector
US5974124A (en) 1997-01-21 1999-10-26 Med Graph Method and system aiding medical diagnosis and treatment
US6122351A (en) 1997-01-21 2000-09-19 Med Graph, Inc. Method and system aiding medical diagnosis and treatment
JP4555919B2 (en) * 1997-03-17 2010-10-06 ノンインベイシブ モニタリング システムズ インコーポレイテッド Physiological signature feedback system
WO1998043537A1 (en) 1997-03-31 1998-10-08 Telecom Medical, Inc. Patient monitoring apparatus
US5981166A (en) 1997-04-23 1999-11-09 Pharmaseq, Inc. Screening of soluble chemical compounds for their pharmacological properties utilizing transponders
DE19717023C2 (en) 1997-04-23 2003-02-06 Micronas Gmbh Device for treating malignant, tumorous tissue areas
US5921925A (en) 1997-05-30 1999-07-13 Ndm, Inc. Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector
US7267665B2 (en) * 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6231583B1 (en) * 1997-07-09 2001-05-15 Joseph Y. Lee Corneal circular channel dissecting device
GB2327591A (en) 1997-07-24 1999-02-03 Nestle Sa Reduced fat chocolate
US5984875A (en) * 1997-08-22 1999-11-16 Innotek Pet Products, Inc. Ingestible animal temperature sensor
US5862808A (en) 1997-08-26 1999-01-26 Cigar Savor Enterprises Llc Cigar punch
US6409674B1 (en) 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US20020180605A1 (en) * 1997-11-11 2002-12-05 Ozguz Volkan H. Wearable biomonitor with flexible thinned integrated circuit
US5948227A (en) * 1997-12-17 1999-09-07 Caliper Technologies Corp. Methods and systems for performing electrophoretic molecular separations
JP3697629B2 (en) * 1999-09-13 2005-09-21 日本光電工業株式会社 Communication system for biological signals
US6140740A (en) * 1997-12-30 2000-10-31 Remon Medical Technologies, Ltd. Piezoelectric transducer
US6097927A (en) 1998-01-27 2000-08-01 Symbix, Incorporated Active symbolic self design method and apparatus
US6038464A (en) * 1998-02-09 2000-03-14 Axelgaard Manufacturing Co., Ltd. Medical electrode
US6275476B1 (en) 1998-02-19 2001-08-14 Micron Technology, Inc. Method of addressing messages and communications system
US7542878B2 (en) 1998-03-03 2009-06-02 Card Guard Scientific Survival Ltd. Personal health monitor and a method for health monitoring
US6141592A (en) 1998-03-06 2000-10-31 Intermedics Inc. Data transmission using a varying electric field
US6579231B1 (en) 1998-03-27 2003-06-17 Mci Communications Corporation Personal medical monitoring unit and system
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
CA2332112C (en) 1998-05-13 2004-02-10 Cygnus, Inc. Monitoring of physiological analytes
TW406018B (en) 1998-05-21 2000-09-21 Elan Corp Plc Improved adhesive system for medical devices
AU4094599A (en) 1998-05-21 1999-12-06 Telecom Medical, Inc. Patient monitoring apparatus
US6477424B1 (en) 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US6704602B2 (en) * 1998-07-02 2004-03-09 Medtronic, Inc. Implanted medical device/external medical instrument communication utilizing surface electrodes
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7548787B2 (en) 2005-08-03 2009-06-16 Kamilo Feher Medical diagnostic and communication system
US6703047B2 (en) 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
CA2341708A1 (en) 1998-09-04 2000-03-16 Wolfe Research Pty. Ltd. Medical implant system
CA2343404C (en) 1998-09-11 2002-11-12 Key-Trak, Inc. Object tracking system with non-contact object detection and identification
FI116957B (en) 1998-10-29 2006-04-13 Nokia Corp The method of communication between the wireless device and the electronic device and the communication device
US6708060B1 (en) 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
AU1832800A (en) 1998-11-25 2000-06-19 Ball Semiconductor Inc. Method of and system for identifying medical products
US6217744B1 (en) * 1998-12-18 2001-04-17 Peter Crosby Devices for testing fluid
WO2000037114A2 (en) 1998-12-21 2000-06-29 Sequella, Inc. Methods and compositions comprising monitoring devices
US6115636A (en) 1998-12-22 2000-09-05 Medtronic, Inc. Telemetry for implantable devices using the body as an antenna
US6117077A (en) 1999-01-22 2000-09-12 Del Mar Medical Systems, Llc Long-term, ambulatory physiological recorder
US6358202B1 (en) * 1999-01-25 2002-03-19 Sun Microsystems, Inc. Network for implanted computer devices
US8636648B2 (en) 1999-03-01 2014-01-28 West View Research, Llc Endoscopic smart probe
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US6494829B1 (en) 1999-04-15 2002-12-17 Nexan Limited Physiological sensor array
US6755783B2 (en) 1999-04-16 2004-06-29 Cardiocom Apparatus and method for two-way communication in a device for monitoring and communicating wellness parameters of ambulatory patients
US6290646B1 (en) 1999-04-16 2001-09-18 Cardiocom Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients
US6200265B1 (en) * 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
DK1182966T3 (en) * 1999-05-25 2004-04-13 Medicotest As Electrode for application to the skin
US7257426B1 (en) 1999-05-26 2007-08-14 Johnson Controls Technology Company Wireless communications systems and method
US6366206B1 (en) * 1999-06-02 2002-04-02 Ball Semiconductor, Inc. Method and apparatus for attaching tags to medical and non-medical devices
EP1060704A3 (en) 1999-06-18 2002-09-18 Agilent Technologies, Inc. (a Delaware corporation) Multi-parameter capability transmitter for wireless telemetry systems
DE19929328A1 (en) 1999-06-26 2001-01-04 Daimlerchrysler Aerospace Ag Device for long-term medical monitoring of people
US6287252B1 (en) 1999-06-30 2001-09-11 Monitrak Patient monitor
US6307468B1 (en) 1999-07-20 2001-10-23 Avid Identification Systems, Inc. Impedance matching network and multidimensional electromagnetic field coil for a transponder interrogator
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6206702B1 (en) * 1999-08-24 2001-03-27 Deborah A. Hayden Methods and devices for treating unilateral neglect
US6526034B1 (en) 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
US6533733B1 (en) 1999-09-24 2003-03-18 Ut-Battelle, Llc Implantable device for in-vivo intracranial and cerebrospinal fluid pressure monitoring
US6990082B1 (en) 1999-11-08 2006-01-24 Intel Corporation Wireless apparatus having a transceiver equipped to support multiple wireless communication protocols
EP1089572B1 (en) 1999-09-30 2011-09-21 Sony Corporation Recording apparatus, recording method, and record medium
WO2001026232A2 (en) 1999-10-07 2001-04-12 La Mont, Llc Physiological signal monitoring apparatus and method
US6852084B1 (en) 2000-04-28 2005-02-08 Peter V. Boesen Wireless physiological pressure sensor and transmitter with capability of short range radio frequency transmissions
US6445951B1 (en) * 1999-10-12 2002-09-03 Pacesetter, Inc. Implantable cardiac stimulating device incorporating high frequency low amplitude lead impedance measurement
US6882881B1 (en) 1999-10-19 2005-04-19 The Johns Hopkins University Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders
US6426863B1 (en) 1999-11-25 2002-07-30 Lithium Power Technologies, Inc. Electrochemical capacitor
US6612984B1 (en) 1999-12-03 2003-09-02 Kerr, Ii Robert A. System and method for collecting and transmitting medical data
GB9930000D0 (en) 1999-12-21 2000-02-09 Phaeton Research Ltd An ingestible device
US6294999B1 (en) 1999-12-29 2001-09-25 Becton, Dickinson And Company Systems and methods for monitoring patient compliance with medication regimens
US8002700B2 (en) 1999-12-30 2011-08-23 Medtronic, Inc. Communications system for an implantable medical device and a delivery device
EP1119137B1 (en) 2000-01-20 2006-08-16 Lucent Technologies Inc. Interoperability for bluetooth/IEEE 802.11
US7039453B2 (en) 2000-02-08 2006-05-02 Tarun Mullick Miniature ingestible capsule
US7177675B2 (en) 2000-02-09 2007-02-13 Cns Response, Inc Electroencephalography based systems and methods for selecting therapies and predicting outcomes
EP1693000B1 (en) 2000-03-08 2013-05-08 Given Imaging Ltd. A device for in vivo imaging
US6526315B1 (en) * 2000-03-17 2003-02-25 Tanita Corporation Portable bioelectrical impedance measuring instrument
GB0007617D0 (en) 2000-03-29 2000-05-17 Psion Dacom Plc A short range radio transceiver device
US6757523B2 (en) 2000-03-31 2004-06-29 Zeus Wireless, Inc. Configuration of transmit/receive switching in a transceiver
US6622050B2 (en) 2000-03-31 2003-09-16 Medtronic, Inc. Variable encryption scheme for data transfer between medical devices and related data management systems
US6922592B2 (en) 2000-04-04 2005-07-26 Medtronic, Inc. Implantable medical device controlled by a non-invasive physiological data measurement device
US6654638B1 (en) 2000-04-06 2003-11-25 Cardiac Pacemakers, Inc. Ultrasonically activated electrodes
US6496705B1 (en) 2000-04-18 2002-12-17 Motorola Inc. Programmable wireless electrode system for medical monitoring
US6441747B1 (en) 2000-04-18 2002-08-27 Motorola, Inc. Wireless system protocol for telemetry monitoring
US6561975B1 (en) 2000-04-19 2003-05-13 Medtronic, Inc. Method and apparatus for communicating with medical device systems
US6836862B1 (en) 2000-04-24 2004-12-28 3Com Corporation Method of indicating wireless connection integrity
US6792247B2 (en) 2000-05-08 2004-09-14 Microtune (San Diego), Inc. Co-located frequency-agile system and method
US6432292B1 (en) 2000-05-16 2002-08-13 Metallic Power, Inc. Method of electrodepositing metal on electrically conducting particles
ATE502567T1 (en) * 2000-05-19 2011-04-15 Welch Allyn Protocol Inc DEVICE FOR MONITORING PATIENTS
US6680923B1 (en) * 2000-05-23 2004-01-20 Calypso Wireless, Inc. Communication system and method
ATE279879T1 (en) 2000-05-29 2004-11-15 Medicotest As ELECTRODE FOR MAKING ELECTRICAL CONTACT WITH THE SKIN
IL163684A0 (en) 2000-05-31 2005-12-18 Given Imaging Ltd Measurement of electrical characteristics of tissue
GB0014855D0 (en) * 2000-06-16 2000-08-09 Isis Innovation Combining measurements from different sensors
US6605038B1 (en) 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US7261690B2 (en) 2000-06-16 2007-08-28 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
US20060122474A1 (en) 2000-06-16 2006-06-08 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
US7689437B1 (en) 2000-06-16 2010-03-30 Bodymedia, Inc. System for monitoring health, wellness and fitness
GB0014854D0 (en) * 2000-06-16 2000-08-09 Isis Innovation System and method for acquiring data
US7009946B1 (en) 2000-06-22 2006-03-07 Intel Corporation Method and apparatus for multi-access wireless communication
GB0016561D0 (en) * 2000-07-05 2000-08-23 Rolls Royce Plc Health monitoring
DK1301123T3 (en) 2000-07-19 2005-01-24 Medicotest As Skin electrode with a bypass element
AU2001277163A1 (en) 2000-07-24 2002-02-05 Motorola, Inc. Ingestible electronic capsule
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
JP4428835B2 (en) * 2000-08-09 2010-03-10 昭和電工株式会社 Magnetic recording medium and method for manufacturing the same
US20020026111A1 (en) * 2000-08-28 2002-02-28 Neil Ackerman Methods of monitoring glucose levels in a subject and uses thereof
US7685005B2 (en) 2000-08-29 2010-03-23 Medtronic, Inc. Medical device systems implemented network scheme for remote patient management
DE60102331T2 (en) * 2000-09-08 2005-03-17 Matsushita Electric Works, Ltd., Kadoma Data transmission system using a human body as a signal transmission path
US6720923B1 (en) * 2000-09-14 2004-04-13 Stata Labs, Llc Antenna design utilizing a cavity architecture for global positioning system (GPS) applications
AU2001292946A1 (en) 2000-09-26 2002-04-08 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US7024248B2 (en) 2000-10-16 2006-04-04 Remon Medical Technologies Ltd Systems and methods for communicating with implantable devices
US7857626B2 (en) 2000-10-23 2010-12-28 Toly Christopher C Medical physiological simulator including a conductive elastomer layer
WO2002034331A2 (en) 2000-10-26 2002-05-02 Medtronic, Inc. Externally worn transceiver for use with an implantable medical device
US6632175B1 (en) 2000-11-08 2003-10-14 Hewlett-Packard Development Company, L.P. Swallowable data recorder capsule medical device
US6929636B1 (en) 2000-11-08 2005-08-16 Hewlett-Packard Development Company, L.P. Internal drug dispenser capsule medical device
ES2177434B1 (en) 2000-12-05 2004-10-16 Gesimpex Comercial, S.L. PROCEDURE AND CAPSULE FOR REMOTE IDENTIFICATION AND MONITORING OF BIRDS.
US6689117B2 (en) * 2000-12-18 2004-02-10 Cardiac Pacemakers, Inc. Drug delivery system for implantable medical device
US6879810B2 (en) 2000-12-20 2005-04-12 Nokia Corporation Control of short range RF communication
TW567695B (en) 2001-01-17 2003-12-21 Ibm Digital baseband system
JP2002224053A (en) 2001-02-05 2002-08-13 Next:Kk Remote medical control system
DE60215924T2 (en) * 2001-02-08 2007-05-10 Mini-Mitter Co., Inc., Bend SKIN PAD WITH TEMPERATURE SENSOR
JP2002282219A (en) 2001-03-22 2002-10-02 Toshio Chiba Intracorporeal capsule
JP2002290212A (en) 2001-03-27 2002-10-04 Nec Corp Voltage controlled oscillator
EP1383575A4 (en) 2001-03-28 2010-01-20 Televital Inc System and method for real-time monitoring, assessment, analysis, retrieval, and storage of physiological data over a wide area network
JP2002291684A (en) 2001-03-29 2002-10-08 Olympus Optical Co Ltd Endoscope for surgical operation, and outer tube
EP1379167A1 (en) 2001-04-06 2004-01-14 Medic4all Inc. A physiological monitoring system for a computational device of a human subject
GR1003802B (en) 2001-04-17 2002-02-08 Micrel �.�.�. ������� ��������� ��������������� ��������� Tele-medicine system
US6694161B2 (en) * 2001-04-20 2004-02-17 Monsanto Technology Llc Apparatus and method for monitoring rumen pH
US6801137B2 (en) 2001-04-23 2004-10-05 Cardionet, Inc. Bidirectional communication between a sensor unit and a monitor unit in patient monitoring
US6782290B2 (en) 2001-04-27 2004-08-24 Medtronic, Inc. Implantable medical device with rechargeable thin-film microbattery power source
US20050182389A1 (en) * 2001-04-30 2005-08-18 Medtronic, Inc Implantable medical device and patch system and method of use
US7970450B2 (en) 2001-05-03 2011-06-28 Halthion Medical Technologies, Inc. Wireless medical monitoring apparatus and system
US7039033B2 (en) 2001-05-07 2006-05-02 Ixi Mobile (Israel) Ltd. System, device and computer readable medium for providing a managed wireless network using short-range radio signals
GB0113212D0 (en) * 2001-05-31 2001-07-25 Oxford Biosignals Ltd Patient condition display
US20020192159A1 (en) 2001-06-01 2002-12-19 Reitberg Donald P. Single-patient drug trials used with accumulated database: flowchart
WO2002102240A2 (en) 2001-06-19 2002-12-27 Digital Sports Media Physiological monitoring and system
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US7044911B2 (en) 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US7783344B2 (en) 2003-08-20 2010-08-24 Philometron, Inc. Hydration monitoring
NZ530434A (en) * 2001-07-02 2005-01-28 Battelle Memorial Institute Intelligent microsensor module
US20030017826A1 (en) 2001-07-17 2003-01-23 Dan Fishman Short-range wireless architecture
FR2827919B1 (en) 2001-07-26 2004-03-05 Thermodyn SEALING FOR COMPRESSOR AND CENTRIFUGAL COMPRESSOR PROVIDED WITH SUCH A SEAL
US6951536B2 (en) * 2001-07-30 2005-10-04 Olympus Corporation Capsule-type medical device and medical system
US6747556B2 (en) 2001-07-31 2004-06-08 Medtronic Physio-Control Corp. Method and system for locating a portable medical device
US20030065536A1 (en) 2001-08-13 2003-04-03 Hansen Henrik Egesborg Portable device and method of communicating medical data information
JP3962250B2 (en) 2001-08-29 2007-08-22 株式会社レアメタル In vivo information detection system and tag device and relay device used therefor
US6650191B2 (en) * 2001-09-07 2003-11-18 Texas Instruments Incorporated Low jitter ring oscillator architecture
US20050137480A1 (en) 2001-10-01 2005-06-23 Eckhard Alt Remote control of implantable device through medical implant communication service band
US6840904B2 (en) 2001-10-11 2005-01-11 Jason Goldberg Medical monitoring device and system
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US6745082B2 (en) 2001-10-22 2004-06-01 Jens Axelgaard Current-controlling electrode with adjustable contact area
US20030152622A1 (en) 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030083559A1 (en) 2001-10-31 2003-05-01 Thompson David L. Non-contact monitor
US6894456B2 (en) * 2001-11-07 2005-05-17 Quallion Llc Implantable medical power module
KR100536188B1 (en) * 2001-11-14 2005-12-14 한국과학기술연구원 Method and apparatus for communication between inside and outside of transmission medium such as human body utilizing itself as a communication line
US6643541B2 (en) 2001-12-07 2003-11-04 Motorola, Inc Wireless electromyography sensor and system
US20030107487A1 (en) 2001-12-10 2003-06-12 Ronen Korman Method and device for measuring physiological parameters at the wrist
GB0130010D0 (en) * 2001-12-14 2002-02-06 Isis Innovation Combining measurements from breathing rate sensors
US7016648B2 (en) 2001-12-18 2006-03-21 Ixi Mobile (Israel) Ltd. Method, system and computer readable medium for downloading a software component to a device in a short distance wireless network
US7729776B2 (en) 2001-12-19 2010-06-01 Cardiac Pacemakers, Inc. Implantable medical device with two or more telemetry systems
US7877273B2 (en) 2002-01-08 2011-01-25 Fredric David Abramson System and method for evaluating and providing nutrigenomic data, information and advice
EP1464026A2 (en) 2002-01-11 2004-10-06 Hexalog SA Systems and methods for medication monitoring
US7184820B2 (en) * 2002-01-25 2007-02-27 Subqiview, Inc. Tissue monitoring system for intravascular infusion
US6958034B2 (en) 2002-02-11 2005-10-25 Given Imaging Ltd. Self propelled device
US6935560B2 (en) 2002-02-26 2005-08-30 Safety Syringes, Inc. Systems and methods for tracking pharmaceuticals within a facility
US20030162556A1 (en) 2002-02-28 2003-08-28 Libes Michael A. Method and system for communication between two wireless-enabled devices
US7043305B2 (en) 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US6968153B1 (en) 2002-03-13 2005-11-22 Nokia Corporation Apparatus, method and system for a Bluetooth repeater
US6957107B2 (en) 2002-03-13 2005-10-18 Cardionet, Inc. Method and apparatus for monitoring and communicating with an implanted medical device
US7188767B2 (en) 2002-03-18 2007-03-13 Precision Dynamics Corporation Physical condition or environmental threat detection appliance system
US7022070B2 (en) 2002-03-22 2006-04-04 Mini-Mitter Co., Inc. Method for continuous monitoring of patients to detect the potential onset of sepsis
US6850788B2 (en) 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
JP3869291B2 (en) 2002-03-25 2007-01-17 オリンパス株式会社 Capsule medical device
US7376435B2 (en) 2002-04-01 2008-05-20 Intel Corporation Transferring multiple data units over a wireless communication link
US7797033B2 (en) 2002-04-08 2010-09-14 Smart Pill Corporation Method of using, and determining location of, an ingestible capsule
CN105326478A (en) 2002-04-22 2016-02-17 马尔西奥·马克·阿布雷乌 Apparatus and method for measuring biologic parameters
EP1356762A1 (en) 2002-04-22 2003-10-29 UbiCom Gesellschaft für Telekommunikation mbH Device for remote monitoring of body functions
US7424268B2 (en) 2002-04-22 2008-09-09 Cisco Technology, Inc. System and method for management of a shared frequency band
US20030216622A1 (en) 2002-04-25 2003-11-20 Gavriel Meron Device and method for orienting a device in vivo
TW553735B (en) * 2002-05-01 2003-09-21 Jin-Shing Luo Common electrode using human body as common electric reservoir and application thereof
JP2003325439A (en) 2002-05-15 2003-11-18 Olympus Optical Co Ltd Capsule type medical treatment device
US20030216729A1 (en) 2002-05-20 2003-11-20 Marchitto Kevin S. Device and method for wound healing and uses therefor
JP3576150B2 (en) * 2002-05-31 2004-10-13 株式会社東芝 Relay device and power control method
US6847844B2 (en) 2002-06-06 2005-01-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of data communication with implanted device and associated apparatus
MXPA04012556A (en) * 2002-07-01 2005-10-19 Gmp Wireless Medicine Inc Wireless ecg system.
US20040008123A1 (en) * 2002-07-15 2004-01-15 Battelle Memorial Institute System and method for tracking medical devices
US20040019172A1 (en) 2002-07-26 2004-01-29 Tou-Hsiung Yang Biodegradable, water absorbable resin and its preparation method
US20040143182A1 (en) 2002-08-08 2004-07-22 Pavel Kucera System and method for monitoring and stimulating gastro-intestinal motility
US6909878B2 (en) 2002-08-20 2005-06-21 Ixi Mobile (Israel) Ltd. Method, system and computer readable medium for providing an output signal having a theme to a device in a short distance wireless network
US7020508B2 (en) 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
US7294105B1 (en) 2002-09-03 2007-11-13 Cheetah Omni, Llc System and method for a wireless medical communication system
US7102508B2 (en) * 2002-09-09 2006-09-05 Persephone, Inc. Method and apparatus for locating and tracking persons
US20040049245A1 (en) 2002-09-09 2004-03-11 Volker Gass Autonomous patch for communication with an implantable device, and medical kit for using said patch
US7388903B2 (en) 2002-09-18 2008-06-17 Conexant, Inc. Adaptive transmission rate and fragmentation threshold mechanism for local area networks
GB2393356B (en) * 2002-09-18 2006-02-01 E San Ltd Telemedicine system
US7118531B2 (en) 2002-09-24 2006-10-10 The Johns Hopkins University Ingestible medical payload carrying capsule with wireless communication
US6842636B2 (en) 2002-09-27 2005-01-11 Axelgaard Manufacturing Co., Ltd. Medical electrode
US7736309B2 (en) 2002-09-27 2010-06-15 Medtronic Minimed, Inc. Implantable sensor method and system
US7209790B2 (en) 2002-09-30 2007-04-24 Medtronic, Inc. Multi-mode programmer for medical device communication
US7686762B1 (en) 2002-10-03 2010-03-30 Integrated Sensing Systems, Inc. Wireless device and system for monitoring physiologic parameters
JP4975249B2 (en) 2002-10-09 2012-07-11 ボディーメディア インコーポレイテッド Device for measuring an individual's state parameters using physiological information and / or context parameters
US20040073454A1 (en) * 2002-10-10 2004-04-15 John Urquhart System and method of portal-mediated, website-based analysis of medication dosing
US20050272989A1 (en) 2004-06-04 2005-12-08 Medtronic Minimed, Inc. Analyte sensors and methods for making and using them
US6959217B2 (en) * 2002-10-24 2005-10-25 Alfred E. Mann Foundation For Scientific Research Multi-mode crystal oscillator system selectively configurable to minimize power consumption or noise generation
US7027871B2 (en) 2002-10-31 2006-04-11 Medtronic, Inc. Aggregation of data from external data sources within an implantable medical device
US20030126593A1 (en) 2002-11-04 2003-07-03 Mault James R. Interactive physiological monitoring system
US7232627B2 (en) 2002-11-08 2007-06-19 Honda Motor Co., Ltd. Electrode for solid polymer fuel cell
US20040092801A1 (en) 2002-11-13 2004-05-13 Budimir Drakulic System for, and method of, acquiring physiological signals of a patient
WO2004049947A2 (en) 2002-11-29 2004-06-17 Given Imaging Ltd. Methods device and system for in vivo diagnosis
NZ539915A (en) 2002-12-11 2007-09-28 Pfizer Prod Inc Controlled-release of an active substance into a high fat environment
US20040167226A1 (en) 2002-12-16 2004-08-26 Serafini Tito A. Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
EP1578260B1 (en) 2002-12-16 2012-10-24 Given Imaging Ltd. Device, system and method for selective activation of in vivo sensors
US7009511B2 (en) 2002-12-17 2006-03-07 Cardiac Pacemakers, Inc. Repeater device for communications with an implantable medical device
EP1590039A1 (en) 2002-12-19 2005-11-02 Koninklijke Philips Electronics N.V. An electrode assembly and a system with impedance control
US7127300B2 (en) 2002-12-23 2006-10-24 Cardiac Pacemakers, Inc. Method and apparatus for enabling data communication between an implantable medical device and a patient management system
US6975174B1 (en) 2002-12-31 2005-12-13 Radioframe Networks, Inc. Clock oscillator
US7396330B2 (en) 2003-01-07 2008-07-08 Triage Data Networks Wireless, internet-based medical-diagnostic system
US20060142648A1 (en) 2003-01-07 2006-06-29 Triage Data Networks Wireless, internet-based, medical diagnostic system
US7512448B2 (en) 2003-01-10 2009-03-31 Phonak Ag Electrode placement for wireless intrabody communication between components of a hearing system
KR100873683B1 (en) 2003-01-25 2008-12-12 한국과학기술연구원 Method and system for data communication in human body and capsule-type endoscope used therein
WO2004066903A2 (en) 2003-01-29 2004-08-12 E-Pill Pharma Ltd. Active drug delivery in the gastrointestinal tract
EP1443780B1 (en) 2003-01-30 2013-05-29 Accenture Global Services Limited Event data acquisition and transmission system
US7002476B2 (en) * 2003-01-30 2006-02-21 Leap Of Faith Technologies, Inc. Medication compliance system
US7149581B2 (en) 2003-01-31 2006-12-12 Medtronic, Inc. Patient monitoring device with multi-antenna receiver
US7215660B2 (en) 2003-02-14 2007-05-08 Rearden Llc Single transceiver architecture for a wireless network
US7392015B1 (en) 2003-02-14 2008-06-24 Calamp Corp. Calibration methods and structures in wireless communications systems
JP4158097B2 (en) 2003-02-27 2008-10-01 ソニー株式会社 Authentication system
US7653031B2 (en) 2003-03-05 2010-01-26 Timothy Gordon Godfrey Advance notification of transmit opportunities on a shared-communications channel
US7155232B2 (en) 2003-03-05 2006-12-26 Conexant Systems, Inc. Transmit request signaling between transceivers
US7321920B2 (en) 2003-03-21 2008-01-22 Vocel, Inc. Interactive messaging system
WO2004084720A2 (en) 2003-03-21 2004-10-07 Welch Allyn, Inc. Personal status physiologic monitor system and architecture and related monitoring methods
DE10313005B4 (en) 2003-03-24 2007-05-03 Siemens Ag Backup battery and method for its manufacture
US20040193446A1 (en) 2003-03-27 2004-09-30 Mayer Steven Lloyd System and method for managing a patient treatment program including a prescribed drug regimen
US7245954B2 (en) 2003-03-27 2007-07-17 Given Imaging Ltd. Measuring a gradient in-vivo
GB0308114D0 (en) 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
GB0308467D0 (en) * 2003-04-11 2003-05-21 Rolls Royce Plc Method and system for analysing tachometer and vibration data from an apparatus having one or more rotary components
FI116117B (en) 2003-04-17 2005-09-30 Polar Electro Oy Measuring device and method for measuring heart rate and the method of manufacture of the measuring device
US7972616B2 (en) 2003-04-17 2011-07-05 Nanosys, Inc. Medical device applications of nanostructured surfaces
JPWO2004096023A1 (en) * 2003-04-25 2006-07-13 オリンパス株式会社 Wireless in-subject information acquisition system and subject external device
US20040218683A1 (en) 2003-05-01 2004-11-04 Texas Instruments Incorporated Multi-mode wireless devices having reduced-mode receivers
US20040225199A1 (en) 2003-05-08 2004-11-11 Evanyk Shane Walter Advanced physiological monitoring systems and methods
TWI226761B (en) 2003-05-08 2005-01-11 Ind Tech Res Inst Dual band transceiver architecture for wireless application
US7031745B2 (en) 2003-05-12 2006-04-18 Shen Ein-Yiao Cellular phone combined physiological condition examination and processing device
WO2004100776A1 (en) * 2003-05-14 2004-11-25 Olympus Corporation Capsule medical device
KR100542101B1 (en) 2003-06-02 2006-01-11 삼성전자주식회사 Power control method and bluetooth device using the same
US20040249257A1 (en) 2003-06-04 2004-12-09 Tupin Joe Paul Article of manufacture for extracting physiological data using ultra-wideband radar and improved signal processing techniques
US7313163B2 (en) 2003-06-17 2007-12-25 Motorola, Inc. Fast synchronization for half duplex digital communications
US20040260154A1 (en) 2003-06-18 2004-12-23 Boris Sidelnik Human physiological and chemical monitoring system
EP2263513B1 (en) * 2003-06-24 2013-08-07 Olympus Corporation Capsule type medical device communication system, capsule type medical device, and biological information reception device
US20070027386A1 (en) 2003-07-16 2007-02-01 Koninklijke Philips Electronics N.V. Portable electronic device and a health management system arranged for monitoring a physiological condition of an individual
WO2005007223A2 (en) 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
US7554452B2 (en) 2003-07-18 2009-06-30 Cary Cole Ingestible tracking and locating device
US7653350B2 (en) 2003-07-24 2010-01-26 Sony Ericsson Mobile Communications Ab Wireless terminals and methods for communicating over cellular and enhanced mode bluetooth communication links
SG145693A1 (en) * 2003-07-29 2008-09-29 Signature R & D Holdings Llc Amino acid prodrugs
US7243118B2 (en) 2003-07-30 2007-07-10 Broadcom Corporation Method and apparatus for efficient derivation of modulo arithmetic for frequency selection
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
EP1670547B1 (en) 2003-08-18 2008-11-12 Cardiac Pacemakers, Inc. Patient monitoring system
US20050172958A1 (en) 2003-08-20 2005-08-11 The Brigham And Women's Hospital, Inc. Inhalation device and system for the remote monitoring of drug administration
JP4398204B2 (en) 2003-08-29 2010-01-13 オリンパス株式会社 In-subject introduction apparatus and wireless in-subject information acquisition system
WO2005024687A1 (en) 2003-09-02 2005-03-17 Fujitsu Limited Medicine dosage management method, medicine, and medicine dosage management device
US20050048960A1 (en) * 2003-09-03 2005-03-03 Sharp Kabushiki Kaisha Information processing device, control device, communication device, communication equipment, electronic device, information processing system, power management method, power management program, and recording medium
US20050062644A1 (en) * 2003-09-08 2005-03-24 Leci Jonathan Ilan Capsule device to identify the location of an individual
KR20140134338A (en) * 2003-09-11 2014-11-21 테라노스, 인코포레이티드 Medical device for analyte monitoring and drug delivery
US7499674B2 (en) 2003-09-12 2009-03-03 Nokia Corporation Method and system for repeat request in hybrid ultra wideband-bluetooth radio
KR101084554B1 (en) * 2003-09-12 2011-11-17 보디미디어 인코퍼레이티드 Method and apparatus for measuring heart related parameters
US7352998B2 (en) 2003-09-12 2008-04-01 Nokia Corporation Method and system for establishing a wireless communications link
JP4153852B2 (en) * 2003-09-18 2008-09-24 オリンパス株式会社 Energy supply coil and wireless in-vivo information acquisition system using the same
US20090157358A1 (en) 2003-09-22 2009-06-18 Hyeung-Yun Kim System for diagnosing and monitoring structural health conditions
CN101014938A (en) 2003-09-22 2007-08-08 金炯胤 Methods for monitoring structural health conditions
US7218967B2 (en) 2003-09-26 2007-05-15 Medtronic, Inc. System and method for real-time remote monitoring of implantable medical devices
US20050096514A1 (en) 2003-11-01 2005-05-05 Medtronic, Inc. Gastric activity notification
US7101343B2 (en) 2003-11-05 2006-09-05 Temple University Of The Commonwealth System Of Higher Education Implantable telemetric monitoring system, apparatus, and method
US20050101843A1 (en) 2003-11-06 2005-05-12 Welch Allyn, Inc. Wireless disposable physiological sensor
JP4600916B2 (en) 2003-11-07 2010-12-22 株式会社タニタ Shielded cable and bioelectrical impedance value or biological composition information acquisition device using shielded cable
US7415242B1 (en) 2003-11-10 2008-08-19 Sprint Spectrum L.P. Method and system for proximity detection for an in-building wireless repeater
DE102004032812B4 (en) 2003-11-11 2006-07-20 Dräger Safety AG & Co. KGaA Combination sensor for physiological measurements
US6987691B2 (en) 2003-12-02 2006-01-17 International Business Machines Corporation Easy axis magnetic amplifier
US7427266B2 (en) 2003-12-15 2008-09-23 Hewlett-Packard Development Company, L.P. Method and apparatus for verification of ingestion
US8306592B2 (en) 2003-12-19 2012-11-06 Olympus Corporation Capsule medical device
JP2005185567A (en) 2003-12-25 2005-07-14 Olympus Corp Medical capsule apparatus
JP4198045B2 (en) * 2003-12-25 2008-12-17 オリンパス株式会社 In-subject position detection system
US7392091B2 (en) 2003-12-30 2008-06-24 Cochlear Limited Implanted antenna and radio communications link
US7342895B2 (en) 2004-01-30 2008-03-11 Mark Serpa Method and system for peer-to-peer wireless communication over unlicensed communication spectrum
US20050177111A1 (en) * 2004-02-06 2005-08-11 Shaul Ozeri Miniature infusion pump
JP2005227874A (en) * 2004-02-10 2005-08-25 Sony Corp System, device, and method for information processing, program, and storage medium
US7647112B2 (en) 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
US20060154642A1 (en) 2004-02-20 2006-07-13 Scannell Robert F Jr Medication & health, environmental, and security monitoring, alert, intervention, information and network system with associated and supporting apparatuses
US20050187789A1 (en) 2004-02-25 2005-08-25 Cardiac Pacemakers, Inc. Advanced patient and medication therapy management system and method
US7904133B2 (en) 2004-02-27 2011-03-08 Koninklijke Philips Electronics N.V. Wearable wireless device for monitoring, analyzing and communicating physiological status
CN1284505C (en) 2004-02-28 2006-11-15 重庆金山科技(集团)有限公司 Radio capsule like endoscope system for medical use
US7406105B2 (en) 2004-03-03 2008-07-29 Alfred E. Mann Foundation For Scientific Research System and method for sharing a common communication channel between multiple systems of implantable medical devices
EP2143369B1 (en) 2004-03-04 2012-06-27 Olympus Corporation Capsule-type medical system
GB0405798D0 (en) 2004-03-15 2004-04-21 E San Ltd Medical data display
JP4520198B2 (en) * 2004-04-07 2010-08-04 オリンパス株式会社 In-subject position display system
US20050234307A1 (en) 2004-04-15 2005-10-20 Nokia Corporation Physiological event handling system and method
US9801527B2 (en) 2004-04-19 2017-10-31 Gearbox, Llc Lumen-traveling biological interface device
JP2005304880A (en) 2004-04-23 2005-11-04 Hitachi Ltd In-vivo object management system utilizing non-contact ic tag
CA2564977C (en) 2004-04-24 2014-08-12 Inrange Systems, Inc. Integrated, non-sequential, remote medication management and compliance system
US20050245794A1 (en) 2004-04-29 2005-11-03 Medtronic, Inc. Communication with implantable monitoring probe
GB0410248D0 (en) 2004-05-07 2004-06-09 Isis Innovation Signal analysis method
EP1750585A1 (en) 2004-05-16 2007-02-14 Medic4all AG Method and device for measuring physiological parameters at the hand
US7575005B2 (en) 2004-05-18 2009-08-18 Excel-Tech Ltd. Mask assembly with integrated sensors
US20050261559A1 (en) 2004-05-18 2005-11-24 Mumford John R Wireless physiological monitoring system
US7125382B2 (en) 2004-05-20 2006-10-24 Digital Angel Corporation Embedded bio-sensor system
KR100592934B1 (en) 2004-05-21 2006-06-23 한국전자통신연구원 Wearable physiological signal detection module and measurement apparatus with the same
US20050259768A1 (en) 2004-05-21 2005-11-24 Oki Techno Centre (Singapore) Pte Ltd Digital receiver and method for processing received signals
US7653542B2 (en) 2004-05-26 2010-01-26 Verizon Business Global Llc Method and system for providing synthesized speech
EP1766591B1 (en) 2004-05-28 2008-01-16 Jan De Geest Communication unit for a person's skin
US20050267556A1 (en) 2004-05-28 2005-12-01 Allan Shuros Drug eluting implants to prevent cardiac apoptosis
US7289855B2 (en) 2004-06-09 2007-10-30 Medtronic, Inc. Implantable medical device package antenna
WO2005123185A1 (en) * 2004-06-10 2005-12-29 Ndi Medical, Llc Implantable system for processing myoelectric signals
US7697994B2 (en) 2004-06-18 2010-04-13 Medtronic, Inc. Remote scheduling for management of an implantable medical device
KR100615431B1 (en) 2004-06-22 2006-08-25 한국전자통신연구원 Physiological signal detection module, a multi-channel connector module and physiological signal detection apparatus with the same
US20050285746A1 (en) 2004-06-25 2005-12-29 Sengupta Uttam K Radio frequency identification based system to track consumption of medication
US7206630B1 (en) 2004-06-29 2007-04-17 Cleveland Medical Devices, Inc Electrode patch and wireless physiological measurement system and method
US20060001496A1 (en) * 2004-07-02 2006-01-05 Abrosimov Igor A Array oscillator and polyphase clock generator
JP4462614B2 (en) 2004-07-05 2010-05-12 ソニー・エリクソン・モバイルコミュニケーションズ株式会社 Short-range wireless communication system, portable terminal device, and wireless communication device
US7343186B2 (en) 2004-07-07 2008-03-11 Masimo Laboratories, Inc. Multi-wavelength physiological monitor
US7505795B1 (en) * 2004-07-07 2009-03-17 Advanced Micro Devices, Inc. Power save management with customized range for user configuration and tuning value based upon recent usage
US20080208009A1 (en) 2004-07-09 2008-08-28 Dror Shklarski Wearable Device, System and Method for Measuring Vital Parameters
WO2006008740A1 (en) 2004-07-21 2006-01-26 Aerotel Medical Systems (1998) Ltd. Wearable device, system and method for measuring physiological and/or environmental parameters
CN100459614C (en) 2004-07-22 2009-02-04 华为技术有限公司 Mobile phone external device and method
US7253716B2 (en) * 2004-08-17 2007-08-07 Tagent Corporation Trackable pills with electronic ID tags
US7317378B2 (en) * 2004-08-17 2008-01-08 Tagent Corporation Product identification tag device and reader
US8518022B2 (en) 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
JP5032321B2 (en) 2004-08-31 2012-09-26 ライフスキャン・スコットランド・リミテッド Manufacturing method of automatic calibration sensor
KR100727817B1 (en) * 2004-09-07 2007-06-13 한국전자통신연구원 The communication apparatus using the human body with the medium and method for the same
CA2578078A1 (en) 2004-09-08 2006-03-16 Alertis Medical As Sensor
GB2418144A (en) 2004-09-17 2006-03-22 Psimedica Ltd Medical device for delivery of beneficial substance
US20060065713A1 (en) * 2004-09-24 2006-03-30 John Russell Kingery System and method for monitored administration of medical products to patients
EP1812880A2 (en) 2004-09-30 2007-08-01 Koninklijke Philips Electronics N.V. System for automatic continuous and reliable patient identification for association of wireless medical devices to patients
US7341560B2 (en) 2004-10-05 2008-03-11 Rader, Fishman & Grauer Pllc Apparatuses and methods for non-invasively monitoring blood parameters
US20060078765A1 (en) * 2004-10-12 2006-04-13 Laixia Yang Nano-structured ion-conducting inorganic membranes for fuel cell applications
US7917199B2 (en) 2004-11-02 2011-03-29 Medtronic, Inc. Patient event marking in combination with physiological signals
WO2006050524A1 (en) 2004-11-02 2006-05-11 Medtronic, Inc. Techniques for data retention upon detection of an event in an implantable medical device
IL171772A (en) 2004-11-04 2009-11-18 Given Imaging Ltd Apparatus and method for receiving device selection and combining
KR20060040500A (en) 2004-11-06 2006-05-10 삼성전자주식회사 Method and appratus for measuring bio signal
US7414534B1 (en) * 2004-11-09 2008-08-19 Pacesetter, Inc. Method and apparatus for monitoring ingestion of medications using an implantable medical device
US7930064B2 (en) 2004-11-19 2011-04-19 Parata Systems, Llc Automated drug discrimination during dispensing
US7214107B2 (en) 2004-11-22 2007-05-08 Cardiodynamics International Corporation Electrical connector apparatus and methods
US8374693B2 (en) 2004-12-03 2013-02-12 Cardiac Pacemakers, Inc. Systems and methods for timing-based communication between implantable medical devices
US7154071B2 (en) 2004-12-07 2006-12-26 Dräger Safety AG & Co. KGaA Device for transmitting an electric signal detected by contact with the skin surface
JP4234177B2 (en) 2004-12-08 2009-03-04 セイコーインスツル株式会社 Information transmission system and transmitter / receiver via human body
ATE545361T1 (en) 2004-12-13 2012-03-15 Koninkl Philips Electronics Nv MOBILE MONITORING
US20080188837A1 (en) 2004-12-14 2008-08-07 Ziv Belsky Local Delivery of Drugs or Substances Using Electronic Permeability Increase
US20060136266A1 (en) 2004-12-20 2006-06-22 E-San Limited Medicinal product order processing system
JP4432766B2 (en) * 2004-12-21 2010-03-17 Jfeスチール株式会社 Electrical resistance measurement method and apparatus
US7146449B2 (en) 2004-12-22 2006-12-05 International Business Machines Corporation Bluetooth association with simple power connection
US7249212B2 (en) 2004-12-22 2007-07-24 International Business Machines Corporation Bluetooth association based on docking connection
DE602005007847D1 (en) 2004-12-30 2008-08-14 Given Imaging Ltd System for localization of an in-vivo signal source
CN2748032Y (en) * 2004-12-30 2005-12-28 雪红梅 Portable multifunctional health status monitoring apparatus with multi-transmission path
US20060148254A1 (en) 2005-01-05 2006-07-06 Mclean George Y Activated iridium oxide electrodes and methods for their fabrication
JP4494985B2 (en) * 2005-01-12 2010-06-30 株式会社国際電気通信基礎技術研究所 Heart rate and respiratory information collection device
CN101107025A (en) 2005-01-17 2008-01-16 诺和诺德公司 Fluide delivery device with integrated monitoring of physiological characteristics
US20080194912A1 (en) * 2005-01-18 2008-08-14 Koninklijke Philips Electronics, N.V. Electronically Controlled Ingestible Capsule for Sampling Fluids in Alimentary Tract
US20080269664A1 (en) 2005-01-18 2008-10-30 Koninklijke Philips Electronics, N.V. System and Method For Controlling Traversal of an Igested Capsule
JP4099484B2 (en) * 2005-02-09 2008-06-11 株式会社カイザーテクノロジー Communications system.
JP4731936B2 (en) 2005-02-09 2011-07-27 本田技研工業株式会社 Rotary variable resistor
US7850645B2 (en) 2005-02-11 2010-12-14 Boston Scientific Scimed, Inc. Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power
WO2006085087A2 (en) 2005-02-11 2006-08-17 The University Court Of The University Of Glasgow Sensing device, apparatus and system, and method for operating the same
US20080275327A1 (en) * 2005-03-09 2008-11-06 Susanne Holm Faarbaek Three-Dimensional Adhesive Device Having a Microelectronic System Embedded Therein
US7504954B2 (en) 2005-03-17 2009-03-17 Spaeder Jeffrey A Radio frequency identification pharmaceutical tracking system and method
BRPI0609511A2 (en) 2005-03-21 2010-04-13 Abbott Diabetes Care Inc system including an infusion device and an analyte monitoring unit, method for integrating analyte monitoring and fluid infusion, apparatus including an analyte sensor and a fluid supply channel, and a fluid supply method and analyte monitoring
DE602006002600D1 (en) 2005-03-22 2008-10-16 Koninkl Philips Electronics Nv ADDRESSING SCHEME FOR INTELLIGENT WIRELESS SENSOR NETWORKS FOR MEDICAL USE
US20060252999A1 (en) 2005-05-03 2006-11-09 Devaul Richard W Method and system for wearable vital signs and physiology, activity, and environmental monitoring
US20060216603A1 (en) 2005-03-26 2006-09-28 Enable Ipc Lithium-ion rechargeable battery based on nanostructures
US20060224326A1 (en) 2005-03-31 2006-10-05 St Ores John W Integrated data collection and analysis for clinical study
GB0506925D0 (en) * 2005-04-06 2005-05-11 Zarlink Semiconductor Ab Ultra low power wake-up solution for implantable RF telemetry devices
EP1893282A1 (en) 2005-04-07 2008-03-05 St. Jude Medical AB System and method for radio communication between an implantable medical device and an external base unit
JP2006312010A (en) * 2005-04-08 2006-11-16 Hitachi Ltd Controller of sensor node, and measuring method for biometric information and program
EP3539463A1 (en) * 2005-04-14 2019-09-18 Hidalgo Limited Apparatus and system for monitoring
US7595697B2 (en) * 2005-04-15 2009-09-29 Ivy Biomedical Systems, Inc. Wireless transmitter
US7270633B1 (en) 2005-04-22 2007-09-18 Cardiac Pacemakers, Inc. Ambulatory repeater for use in automated patient care and method thereof
US20060247505A1 (en) 2005-04-28 2006-11-02 Siddiqui Waqaas A Wireless sensor system
SI1889198T1 (en) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Pharma-informatics system
AU2006244085B2 (en) 2005-05-10 2012-12-13 Carefusion 303, Inc. Medication safety system featuring a multiplexed RFID interrogator panel
US7359674B2 (en) 2005-05-10 2008-04-15 Nokia Corporation Content distribution & communication system for enhancing service distribution in short range radio environment
US20060255064A1 (en) * 2005-05-10 2006-11-16 Par Technologies, Llc Fluid container with integrated valve
US20070222556A1 (en) 2005-05-17 2007-09-27 Robbins Gene A Tracking system for distributable objects which are marked in single laser shot events with dynamically variable images
ATE526952T1 (en) 2005-05-20 2011-10-15 Dow Global Technologies Llc MONITORING CORRECT DELIVERY OF ORAL DRUGS USING RADIO FREQUENCY IDENTIFICATION LABELS
US8285205B2 (en) 2005-05-26 2012-10-09 Broadcom Corporation Method and system for a single chip integrated Bluetooth and FM transceiver and baseband processor
US7387607B2 (en) 2005-06-06 2008-06-17 Intel Corporation Wireless medical sensor system
US20060277097A1 (en) 2005-06-06 2006-12-07 Event Doctors, Llc Digital marketing and fulfillment system
KR100695152B1 (en) 2005-06-07 2007-03-14 삼성전자주식회사 electrode for measuring electrocardiogram and device for measuring electrocardiogram comprising the same
EP1904173B8 (en) * 2005-06-09 2016-06-08 Medtronic, Inc. Implantable medical device with electrodes on multiple housing surfaces
US20060282001A1 (en) 2005-06-09 2006-12-14 Michel Noel Physiologic sensor apparatus
WO2006130988A1 (en) 2005-06-10 2006-12-14 Telecommunications Research Laboratories Wireless communication system
ITTO20050407A1 (en) 2005-06-13 2006-12-14 Ist Superiore Mario Boella REMOTE MONITORING SYSTEM FOR PHYSIOLOGICAL PARAMETERS OF AN INDIVIDUAL, PROCEDURE AND IT PRODUCT
US7616111B2 (en) 2005-06-20 2009-11-10 Carestream Health, Inc. System to monitor the ingestion of medicines
US7782189B2 (en) * 2005-06-20 2010-08-24 Carestream Health, Inc. System to monitor the ingestion of medicines
US7299034B2 (en) 2005-06-21 2007-11-20 Lawrence Kates System and method for wearable electronics
WO2007002697A2 (en) 2005-06-28 2007-01-04 Mayo Foundation For Medical Education And Research System for monitoring a physical parameter of a subject
FI20055366A0 (en) 2005-06-30 2005-06-30 Gen Electric An electrode for obtaining a biopotential signal
US20070016089A1 (en) 2005-07-15 2007-01-18 Fischell David R Implantable device for vital signs monitoring
JP5341513B2 (en) 2005-07-20 2013-11-13 ニール・アール.・イウリアーノ Medication compliance system and related methods
EP1909765A1 (en) 2005-07-22 2008-04-16 Dow Gloval Technologies Inc. Oral drug compliance monitoring using sound detection
CN100471445C (en) 2005-08-01 2009-03-25 周常安 Paster style physiological monitoring device, system and network
WO2007021496A2 (en) 2005-08-18 2007-02-22 Walker Digital, Llc Systems and methods for improved health care compliance
WO2007023477A2 (en) 2005-08-22 2007-03-01 University Of Limerick A tracking system
US8116809B2 (en) * 2005-08-29 2012-02-14 Intel Corporation Method and apparatus of multiple entity wireless communication adapter
US8827904B2 (en) 2005-08-31 2014-09-09 Medtronic, Inc. Automatic parameter status on an implantable medical device system
WO2007028035A2 (en) 2005-09-01 2007-03-08 Proteus Biomedical, Inc. Implantable zero-wire communications system
JP2007068622A (en) 2005-09-05 2007-03-22 Olympus Corp Acquisition system for biological information of subject
JP2009507617A (en) 2005-09-14 2009-02-26 ネオガイド システムズ, インコーポレイテッド Method and apparatus for performing transluminal and other operations
US20070196456A1 (en) 2005-09-15 2007-08-23 Visible Assets, Inc. Smart patch
US7673679B2 (en) * 2005-09-19 2010-03-09 Schlumberger Technology Corporation Protective barriers for small devices
US20080058614A1 (en) 2005-09-20 2008-03-06 Triage Wireless, Inc. Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic
GB0519836D0 (en) 2005-09-29 2005-11-09 Smartlife Technology Ltd Contact sensors
GB0519837D0 (en) 2005-09-29 2005-11-09 Smartlife Technology Ltd Knitting techniques
GB0519945D0 (en) 2005-09-30 2005-11-09 Cambridge Silicon Radio Ltd Communication in dual protocol environments
US20070078324A1 (en) 2005-09-30 2007-04-05 Textronics, Inc. Physiological Monitoring Wearable Having Three Electrodes
CN100466966C (en) 2005-10-08 2009-03-11 周常安 Physiological signal extracting and monitoring device and system
US7733224B2 (en) 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US9154616B2 (en) 2005-10-18 2015-10-06 Oia Intellectuals, Inc. Wearable capture and communication
US7720036B2 (en) 2005-10-26 2010-05-18 Intel Corporation Communication within a wireless network using multiple frequency bands
US7499739B2 (en) 2005-10-27 2009-03-03 Smiths Medical Pm, Inc. Single use pulse oximeter
US8515348B2 (en) 2005-10-28 2013-08-20 Electro Industries/Gauge Tech Bluetooth-enable intelligent electronic device
GB0523447D0 (en) 2005-11-17 2005-12-28 E San Ltd System and method for communicating environmentally-based medical support advice
EP1956973B1 (en) 2005-11-30 2017-09-13 Koninklijke Philips N.V. Electro-mechanical connector for thin medical monitoring patch
US8016776B2 (en) 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
CN1991868B (en) 2005-12-02 2013-02-06 株式会社半导体能源研究所 Semiconductor device
US8295932B2 (en) 2005-12-05 2012-10-23 Metacure Limited Ingestible capsule for appetite regulation
WO2007075477A2 (en) 2005-12-19 2007-07-05 University Of Florida Closed-loop state-dependent seizure prevention systems
CN1985752A (en) 2005-12-19 2007-06-27 周常安 Distributed physiological signal monitor
US8725243B2 (en) * 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20070156016A1 (en) 2005-12-29 2007-07-05 Ido Betesh Method and system for communication with an ingestible imaging device
US7678043B2 (en) * 2005-12-29 2010-03-16 Given Imaging, Ltd. Device, system and method for in-vivo sensing of a body lumen
TWI306023B (en) * 2005-12-30 2009-02-11 Ind Tech Res Inst Monitoring apparatus for physical movements of a body organ and method for acouiring the same
US8301254B2 (en) 2006-01-09 2012-10-30 Greatbatch Ltd. Cross-band communications in an implantable device
US20070162089A1 (en) 2006-01-09 2007-07-12 Transoma Medical, Inc. Cross-band communications in an implantable device
US8078278B2 (en) 2006-01-10 2011-12-13 Remon Medical Technologies Ltd. Body attachable unit in wireless communication with implantable devices
JP5306824B2 (en) * 2006-01-11 2013-10-02 クゥアルコム・インコーポレイテッド Method and apparatus related to timing and / or synchronization including use of wireless terminal beacon signals
CN100571239C (en) 2006-01-16 2009-12-16 华为技术有限公司 Synchronizing pilot sequence generation system and method in the communication system
JP2009523525A (en) 2006-01-23 2009-06-25 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Improved biomedical electrode for extended patient wear featuring taps or snaps isolated from the holding seal
US7606622B2 (en) 2006-01-24 2009-10-20 Cardiac Pacemakers, Inc. Method and device for detecting and treating depression
US20070185393A1 (en) 2006-02-03 2007-08-09 Triage Wireless, Inc. System for measuring vital signs using an optical module featuring a green light source
WO2007092543A2 (en) 2006-02-06 2007-08-16 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive cardiac monitor and methods of using continuously recorded cardiac data
US7809399B2 (en) 2006-02-10 2010-10-05 Syntek International Holding Ltd. Method and device for providing multiple communication protocols with a single transceiver
US20090023391A1 (en) 2006-02-24 2009-01-22 Koninklijke Philips Electronics N. V. Wireless body sensor network
WO2007101141A2 (en) 2006-02-24 2007-09-07 Hmicro, Inc. A medical signal processing system with distributed wireless sensors
US8200320B2 (en) 2006-03-03 2012-06-12 PhysioWave, Inc. Integrated physiologic monitoring systems and methods
US8457798B2 (en) 2006-03-14 2013-06-04 Jamie Hackett Long-range radio frequency receiver-controller module and wireless control system comprising same
US8920343B2 (en) 2006-03-23 2014-12-30 Michael Edward Sabatino Apparatus for acquiring and processing of physiological auditory signals
CA2645903A1 (en) 2006-03-30 2007-10-11 Dow Global Technologies Inc. Method and system for monitoring and analyzing compliance with internal dosing regimen
TW200738212A (en) 2006-04-12 2007-10-16 Guo Terry Bo Jau Miniature wireless apparatus for collecting physiological signals of animals
JP2009535103A (en) 2006-04-25 2009-10-01 ダウ グローバル テクノロジーズ インコーポレイティド Compliance monitoring of oral drugs using magnetic field sensors
US7912537B2 (en) 2006-04-27 2011-03-22 Medtronic, Inc. Telemetry-synchronized physiological monitoring and therapy delivery systems
US20070255125A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems
CN101496042A (en) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 Patient customized therapeutic regimens
GB0608829D0 (en) 2006-05-04 2006-06-14 Husheer Shamus L G In-situ measurement of physical parameters
WO2007128165A1 (en) 2006-05-09 2007-11-15 Fangen Xiong A short-range wireless networks system and erection method which allot time slots with multi-channel rf transceiver
US7558622B2 (en) 2006-05-24 2009-07-07 Bao Tran Mesh network stroke monitoring appliance
US8384525B2 (en) 2006-05-15 2013-02-26 Nokia Corporation Contactless programming and testing of memory elements
US7539533B2 (en) 2006-05-16 2009-05-26 Bao Tran Mesh network monitoring appliance
US20080119716A1 (en) 2006-05-17 2008-05-22 Olga Boric-Lubecke Determining presence and/or physiological motion of one or more subjects with quadrature doppler radar receiver systems
CN101073494B (en) 2006-05-18 2010-09-08 周常安 Non-invasive life evidence monitor, monitor system and method
EP2029194A2 (en) 2006-05-19 2009-03-04 CVRX, Inc. Characterization and modulation of physiologic response using baroreflex activation in conjunction with drug therapy
US20070279217A1 (en) 2006-06-01 2007-12-06 H-Micro, Inc. Integrated mobile healthcare system for cardiac care
EP2020919B1 (en) 2006-06-01 2019-07-31 ResMed Sensor Technologies Limited Apparatus, system, and method for monitoring physiological signs
FI120482B (en) 2006-06-08 2009-11-13 Suunto Oy Anturointijärjestely
US7346380B2 (en) 2006-06-16 2008-03-18 Axelgaard Manufacturing Co., Ltd. Medical electrode
WO2008076464A2 (en) 2006-06-21 2008-06-26 Surgisense Corporation Wireless medical telemetry system and methods using radio-frequency energized biosensors
JP2009540932A (en) 2006-06-21 2009-11-26 プロテウス バイオメディカル インコーポレイテッド Implantable medical device with cathodic arc fabrication structure
US7949404B2 (en) 2006-06-26 2011-05-24 Medtronic, Inc. Communications network for distributed sensing and therapy in biomedical applications
US20080046038A1 (en) * 2006-06-26 2008-02-21 Hill Gerard J Local communications network for distributed sensing and therapy in biomedical applications
DE212007000046U1 (en) * 2006-06-28 2009-03-05 Anoto Ab Operation control and data processing in an electronic pen
JP5241714B2 (en) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス, インコーポレイテッド Smart parenteral delivery system
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080020037A1 (en) 2006-07-11 2008-01-24 Robertson Timothy L Acoustic Pharma-Informatics System
US7962174B2 (en) 2006-07-12 2011-06-14 Andrew Llc Transceiver architecture and method for wireless base-stations
US20080021521A1 (en) 2006-07-18 2008-01-24 Cardiac Pacemakers, Inc. Implantable Medical Device Communication System
DE102007020583B4 (en) 2006-07-19 2012-10-11 Erbe Elektromedizin Gmbh Electrode device with an impedance measuring device and method for producing such an electrode device
EP2051615A4 (en) 2006-08-10 2011-03-23 Given Imaging Ltd System and method for in vivo imaging
US20080097549A1 (en) 2006-09-01 2008-04-24 Colbaugh Michael E Electrode Assembly and Method of Using Same
US7756573B2 (en) 2006-09-05 2010-07-13 Cardiac Pacemakers, Inc. Implantable medical device diagnostic data acquisition and storage
EP2063785A4 (en) 2006-09-06 2011-08-31 Innurvation Inc System and method for acoustic information exchange involving an ingestible low power capsule
US8588887B2 (en) 2006-09-06 2013-11-19 Innurvation, Inc. Ingestible low power sensor device and system for communicating with same
US20090273467A1 (en) 2006-09-18 2009-11-05 Koninklijke Philips Electronics N. V. Ip based monitoring and alarming
US20080077184A1 (en) 2006-09-27 2008-03-27 Stephen Denker Intravascular Stimulation System With Wireless Power Supply
US20080077028A1 (en) 2006-09-27 2008-03-27 Biotronic Crm Patent Personal health monitoring and care system
US20080091114A1 (en) 2006-10-11 2008-04-17 Pacesetter, Inc. Techniques for Correlating Thoracic Impedance with Physiological Status
US20080091089A1 (en) 2006-10-12 2008-04-17 Kenneth Shane Guillory Single use, self-contained surface physiological monitor
WO2008066617A2 (en) 2006-10-17 2008-06-05 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US20080097917A1 (en) 2006-10-24 2008-04-24 Kent Dicks Systems and methods for wireless processing and medical device monitoring via remote command execution
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8214007B2 (en) 2006-11-01 2012-07-03 Welch Allyn, Inc. Body worn physiological sensor device having a disposable electrode module
US20080119705A1 (en) 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
US8718193B2 (en) * 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
JP5830222B2 (en) 2006-11-21 2015-12-09 メディメトリクス ペルソナリズド ドルグ デリヴェリー ベー ヴェ Ingestible electronic capsule and in vivo drug delivery or diagnostic system
GB0624085D0 (en) * 2006-12-01 2007-01-10 Oxford Biosignals Ltd Biomedical signal analysis method
GB0624081D0 (en) * 2006-12-01 2007-01-10 Oxford Biosignals Ltd Biomedical signal analysis method
US8180425B2 (en) 2006-12-05 2012-05-15 Tyco Healthcare Group Lp ECG lead wire organizer and dispenser
US20080137566A1 (en) 2006-12-06 2008-06-12 Bojko Marholev Method and System for Shared High-Power Transmit Path for a Multi-Protocol Transceiver
CN101547635B (en) 2006-12-07 2011-09-14 皇家飞利浦电子股份有限公司 Handheld, repositionable ECG detector
US20080146889A1 (en) 2006-12-13 2008-06-19 National Yang-Ming University Method of monitoring human physiological parameters and safty conditions universally
US8157730B2 (en) 2006-12-19 2012-04-17 Valencell, Inc. Physiological and environmental monitoring systems and methods
CN101606379A (en) 2007-01-10 2009-12-16 卡米洛·里科尔迪 Mobile emergency alert system
WO2008089232A1 (en) 2007-01-16 2008-07-24 Dow Global Technologies Inc. Oral drug capsule component incorporating a communication device
WO2008091683A2 (en) 2007-01-25 2008-07-31 Senior Vitals, Inc. System and method for physiological data readings, transmission and presentation
US20080183245A1 (en) 2007-01-31 2008-07-31 Van Oort Geeske Telemetry of external physiological sensor data and implantable medical device data to a central processing system
ES2930588T3 (en) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Ingestible Event Marker Systems
US20080214985A1 (en) 2007-02-02 2008-09-04 Activatek, Inc. Active transdermal medicament patch
WO2008097652A2 (en) 2007-02-08 2008-08-14 Senior Vitals, Inc. Body patch for none-invasive physiological data readings
KR101528748B1 (en) * 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US20080303638A1 (en) 2007-03-24 2008-12-11 Hap Nguyen Portable patient devices, systems, and methods for providing patient aid and preventing medical errors, for monitoring patient use of ingestible medications, and for preventing distribution of counterfeit drugs
WO2008120128A2 (en) 2007-03-30 2008-10-09 Koninklijke Philips Electronics N.V. System and method for pill communication and control
KR100895297B1 (en) 2007-04-30 2009-05-07 한국전자통신연구원 A multi channel electrode sensor apparatus for measuring a plurality of physiological signals
US20100256461A1 (en) 2007-05-01 2010-10-07 Urodynamix Technologies Ltd. Apparatus and methods for evaluating physiological conditions of tissue
GB0709248D0 (en) 2007-05-14 2007-06-20 T & Medical Ltd System for monitoring chemotherapy associated adverse drug reactions
US8412293B2 (en) 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
US8718742B2 (en) * 2007-05-24 2014-05-06 Hmicro, Inc. Integrated wireless patch for physiological monitoring
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US20080300572A1 (en) 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
US20080311852A1 (en) 2007-06-15 2008-12-18 Broadcom Corporation Multiple communication link coordination for shared data transmissions
US8060175B2 (en) 2007-06-15 2011-11-15 General Electric Company System and apparatus for collecting physiological signals from a plurality of electrodes
GB2450517A (en) 2007-06-27 2008-12-31 Smartlife Technology Ltd Electrical resistance of yarn or fabric changes with temperature
CN201076456Y (en) 2007-06-29 2008-06-25 洪金叶 Clamp style wireless transmission pulse detection device
US20090009332A1 (en) 2007-07-03 2009-01-08 Endotronix, Inc. System and method for monitoring ingested medication via rf wireless telemetry
US8340750B2 (en) 2007-07-19 2012-12-25 Medtronic, Inc. Mechanical function marker channel for cardiac monitoring and therapy control
GB0714807D0 (en) 2007-07-30 2007-09-12 Oxford Biosignals Ltd Method and apparatus for measuring breathing rate
KR101080423B1 (en) 2007-08-03 2011-11-04 삼성전자주식회사 Multi module combination type portable electronic device
KR100863064B1 (en) 2007-08-03 2008-10-13 한국전자통신연구원 Garment for measuring physiological signals and method of fabricating the same
US20090048498A1 (en) * 2007-08-17 2009-02-19 Frank Riskey System and method of monitoring an animal
US8926509B2 (en) 2007-08-24 2015-01-06 Hmicro, Inc. Wireless physiological sensor patches and systems
US20090062670A1 (en) 2007-08-30 2009-03-05 Gary James Sterling Heart monitoring body patch and system
JP5602629B2 (en) 2007-09-07 2014-10-08 フローレ,インゴ Diagnostic sensor unit
US20090069642A1 (en) 2007-09-11 2009-03-12 Aid Networks, Llc Wearable Wireless Electronic Patient Data Communications and Physiological Monitoring Device
EP3922171A1 (en) 2007-09-14 2021-12-15 Medtronic Monitoring, Inc. Adherent cardiac monitor with advanced sensing capabilities
US9411936B2 (en) 2007-09-14 2016-08-09 Medtronic Monitoring, Inc. Dynamic pairing of patients to data collection gateways
US8249686B2 (en) 2007-09-14 2012-08-21 Corventis, Inc. Adherent device for sleep disordered breathing
WO2009036334A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Adherent multi-sensor device with empathic monitoring
WO2009036313A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Adherent device with multiple physiological sensors
US20090076397A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Adherent Emergency Patient Monitor
DK2192946T3 (en) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
US20090088618A1 (en) * 2007-10-01 2009-04-02 Arneson Michael R System and Method for Manufacturing a Swallowable Sensor Device
US8134459B2 (en) 2007-10-19 2012-03-13 Smiths Medical Asd, Inc. Wireless telecommunications system adaptable for patient monitoring
US20090105567A1 (en) 2007-10-19 2009-04-23 Smiths Medical Pm, Inc. Wireless telecommunications network adaptable for patient monitoring
US8139225B2 (en) 2007-10-24 2012-03-20 Siemens Medical Solutions Usa, Inc. System for processing patient monitoring power and data signals
GB0721117D0 (en) 2007-10-26 2007-12-05 T & Medical Ltd system for assisting in drug dose optimisaion
US20090112626A1 (en) 2007-10-30 2009-04-30 Cary Talbot Remote wireless monitoring, processing, and communication of patient data
WO2009063377A1 (en) 2007-11-13 2009-05-22 Koninklijke Philips Electronics N.V. Ingestible electronic capsule
SG190590A1 (en) 2007-11-27 2013-06-28 Proteus Digital Health Inc Transbody communication systems employing communication channels
US20090157113A1 (en) 2007-12-18 2009-06-18 Ethicon Endo-Surgery, Inc. Wearable elements for implantable restriction systems
EP2241032B1 (en) 2007-12-20 2018-02-28 Koninklijke Philips N.V. Capacitive sensing and communicating
JP5091657B2 (en) 2007-12-21 2012-12-05 株式会社東芝 Wireless communication apparatus and wireless communication method
US20090171180A1 (en) 2007-12-28 2009-07-02 Trevor Pering Method and apparatus for configuring wearable sensors
US7844341B2 (en) 2008-01-15 2010-11-30 Cardiac Pacemakers, Inc. Implantable medical device with antenna
WO2009091910A1 (en) 2008-01-15 2009-07-23 Cardiac Pacemakers, Inc. Implantable medical device with wireless communications
GB2456567B (en) 2008-01-18 2010-05-05 Oxford Biosignals Ltd Novelty detection
JP5132335B2 (en) 2008-01-29 2013-01-30 富士フイルム株式会社 Capsule endoscope and capsule endoscope system
JP5156427B2 (en) 2008-02-13 2013-03-06 富士フイルム株式会社 Capsule endoscope system
US20090247836A1 (en) 2008-02-28 2009-10-01 Confidant Inc. Medical System and Method for Serving Users with a Chronic Disease or Health State
ES2840773T3 (en) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Multimode Communication Ingestible Event Markers and Systems
WO2009112972A2 (en) 2008-03-10 2009-09-17 Koninklijke Philips Electronics, N.V. Continuous outpatient ecg monitoring system
JP5495240B2 (en) 2008-03-10 2014-05-21 コーニンクレッカ フィリップス エヌ ヴェ ECG monitoring system with configurable warning limits
US20090243833A1 (en) 2008-03-31 2009-10-01 Ching Ching Huang Monitoring system and method for patient care
WO2009146082A2 (en) 2008-04-01 2009-12-03 The Research Foundation Of The State University Of New York Rfid monitoring of drug regimen compliance
US20090253960A1 (en) 2008-04-03 2009-10-08 Olympus Medical Systems Corp. Antenna unit and receiving apparatus for capsule medical apparatus
US8170515B2 (en) * 2008-05-21 2012-05-01 Medtronic, Inc. Method and apparatus for the phased detection of a signal including a frequency deviation detection phase
US20090292194A1 (en) 2008-05-23 2009-11-26 Corventis, Inc. Chiropractic Care Management Systems and Methods
US9538937B2 (en) 2008-06-18 2017-01-10 Covidien Lp System and method of evaluating a subject with an ingestible capsule
US9014778B2 (en) 2008-06-24 2015-04-21 Biosense Webster, Inc. Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
CH699071A2 (en) 2008-07-02 2010-01-15 Flakes S A A braking and / or mechanical locking.
EP2320875B1 (en) 2008-07-23 2019-07-03 I-Property Holding Corp. Secure tracking of tablets
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
KR101028584B1 (en) 2008-08-27 2011-04-12 주식회사 바이오프로테크 Tab electrode and wire leading to the same
US20100056878A1 (en) 2008-08-28 2010-03-04 Partin Dale L Indirectly coupled personal monitor for obtaining at least one physiological parameter of a subject
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US20100063841A1 (en) * 2008-09-05 2010-03-11 Vital Data Technology, Llc System and method of notifying designated entities of access to personal medical records
US20100069002A1 (en) 2008-09-16 2010-03-18 Vcan Sports, Inc. Method and apparatus for a wireless communication device utilizing bluetooth technology
WO2010057049A2 (en) 2008-11-13 2010-05-20 Proteus Biomedical, Inc. Ingestible therapy activator system and method
CN102271578B (en) 2008-12-11 2013-12-04 普罗秋斯数字健康公司 Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
US20100160742A1 (en) 2008-12-18 2010-06-24 General Electric Company Telemetry system and method
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
US8073401B2 (en) 2009-02-17 2011-12-06 Rfaxis, Inc. Multi mode radio frequency transceiver front end circuit with inter-stage matching circuit
WO2010099268A1 (en) 2009-02-25 2010-09-02 Xanthia Global Limited Wireless physiology monitor
US8452366B2 (en) 2009-03-16 2013-05-28 Covidien Lp Medical monitoring device with flexible circuitry
US8805528B2 (en) 2009-03-31 2014-08-12 Medtronic, Inc. Channel assessment and selection for wireless communication between medical devices
WO2010115194A1 (en) 2009-04-03 2010-10-07 Intrapace, Inc. Feedback systems and methods for communicating diagnostic and/or treatment signals to enhance obesity treatments
US8738118B2 (en) 2009-05-20 2014-05-27 Sotera Wireless, Inc. Cable system for generating signals for detecting motion and measuring vital signs
US8440274B2 (en) 2009-05-26 2013-05-14 Apple Inc. Electronic device moisture indicators
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
US20130030259A1 (en) 2009-12-23 2013-01-31 Delta, Dansk Elektronik, Lys Og Akustik Monitoring system
US8560040B2 (en) 2010-01-04 2013-10-15 Koninklijke Philips N.V. Shielded biomedical electrode patch
US20110166937A1 (en) 2010-01-05 2011-07-07 Searete Llc Media output with micro-impulse radar feedback of physiological response
KR101034998B1 (en) 2010-02-18 2011-05-17 대한메디칼시스템(주) Connecting structure for snap electrode and electric wire
EP3387991B1 (en) 2010-05-12 2022-06-15 Irhythm Technologies, Inc. Device features and design elements for long-term adhesion
US8301232B2 (en) 2010-06-08 2012-10-30 Alivecor, Inc. Wireless, ultrasonic personal health monitoring system
US20110301439A1 (en) 2010-06-08 2011-12-08 AliveUSA LLC Wireless, ultrasonic personal health monitoring system
US9585620B2 (en) 2010-07-27 2017-03-07 Carefusion 303, Inc. Vital-signs patch having a flexible attachment to electrodes
US20120089000A1 (en) 2010-10-08 2012-04-12 Jon Mikalson Bishay Ambulatory Electrocardiographic Monitor For Providing Ease Of Use In Women And Method Of Use
USD639437S1 (en) 2010-10-08 2011-06-07 Cardiac Science Corporation Wearable ambulatory electrocardiographic monitor
CN102753088B (en) 2011-01-18 2014-08-27 北京超思电子技术股份有限公司 Measuring apparatus
US20120197144A1 (en) 2011-01-27 2012-08-02 Koninklijke Philips Electronics N.V. Exchangeable electrode and ecg cable snap connector
GB2487758A (en) 2011-02-03 2012-08-08 Isansys Lifecare Ltd Health monitoring electrode assembly

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JP特开2004-7187A 2004.01.08
JP特开2006-177699A 2006.07.06
JP特开平10-14898A 1998.01.20
JP特表2005-532841A 2005.11.04
JP特表2005-532849A 2005.11.04

Also Published As

Publication number Publication date
AU2009330321A1 (en) 2011-07-14
JP5591298B2 (en) 2014-09-17
US20140236077A1 (en) 2014-08-21
CA2747156C (en) 2013-10-22
WO2010075115A2 (en) 2010-07-01
ES2962610T3 (en) 2024-03-20
JP2014208301A (en) 2014-11-06
EP3205265B1 (en) 2023-10-18
IL213491A (en) 2013-11-28
JP5143290B2 (en) 2013-02-13
TW201034625A (en) 2010-10-01
CN102316795A (en) 2012-01-11
EP3205265C0 (en) 2023-10-18
CA3030268C (en) 2022-05-31
HK1162903A1 (en) 2012-09-07
TW201320961A (en) 2013-06-01
EP2358271A4 (en) 2013-12-18
JP2012511969A (en) 2012-05-31
US20100312188A1 (en) 2010-12-09
TWI503101B (en) 2015-10-11
CA2792224C (en) 2019-02-26
CA2747156A1 (en) 2010-07-01
US9149577B2 (en) 2015-10-06
AU2009330321B2 (en) 2013-03-07
EP3205265A3 (en) 2018-01-24
EP2358271A2 (en) 2011-08-24
SG172165A1 (en) 2011-07-28
US20120101430A1 (en) 2012-04-26
US8114021B2 (en) 2012-02-14
EP3205265A2 (en) 2017-08-16
IL221790A (en) 2015-08-31
CN102885615A (en) 2013-01-23
IL213491A0 (en) 2011-07-31
TWI424832B (en) 2014-02-01
IL221790A0 (en) 2012-10-31
WO2010075115A3 (en) 2010-09-23
KR101146555B1 (en) 2012-05-25
CA2792224A1 (en) 2010-07-01
KR20110094147A (en) 2011-08-19
JP2013010029A (en) 2013-01-17
HK1180572A1 (en) 2013-10-25
CA3030268A1 (en) 2010-07-01
CN102885615B (en) 2016-01-20
MY159213A (en) 2016-12-30
MY172069A (en) 2019-11-13
US8545436B2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
CN102316795B (en) Body-associated receiver and method
KR101475666B1 (en) ingestible event marker systems
AU2012216694B2 (en) Body-associated receiver and method
AU2012247015B2 (en) Ingestible event marker systems

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1162903

Country of ref document: HK

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: California, USA

Applicant after: PROTEUS BIOMEDICAL, Inc.

Address before: California, USA

Applicant before: PROTEUS BIOMEDICAL, Inc.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: PROTEUS BIOMEDICAL INC. TO: PROTEUS DIGITAL HEALTH, INC.

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1162903

Country of ref document: HK

TR01 Transfer of patent right

Effective date of registration: 20210609

Address after: American Maryland

Patentee after: Otsuka pharmaceutical Co.

Address before: California, USA

Patentee before: PROTEUS BIOMEDICAL, Inc.

Effective date of registration: 20210609

Address after: Tokyo, Japan

Patentee after: OTSUKA PHARMACEUTICAL Co.,Ltd.

Address before: American Maryland

Patentee before: Otsuka pharmaceutical Co.

TR01 Transfer of patent right